Sentence,class,file
"[http://dx.doi.org/10.1097/01.blo.0000062384.79828.3b ] [PMID: 12771818 ] [6] Freeman MA, Pinskerova V. The movement of the knee studied by magnetic resonance imaging.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1097/01.blo.0000063598.67412.0d ] [PMID: 12771815 ] [7] Freeman MA, Pinskerova V. The movement of the normal tibio-femoral joint.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.jbiomech.2004.02.006 ] [PMID: 15598446 ] [8] Johal P, Williams A, Wragg P, Hunt D, Gedroyc W. Tibio-femoral movement in the living knee.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.jbiomech.2004.02.008 ] [PMID: 15598453 ] [9] Martelli S, Pinskerova V. The shapes of the tibial and femoral articular surfaces in relation to tibiofemoral movement.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1302/0301-620X.84B4.12149 ] [PMID: 12043788 ] [10] Williams A, Logan M. Understanding tibiofemoral motion.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.knee.2003.12.004 ] [PMID: 15066615 ] [11] Dennis DA, Komistek RD, Mahfouz MR, Haas BD, Stiehl JB.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1097/01.blo.0000092986.12414.b5 ] [PMID: 14646738 ] [12] Benedetti MG, Catani F, Bilotta TW, Marcacci M, Mariani E, Giannini S. Muscle activation pattern and gait biomechanics after total knee replacement.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/S0268-0033(03)00146-3 ] [PMID: 14527815 ] [13] Levinger P, Menz HB, Morrow AD, Feller JA, Bartlett JR, Bergman NR.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.arth.2012.10.018 ] [PMID: 23523504 ] [14] McClelland JA, Webster KE, Feller JA.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.knee.2007.04.003 ] [PMID: 17531493 ] [15] McClelland JA, Webster KE, Feller JA, Menz HB.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
[http://dx.doi.org/10.1016/j.knee.2010.04.005 ] [PMID: 20537900 ] [16] Milner CE.,OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1007/s00776-008-1285-8 ] [PMID: 19214698 ] [17] Wilson SA, McCann PD, Gotlin RS, Ramakrishnan HK, Wootten ME, Insall JN.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/S0883-5403(96)80023-4 ] [PMID: 8792240 ] [18] Mandeville D, Osternig LR, Lantz BA, Mohler CG, Chou LS.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
[http://dx.doi.org/10.1016/j.clinbiomech.2008.04.011 ] [PMID: 18534724 ] [19] Miller MD.,OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1080/00016470510030661 ] [PMID: 16097553 ] [21] Orishimo KF, Kremenic IJ, Deshmukh AJ, Nicholas SJ, Rodriguez JA.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1007/s11999-011-2196-0 ] [PMID: 22125248 ] [22] Kramers-de Quervain IA, Stüssi E, Müller R, Drobny T, Munzinger U, Gschwend N. Quantitative gait analysis after bilateral total knee arthroplasty with two different systems within each subject.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/S0883-5403(97)90063-2 ] [PMID: 9139099 ] [23] Ethgen O, Bruyère O, Richy F, Dardennes C, Reginster JY.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1097/01.blo.0000150130.03519.fb ] [PMID: 15685070 ] [26] Bourne RB, Chesworth B, Davis A, Mahomed N, Charron K. Comparing patient outcomes after THA and TKA: is there a difference?",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1007/s11999-009-1046-9 ] [PMID: 19760472 ] [27] Collins M, Lavigne M, Girard J, Vendittoli PA. Joint perception after hip or knee replacement surgery.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.otsr.2011.08.021 ] [PMID: 22459101 ] [28] Ganjikia S, Duval N, Yahia L, de Guise J. Three-dimensional knee analyzer validation by simple fluoroscopic study.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/S0968-0160(00)00063-6 ] [PMID: 11104914 ] [29] Hagemeister N, Yahia LH, Duval N, de Guise JA.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
[http://dx.doi.org/10.1016/S0968-0160(99)00004-6 ],OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.jbiomech.2005.05.013 ] [PMID: 15996675 ] [31] Labbe DR, Hagemeister N, Tremblay M, de Guise J.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.gaitpost.2007.11.002 ] [PMID: 18155553 ] [32] Sati M, de Guise JA, Larouche S, Drouin G. Improving in vivo  knee kinematic measurements: application to prosthetic ligament analysis.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/S0968-0160(96)00209-8 ] [33] Van de Putte M, Hagemeister N, St-Onge N, Parent G, de Guise JA.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1097/00005650-199603000-00003 ] [PMID: 8628042 ] [36] Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1186/1477-7525-1-17 ] [PMID: 12801417 ] [38] Halder A, Kutzner I, Graichen F, Heinlein B, Beier A, Bergmann G. Influence of limb alignment on mediolateral loading in total knee replacement: in vivo  measurements in five patients.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.2106/JBJS.K.00927 ] [PMID: 22637208 ] [39] Milner CE, O’Bryan ME.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"[http://dx.doi.org/10.1016/j.apmr.2008.02.034 ] [PMID: 18929025 ] [40] Judge JO, Ounpuu S, Davis RB III.",OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/c3/TOORTHJ-10-155.PMC4897418.pdf
Ott SM Osteoporosis web site: http://courses.wash- ington.edu/bonephys Accessed 20 August 2008.,Non-OADS,/arxiv_data1/oa_pdf/fa/ef/main.PMC4897555.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/f3/jjm-09-04-26505.PMC4897598.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/9b/jjm-09-04-33765.PMC4897599.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/8c/main.PMC4897662.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.10.005 1008-1275/ ©2015 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/24/8c/main.PMC4897662.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 119 e121,Non-OADS,/arxiv_data1/oa_pdf/24/8c/main.PMC4897662.pdf
Available at: http://www.aaos.org/news/aaosnow/ may14/clinical4.asp .,Non-OADS,/arxiv_data1/oa_pdf/24/8c/main.PMC4897662.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/47/main.PMC4897826.pdf
1These authors had equal contribution to the project.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.07.009 1008-1275/ ©2015 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/36/47/main.PMC4897826.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 45 e48,Non-OADS,/arxiv_data1/oa_pdf/36/47/main.PMC4897826.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/52/main.PMC4897827.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.12.005 1008-1275/ ©2015 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/14/52/main.PMC4897827.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 25 e27,Non-OADS,/arxiv_data1/oa_pdf/14/52/main.PMC4897827.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/7c/main.PMC4897828.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.08.008 1008-1275/ ©2015 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/46/7c/main.PMC4897828.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 56 e58,Non-OADS,/arxiv_data1/oa_pdf/46/7c/main.PMC4897828.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/1c/main.PMC4897829.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.12.006 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/08/1c/main.PMC4897829.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 79 e84,Non-OADS,/arxiv_data1/oa_pdf/08/1c/main.PMC4897829.pdf
Available from: http://www.who.int/violence_ injury_prevention/road_safety_status/2013/country_pro ﬁles/iran.pdf .,Non-OADS,/arxiv_data1/oa_pdf/08/1c/main.PMC4897829.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.11.016 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 63 e69,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://www.euroncap.com ; Accessed 22.09.15.,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://www.eevc.org .,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://www.nhtsa.gov/cars/rules/import/FMVSS ; Accessed 22.09.15.,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://www.eesc.europa.eu/self-and-coregulation/full.asp?id ¼18.,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://www.eevc.org ; Accessed 22.09.15.12.,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://eu.vlex.com/vid/approval-pedestrians-vulnerable-road- users-51656310 ; Accessed 22.09.15.,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://eur-lex.europa.eu/ legal-content/EN/TXT/?uri ¼celex:3A32003L0020 .,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://www.unece.org/trans/main/wp29/wp29wgs/wp29gen/wp29glob_ registry.html .,OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://www.assess-project.eu ; Accessed 22.09.15.,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
Available from: http://www.euroncap.,Non-OADS,/arxiv_data1/oa_pdf/18/b1/main.PMC4897830.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/5b/main.PMC4897832.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.07.010 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/08/5b/main.PMC4897832.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 39 e44,Non-OADS,/arxiv_data1/oa_pdf/08/5b/main.PMC4897832.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/bc/main.PMC4897834.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.001 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/db/bc/main.PMC4897834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 3 e6,Non-OADS,/arxiv_data1/oa_pdf/db/bc/main.PMC4897834.pdf
"In 2011, three major funding agencies (European Com- mission, US National Institute of Neurological Disorders and Stroke, and Canadian Institute of Health Research and its national funding partners) joined forces in research to improve the treat- ment of TBI by establishing InTBIR (International Initiative for Traumatic Brain Injury Research: http://intbir.nih.gov/ ).27InTBIR is an open community and welcomes the participation of other agencies and funding bodies.",Non-OADS,/arxiv_data1/oa_pdf/db/bc/main.PMC4897834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/81/main.PMC4897835.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.004 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/10/81/main.PMC4897835.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 11 e15,Non-OADS,/arxiv_data1/oa_pdf/10/81/main.PMC4897835.pdf
"Prediction of transcription factors and corresponding motifs The putative transcription factors of the promoter region and the corresponding motif areas were identi ﬁed using TRANSFAC® database (BIOBASE), which was available at http://www.biobase.",OADS,/arxiv_data1/oa_pdf/10/81/main.PMC4897835.pdf
"Identi ﬁcation of SNPs in the motif areas For computational identi ﬁcation, single Nucleotide Poly- morphism Database (dbSNP) ( http://www.ncbi.nlm.nih.gov/SNP/ ) was used to identify SNPs in the motif areas.",OADS,/arxiv_data1/oa_pdf/10/81/main.PMC4897835.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/4e/main.PMC4897836.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.008 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/f5/4e/main.PMC4897836.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 35 e38,Non-OADS,/arxiv_data1/oa_pdf/f5/4e/main.PMC4897836.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/17/main.PMC4897837.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.05.006 1008-1275/ ©2015 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/47/17/main.PMC4897837.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 104 e108,Non-OADS,/arxiv_data1/oa_pdf/47/17/main.PMC4897837.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/e3/main.PMC4897838.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.12.003 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/9d/e3/main.PMC4897838.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 49 e51,Non-OADS,/arxiv_data1/oa_pdf/9d/e3/main.PMC4897838.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/68/main.PMC4897839.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.005 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/7f/68/main.PMC4897839.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 28 e30,Non-OADS,/arxiv_data1/oa_pdf/7f/68/main.PMC4897839.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/86/main.PMC4897841.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.04.006 1008-1275/ ©2015 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/11/86/main.PMC4897841.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 113 e115,Non-OADS,/arxiv_data1/oa_pdf/11/86/main.PMC4897841.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/bd/main.PMC4897842.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.12.007 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/41/bd/main.PMC4897842.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 70 e74,Non-OADS,/arxiv_data1/oa_pdf/41/bd/main.PMC4897842.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/main.PMC4897843.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.10.004 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/main.PMC4897843.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 75 e78,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/main.PMC4897843.pdf
Available at: http://emedicine.medscape.com/article/435031-overview ; Accessed 11.01.15.,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/main.PMC4897843.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/ea/main.PMC4897844.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.08.005 1008-1275/ ©2015 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/43/ea/main.PMC4897844.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 97 e103,Non-OADS,/arxiv_data1/oa_pdf/43/ea/main.PMC4897844.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/90/main.PMC4897845.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.006 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/bb/90/main.PMC4897845.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 59 e62,Non-OADS,/arxiv_data1/oa_pdf/bb/90/main.PMC4897845.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/c9/main.PMC4897846.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.06.002 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/25/c9/main.PMC4897846.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 52 e53,Non-OADS,/arxiv_data1/oa_pdf/25/c9/main.PMC4897846.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/50/main.PMC4897847.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.009 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/2f/50/main.PMC4897847.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 122 e124,Non-OADS,/arxiv_data1/oa_pdf/2f/50/main.PMC4897847.pdf
The Chinese Ministry of Public Security has Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE Chinese Journal of Traumatology 19 (2016) 1 e2 http://dx.doi.org/10.1016/j.cjtee.2016.01.002 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/88/57/main.PMC4897848.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/57/main.PMC4897848.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/de/main.PMC4897849.pdf
1Those authors contributed equally to this study.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.09.007 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/8e/de/main.PMC4897849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 94 e96,Non-OADS,/arxiv_data1/oa_pdf/8e/de/main.PMC4897849.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/main.PMC4897850.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.09.008 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/main.PMC4897850.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 16 e24,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/main.PMC4897850.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/4b/main.PMC4897851.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.003 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/6d/4b/main.PMC4897851.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 7 e10,Non-OADS,/arxiv_data1/oa_pdf/6d/4b/main.PMC4897851.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/91/40/main.PMC4897852.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.07.011 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/91/40/main.PMC4897852.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 85 e93,Non-OADS,/arxiv_data1/oa_pdf/91/40/main.PMC4897852.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/6c/main.PMC4897853.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.007 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/33/6c/main.PMC4897853.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 116 e118,Non-OADS,/arxiv_data1/oa_pdf/33/6c/main.PMC4897853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/9b/main.PMC4897920.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2016.01.012 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/41/9b/main.PMC4897920.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 109 e112,Non-OADS,/arxiv_data1/oa_pdf/41/9b/main.PMC4897920.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/02/main.PMC4897927.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier .com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.09.009 1008-1275/ ©2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.,Non-OADS,/arxiv_data1/oa_pdf/05/02/main.PMC4897927.pdf
This is a n open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 31 e34,Non-OADS,/arxiv_data1/oa_pdf/05/02/main.PMC4897927.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/4e/main.PMC4897970.pdf
Peer review under responsibility of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.HOSTED BY Contents lists available at ScienceDirect Chinese Journal of Traumatology journal homepage: http://www.elsevier.com/locate/CJTEE http://dx.doi.org/10.1016/j.cjtee.2015.08.007 1008-1275/ ©2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universi ty.,Non-OADS,/arxiv_data1/oa_pdf/cf/4e/main.PMC4897970.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Journal of Traumatology 19 (2016) 54 e55,Non-OADS,/arxiv_data1/oa_pdf/cf/4e/main.PMC4897970.pdf
Link to PubMed Abstract: http://www.ncbi.nlm.nih.gov/pubmed/9084078?dopt=Abstract  16.,Non-OADS,/arxiv_data1/oa_pdf/b8/f5/main.PMC4898002.pdf
1948; 30B(2):266-79.Link to PubMed Abstract:  http://www.ncbi.nlm.nih.gov/pubmed/18861065?dopt=Abstract,Non-OADS,/arxiv_data1/oa_pdf/b8/f5/main.PMC4898002.pdf
77 –84 doi: 10.1049/htl.2015.003077 This is an open access article published by the IET under the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/),Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
"2 Forward search concept to ﬁnd peak of QRS complex aForward search region for QRS complex peak bForward search region for Q wave peak and S wave peak 78 This is an open access article published by the IET under the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/)Healthcare Technology Letters , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
77 –84 doi: 10.1049/htl.2015.003079 This is an open access article published by the IET under the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/),Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
"4 ASIC fabricated in 130-nm CMOS technology Table 1 Algorithm comparison for MIT-BIH arrhythmia database Algorithm Total beats TP FP FN FDR, % Se, % Sp, % this work 109,496 109,329 80 167 0.23 99.85 99.93 [3] 109,267 108,927 248 340 0.54 99.69 99.77 algorithm 1 [ 17] 110,050 109,548 376 341 0.65 99.69 99.66 algorithm 2 [ 17] 110,050 109,615 386 288 0.61 99.74 99.65 [18] 109,428 109,208 153 220 0.34 99.80 99.86 For algorithms 1 and 2 [ 17], FP and FN includes shifted false negative errors and shifted false positive errors, respectivelyTable 2 Disease detection performance for 290 patients in PTB diagnostic ECG database Disease Total patients TP FN FP FDR, % Se, % Sp, % BBB 15 15 0 2 0.69 100.00 99.32 hypertrophy 7 5 2 1 1.03 99.32 99.66 dysrhythmia 14 14 0 1 0.34 100.00 99.66 BBB: bundle branch block 80 This is an open access article published by the IET under the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/)Healthcare Technology Letters , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
77 –84 doi: 10.1049/htl.2015.003081 This is an open access article published by the IET under the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/),Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
"The authors have not reported these parameters for their work cEnergy is calculated based on dynamic power and leakage power as given in [ 29] 82 This is an open access article published by the IET under the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/)Healthcare Technology Letters , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
77 –84 doi: 10.1049/htl.2015.003083 This is an open access article published by the IET under the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/),Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
"Available at: http://www.physionet.org [12] Elgendi M., Jonkman M., De Boer F.: ‘Frequency bands effects on QRS detection ’.",OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
"Retrieved on April 14, 2010, http://www.ecg.",Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
"2686 –2698 84 This is an open access article published by the IET under the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/)Healthcare Technology Letters , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/bb/HTL.2015.0030.PMC4898010.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/71/b4/idr-9-079.PMC4898026.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Infection and Drug Resistance 2016:9 79–86Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  79RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S8141 6Isavuconazole in the treatment of invasive  aspergillosis and mucormycosis infections Monica A Donnelley1,2 elizabeth S Zhu1 George R Thompson 3rd3 1Department of Inpatient Pharmacy,   University of California – Davis,   Sacramento, 2Department of Clinical  Sciences, Touro University College  of Pharmacy, vallejo, 3Department  of Medicine, Division of Infectious  Diseases, University of California –  Davis, Davis, CA, USA Correspondence: George R Thompson 3rd   Department of Medicine, Division  of Infectious Diseases, University of  California – Davis, One Shields Ave,  T upper Hall, Rm 3138, Davis, CA 95616,  USA  T el +1 530 752 3545   Fax +1 530 752 8692   email grthompson@ucdavis.ed uAbstract:  We have a limited arsenal with which to treat invasive fungal infections caused  by Aspergillus  and Mucorales.",Non-OADS,/arxiv_data1/oa_pdf/71/b4/idr-9-079.PMC4898026.pdf
"Avail - able from: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials /Drugs/Anti- InfectiveDrugsAdvisoryC ommittee /UCM430748.pd f. Accessed January 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/71/b4/idr-9-079.PMC4898026.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/71/b4/idr-9-079.PMC4898026.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/b4/idr-9-079.PMC4898026.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/1e/dddt-10-1857.PMC4898027.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1857–1867Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1857Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9765 3 Resistance to anti-veGF therapy in neovascular  age-related macular degeneration: a   comprehensive review Shiqi Yang1 Jingke Zhao1 Xiaodong Sun1–3 1Department of Ophthalmology,   Shanghai General Hospital, Shanghai  Jiao Tong University School of  Medicine, 2eye Research institute  of Shanghai Jiao T ong University,   3Shanghai Key Laboratory of Fundus  Disease, Shanghai, People’s Republic  of ChinaAbstract:  As a progressive chronic disease, age-related macular degeneration (AMD) is the  leading cause of irreversible vision impairment worldwide.",Non-OADS,/arxiv_data1/oa_pdf/56/1e/dddt-10-1857.PMC4898027.pdf
"Pegaptanib became the first one to be approved by the US Food and Drug Administra - tion (FDA), which selectively binds VEGF165.14–16 The VISION study demonstrated  that pegaptanib 0.3 mg given intravitreally every 6 weeks resulted in 70% of patients  losing fewer than 15 letters of visual acuity.8 However, pegaptanib has been gradually Correspondence: Xiaodong Sun Department of Ophthalmology,  Shanghai General Hospital, Shanghai Jiao  Tong University School of Medicine,  100 Haining Road, Shanghai 200080,  People’s Republic of China Tel/fax +86 21 6324 0090 x6822 email xdsun@sjtu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Y ang et al Running head recto: Resistance to anti-VEGF therapy in neovascular AMD DOI: http://dx.doi.org/10.2147/DDDT.S97653",Non-OADS,/arxiv_data1/oa_pdf/56/1e/dddt-10-1857.PMC4898027.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/56/1e/dddt-10-1857.PMC4898027.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/56/1e/dddt-10-1857.PMC4898027.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/1e/dddt-10-1857.PMC4898027.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/99/copd-11-1179.PMC4898028.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1179–1188International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1179RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S7697 0 Action plans for COPD: strategies to manage  exacerbations and improve outcomes Leena Jalota1 vipul v Jain1,2 1Department of Internal Medicine,   Division of Pulmonary and Critical  Care Medicine, University of  California, San Francisco, 2Chronic  Lung Disease Program, UCSF-Fresno,   Community Regional Medical Center,   Fresno, CA, USAAbstract:  COPD is the third-largest killer in the world, and certainly takes a toll on the health  care system.",Non-OADS,/arxiv_data1/oa_pdf/fc/99/copd-11-1179.PMC4898028.pdf
"Asthma action plans rely on the variability in symptomatology and peak expiratory Correspondence: vipul v Jain Chronic Lung Disease Program, UCSF- Fresno, 2823 Fresno Street, Suite A,  Fresno, CA 93721, USA Tel +1 559 459 5713 Fax +1 559 459 6119 email vjain@fresno.ucsf.ed u Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Jalota and Jain Running head recto: Action plans for COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S76970",Non-OADS,/arxiv_data1/oa_pdf/fc/99/copd-11-1179.PMC4898028.pdf
"Available from:  http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis- management.htm l. Accessed April 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/fc/99/copd-11-1179.PMC4898028.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fc/99/copd-11-1179.PMC4898028.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/99/copd-11-1179.PMC4898028.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c5/cd/ijn-11-2491.PMC4898029.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2491–2504International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2491RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S10871 5 Recent insights into nanotechnology development  for detection and treatment of colorectal cancer Buddolla viswanath1 Sanghyo Kim1 Kiyoung Lee2 1Department of Bionanotechnology,   Gachon University, Gyeonggi-Do,   2Division of endocrinology and  Metabolism, Gachon University Gil  Hospital, Incheon, Republic of KoreaAbstract:  The global incidence of colorectal cancer (CRC) is 1.3 million cases.",Non-OADS,/arxiv_data1/oa_pdf/c5/cd/ijn-11-2491.PMC4898029.pdf
"Although several factors  contribute and influence the initiation and progression of the disease, the number of  potential targets continues to increase.7 This targeting potential will eventually lead to Correspondence: Kiyoung Lee Division of endocrinology and  Metabolism, Gachon University  Gil Hospital, Incheon 405-760,  Republic of Korea email kylee@gilhospital.co m  Sanghyo Kim Department of Bionanotechnology,  Gachon University, San 65, Bokjeong- Dong, Sujeong-Gu, Seongnam-Si,  Gyeonggi-Do 461-701, Republic of Korea Tel +82 31 750 8554 email samkim@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Viswanath et al Running head recto: Nanotechnology – colorectal cancer DOI: http://dx.doi.org/10.2147/IJN.S108715",Non-OADS,/arxiv_data1/oa_pdf/c5/cd/ijn-11-2491.PMC4898029.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c5/cd/ijn-11-2491.PMC4898029.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/cd/ijn-11-2491.PMC4898029.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/ac/clep-8-151.PMC4898030.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Latitude of the study place and age of the patient  are associated with incidence of mediastinitis and  microbiology in open-heart surgery: a systematic  review and meta-analysis M Abdelnoor1,2 Ø A Vengen3 O Johansen4 I Sandven2 AM Abdelnoor5 1Centre for Clinical Heart Research,   Department of Cardiology 2Oslo  Centre for Biostatistics and  Epidemiology, 3Department of  Cardiovascular Surgery, 4Department  of Cardiology, Oslo University  Hospital, Oslo, Norway; 5Department  of Experimental Pathology,   Immunology and Microbiology,   American University of Beirut, Beirut,   Lebanon Correspondence: M Abdelnoor   Centre for Clinical Heart Research,  Oslo University Hospital, Ullevaal,  Kirkeveien 166, 02770 Oslo, Norway   T el +47 995 40 888   Email michelab@online.n oObjective:  We aimed to summarize the pooled frequency of mediastinitis following open-heart  surgery caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus   (MRSA), and Gram-negative bacteria.",Non-OADS,/arxiv_data1/oa_pdf/a9/ac/clep-8-151.PMC4898030.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/a9/ac/clep-8-151.PMC4898030.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Cost-effectiveness of amlodipine compared with  valsartan in preventing stroke and myocardial  infarction among hypertensive patients in Taiwan Lung Chan1 Chen-Huan Chen2 Juey-Jen Hwang3 San-Jou Yeh4 Kou-Gi Shyu5 Ruey-Tay Lin6 Yi-Heng Li7 Larry Z Liu8 Jim Z Li9 Wen-Yi Shau10 T e-Chang Weng10 1Department of Neurology, Shuang-Ho  Hospital, School of Medicine, College  of Medicine, Taipei Medical University,   New Taipei, 2Department of Internal  Medicine, Faculty of Medicine,   National Yang-Ming University,   3Division of Cardiology, Department  of Internal Medicine, National  Taiwan University Hospital, Taipei,   4Division of Cardiology, Department  of Internal Medicine, Chang Gung  Memorial Hospital, Taoyuan, 5Division  of Cardiology, Department of  Internal Medicine, Shin Kong Wu  Ho-Su Memorial Hospital, Taipei,   6Department of Neurology, Kaohsiung  Medical University Hospital,   Kaohsiung, 7Division of Cardiology,   Department of Internal Medicine,   National Cheng Kung University  Hospital, Tainan, Taiwan; 8Pfizer Inc,   New Y ork, NY, USA; 9Pfizer Inc, San  Diego, CA ,USA; 10Pfizer Ltd., New  Taipei City, Taiwan Correspondence: Yi-Heng Li   Division of Cardiology, Department of  Internal Medicine, National Cheng Kung  University Hospital, No 138 Sheng Li  Road, Tainan 704, Taiwan   T el +866 6 235 3535   Email heng@mail.ncku.edu.t wAbstract:  Hypertension is a major risk factor for strokes and myocardial infarction (MI).",Non-OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
"Available from: http://www.pitdc.org.tw/member/%E4%   B8%AD%E8%A5%BF%E8%97%A5%E5%B8%82%E5%A0%B4/   %E8%A5%BF%E8%97%A5/%E9%AB%98%E8%A1%80%E5%   A3%93%E6%B2%BB%E7%99%82%E8%97%A5%E5%B8%82%   E5%A0%B4%E6%A6%82%E8%BF%B0-%E4%B8%8A.pd f.  Accessed January 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
Available from:  http://labeling.pfizer.com/ShowLabeling.aspx?id =562.,Non-OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
Available from: http://www.mohw.gov.,Non-OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
Available  from: http://www.mohw.gov.tw/EN/Ministry/Statistic_P .aspx?f_list_ no=474&fod_list_no =3477&doc_no =2778 7.,OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
Available from: http://www.amcp.org/WorkArea/DownloadAsset.,Non-OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
Available from: http://www.mohw.gov.tw/EN/Ministry/Statistic.,OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/4d/ijgm-9-175.PMC4898031.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/76/ijn-11-2515.PMC4898033.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2515–2529International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2515OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10191 8 Preparation, characterization, and evaluation of  antitumor effect of Brucea javanica  oil cationic  nanoemulsions Ting-ting liu1–3 li-Qiu Mu1–3 Wei Dai1–3 chuan-bang Wang1–3 Xin-Yi liu1–3 Da-Xiong Xiang1–3 1Department of Pharmacy, The second  Xiangya hospital, 2Institute of clinical  Pharmacy, central south University,   3Key laboratory for New T echnology  of chinese Medicine Preparations of  hunan Province, changsha, People’s  republic of chinaAbstract:  The purpose of this study was to prepare Brucea javanica  oil cationic nanoemulsions  (BJO-CN) with BJO as drug as well as oil phase and chitosan as cationic inducer, to explore the  practical suitability of using cationic nanoemulsions for oral delivery of mixed oil, and to test its  bioavailability and antitumor effect.",Non-OADS,/arxiv_data1/oa_pdf/89/76/ijn-11-2515.PMC4898033.pdf
"Thus, there is a need to improve the treat - ment strategy to one which can not only kill cancer but also reduce the side effects  of chemotherapy, thus improving patients’ quality of life.correspondence: Da-Xiong Xiang The second Xiangya hospital of central  south University, No 139 Middle  renmin road, changsha, hunan 410011,  People’s republic of china Tel +86 731 8529 2129 email xiangdaxiong@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Antitumor effect of Brucea javanica  oil cationic nanoemulsions DOI: http://dx.doi.org/10.2147/IJN.S101918",Non-OADS,/arxiv_data1/oa_pdf/89/76/ijn-11-2515.PMC4898033.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/89/76/ijn-11-2515.PMC4898033.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/76/ijn-11-2515.PMC4898033.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a8/a5/idr-9-087.PMC4898034.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a8/a5/idr-9-087.PMC4898034.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 87–92Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 87 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S107961Optimizing the detection of methicillin-resistant  Staphylococcus aureus with elevated vancomycin  minimum inhibitory concentrations within the  susceptible range Cameron J Phillips1–3 Nicholas A Wells4 Marianne Martinello4 Simon Smith4 Richard J Woodman5 David L Gordon2,4 1SA Pharmacy, Flinders Medical  Centre, Bedford Park, SA, Australia;   2Department of Microbiology  and Infectious Diseases, School  of Medicine, Flinders University,  Adelaide, SA, Australia;  3School of  Pharmacy and Medical Sciences,  University of South Australia,  Adelaide, SA, Australia;  4SA Pathology,   Microbiology and Infectious Diseases,  Flinders Medical Centre, Bedford Park, SA, Australia;  5Flinders Centre  for Epidemiology and Biostatistics,  School of Medicine, Flinders University, Adelaide, SA, AustraliaBackground: Determination of vancomycin minimum inhibitory concentration (MIC) can  influence the agent used to treat methicillin-resistant Staphylococcus aureus (MRSA) infec- tion.",Non-OADS,/arxiv_data1/oa_pdf/a8/a5/idr-9-087.PMC4898034.pdf
"Keywords: MIC, MRSA, sensitivity, specificity, susceptibility, vancomycin Background Vancomycin remains the antibiotic of choice for treating serious infection with  methicillin-resistant Staphylococcus aureus (MRSA) and other serious Gram-positive  infections despite its continuous use for over half a century.1,2 However, some have  called into question “how long vancomycin may remain an effective therapy”.3,4 In  recent years, there have been a number of new agents licensed by the US Food and Drug Correspondence: Cameron J Phillips SA Pharmacy, Flinders Medical Centre, 1 Flinders Drive, Bedford Park, SA 5042, AustraliaEmail Cameron.Phillips@sa.gov.au Journal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Phillips et alRunning head recto: Optimizing the detection of MRSA with elevated vancomycinDOI: http://dx.doi.org/10.2147/IDR.S107961",Non-OADS,/arxiv_data1/oa_pdf/a8/a5/idr-9-087.PMC4898034.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/a8/a5/idr-9-087.PMC4898034.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 92 Phillips et al 22.,Non-OADS,/arxiv_data1/oa_pdf/a8/a5/idr-9-087.PMC4898034.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a2/6f/copd-11-1171.PMC4898035.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1171–1178International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1171OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10361 4Determinants for changing the treatment of COPD:  a regression analysis from a clinical audit Jose luis lópez-Campos,1,2  María abad arranz,1 Carmen  Calero acuña,1,2 Fernando  romero Valero,3 ruth ayerbe  garcía,4 antonio hidalgo  Molina,3 ricardo I aguilar  Perez-grovas,4 Francisco  garcía gil,5 Francisco Casas  Maldonado,6 laura Caballero  Ballesteros,5 María sánchez  Palop,6 Dolores Pérez- T ejero,7 alejandro segado,7  Jose Calvo Bonachera,8  Bárbara hernández sierra,8  adolfo Doménech,9  Macarena arroyo Varela,9  Francisco gonzález Vargas,10  Juan J Cruz rueda10 1Unidad Médico-Quirúrgica de  enfermedades respiratorias, Instituto de  Biomedicina de sevilla (IBi s), hospital  Universitario Virgen del rocío/Universidad  de sevilla, seville, 2Centro de Investigación  Biomédica en red de enfermedades  respiratorias (CIB eres ), Instituto de salud  Carlos III, Madrid, 3hospital Universitario  Puerta del Mar, Cádiz, 4hospital Juan  ramón Jiménez, huelva, 5hospital  Universitario reina sofía, Córdoba,   6hospital Universitario san Cecilio,   granada, 7hospital Infanta Margarita, Cabra,   Córdoba, 8hospital T orrecárdenas, almería,   9hospital regional Universitario de Málaga,   10hospital Universitario Virgen de las  nieves, granada, spainIntroduction:  This study is an analysis of a pilot COPD clinical audit that evaluated adherence  to guidelines for patients with COPD in a stable disease phase during a routine visit in specialized  secondary care outpatient clinics in order to identify the variables associated with the decision  to step-up or step-down pharmacological treatment.",Non-OADS,/arxiv_data1/oa_pdf/a2/6f/copd-11-1171.PMC4898035.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a2/6f/copd-11-1171.PMC4898035.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/6f/copd-11-1171.PMC4898035.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/5f/dddt-10-1847.PMC4898036.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1847–1856Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1847Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10551 1 Indigofera oblongifolia  mitigates lead-acetate- induced kidney damage and apoptosis in a  rat model Mohamed a Dkhil1,2 Mohamed s al-Khalifa1 saleh al-Quraishy1 rafat Zrieq3 ahmed esmat abdel Moneim2 1Department of Zoology, college of  science, King saud University, riyadh,   saudi arabia; 2Department of Zoology  and entomology, Faculty of science,   helwan University, cairo, egypt;   3Department of clinical laboratory  sciences, college of applied Medical  sciences, University of hail, hail,    saudi arabiaAbstract:  This study was conducted to appraise the protective effect of Indigofera oblongifolia   leaf extract on lead acetate (PbAc)-induced nephrotoxicity in rats.",Non-OADS,/arxiv_data1/oa_pdf/56/5f/dddt-10-1847.PMC4898036.pdf
"Consistently, Pb has been found to  inhibit sulfhydryl-dependent enzymes, interfere with metals that are important for anti - oxidant enzyme activities, and/or increase the vulnerability of cells to oxidative attack  by impairing the integrity and fatty acid composition of renal cell membranes.6,7correspondence: ahmed esmat abdel  Moneim Department of Zoology and entomology,  Faculty of science, helwan University,  cairo 11795, egypt Tel +2 11 5332 2079 email aest1977@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dkhil et al Running head recto: Renal protective effects of Indigofera oblongifolia DOI: http://dx.doi.org/10.2147/DDDT.S105511",Non-OADS,/arxiv_data1/oa_pdf/56/5f/dddt-10-1847.PMC4898036.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/56/5f/dddt-10-1847.PMC4898036.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/5f/dddt-10-1847.PMC4898036.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/73/c3/dmso-9-177.PMC4898037.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/73/c3/dmso-9-177.PMC4898037.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Assessing the incremental benefit of an extended  duration lifestyle intervention for the components  of the metabolic syndrome Patrick Walden Qingmei Jiang Elizabeth A Jackson Elif A Oral Martha S Weintraub  Melvyn Rubenfire Division of Cardiovascular Medicine,   Cardiovascular Medicine at Domino’s  Farms, University of Michigan Health  System, Ann Arbor, MI, USA Correspondence: Melvyn Rubenfire   Division of Cardiovascular Medicine,  Cardiovascular Medicine at Domino’s  Farms, University of Michigan Health  System, 24 Frank Lloyd Wright Drive,  Suite A3700, Ann Arbor, MI 48016, USA   T el +1 734 998 7411   Email mrubenfi@med.umich.ed uBackground:  Lifestyle interventions targeting the components of the metabolic syndrome  (MetSyn) have been demonstrated to be a cost-effective and suitable treatment strategy for  reducing one’ s risk of developing coronary artery disease and diabetes.",Non-OADS,/arxiv_data1/oa_pdf/73/c3/dmso-9-177.PMC4898037.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/73/c3/dmso-9-177.PMC4898037.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/c3/dmso-9-177.PMC4898037.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/hiv-8-109.PMC4898038.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/50/eb/hiv-8-109.PMC4898038.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).HIV/AIDS - Research and Palliative Care 2016:8 109–117HIV/AIDS - Research and Palliative Care Dovepress submit your manuscript | www.dovepress.com Dovepress 109 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S99904Usefulness of calcaneal quantitative ultrasound  stiffness for the evaluation of bone health in HIV- 1-infected subjects: comparison with dual X-ray  absorptiometry Alessandra Fantauzzi1 Marco Floridia2 Fabrizio Ceci3 Francesco Cacciatore4 Vincenzo Vullo5 Ivano Mezzaroma1 1Department of Clinical Medicine,   Sapienza – University of Rome,   2Department of Therapeutic  Research and Medicines Evaluation,   Istituto Superiore di Sanità (ISS),  3Department of Cellular  Biotechnologies and Hematology,  Sapienza University of Rome, Rome,   4U.O.",Non-OADS,/arxiv_data1/oa_pdf/50/eb/hiv-8-109.PMC4898038.pdf
"Keywords: bone mineral density, fracture risk, calcaneal quantitative ultrasound, DXA   Introduction People living with human immunodeficiency virus type-1 (HIV -1) infection have a  life expectancy quite similar to that of uninfected population due to the extensive use of combined antiretroviral therapies (cARTs) that have contributed to modifying   Correspondence: Ivano Mezzaroma Department of Clinical Medicine, Sapienza – University of Rome, Viale dell’Università 37, 00185 Rome, ItalyTel +39 6 4997 0908Fax +39 6 4463 328Email ivano.mezzaroma@uniroma1.itJournal name: HIV/AIDS - Research and Palliative Care Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Fantauzzi et alRunning head recto: BMD in HIV -1 infectionDOI: http://dx.doi.org/10.2147/HIV .S99904",Non-OADS,/arxiv_data1/oa_pdf/50/eb/hiv-8-109.PMC4898038.pdf
"HIV/AIDS - Research and Palliative Care 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hivaids---research-and-palliative-care-journalHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open access journal focusing on advances in research in HIV , its clinical progression and management options including antiviral treatment, palliative care and public healthcare policies to control viral spread.",Non-OADS,/arxiv_data1/oa_pdf/50/eb/hiv-8-109.PMC4898038.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 117 BMD in HIV-1 infection 29.,Non-OADS,/arxiv_data1/oa_pdf/50/eb/hiv-8-109.PMC4898038.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijn-11-2481.PMC4898039.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2481–2490International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2481OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10415 2 Magnetic resonance imaging of ultrasmall  superparamagnetic iron oxide-labeled exosomes  from stem cells: a new method to obtain labeled  exosomes alice Busato1,* roberta Bonafede1,* Pietro Bontempi2 Ilaria scambi1 lorenzo schiaffino1 Donatella Benati1 Manuela Malatesta1 andrea sbarbati1 Pasquina Marzola3 raffaella Mariotti1 1Department of Neurosciences,   Biomedicine and Movement sciences,   school of Medicine, 2Department  of Biotechnology, 3Department of  computer science, University of  Verona, Verona, Italy *These authors contributed equally  to this workPurpose:  Recent findings indicate that the beneficial effects of adipose stem cells (ASCs),  reported in several neurodegenerative experimental models, could be due to their paracrine  activity mediated by the release of exosomes.",Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijn-11-2481.PMC4898039.pdf
"Among the different mesenchymal stem cells that can be isolated,  adipose stem cells (ASCs) are of great interest for potential therapeutic applications  due to easy availability, to their ability to migrate to damaged tissue, to their capability  to differentiate, and contribution in reparative processes.1–3 Moreover, it has been  recently demonstrated that in vivo administration of ASCs ameliorates the disease  condition in several neurodegenerative animal models.4–6 In particular, it has been  reported that transplantation of autologous ASCs has a therapeutic effect in experi - mental autoimmune encephalomyelitis and in murine model of familial amyotrophic correspondence: raffaella Mariotti Institute of anatomy and histology,  strada le grazie 8, 37134 Verona, Italy Tel +39 4 5802 7164 Fax +39 4 5802 7163 email raffaella.mariotti@univr.i t  Pasquina Marzola Institute of anatomy and histology,  strada le grazie 8, 37134 Verona, Italy Tel +39 4 5802 7163 Fax +39 4 5802 7614 email pasquina.marzola@univr.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Busato et al Running head recto: MRI of USPIO-labeled exosomes from stem cells DOI: http://dx.doi.org/10.2147/IJN.S104152",Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijn-11-2481.PMC4898039.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijn-11-2481.PMC4898039.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/ijn-11-2481.PMC4898039.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f5/f5/ijn-11-2531.PMC4898043.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2531–2542International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2531OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10376 0 Disinfection effects of undoped and silver-doped  ceria powders of nanometer crystallite size Dah-shyang Tsai1 Tzu-sen Yang2,3 Yu-sheng huang1 Pei-Wen Peng2,4 Keng-liang Ou3,4 1Department of chemical engineering,   National Taiwan University of science  and T echnology, 2school of Dental  T echnology, 3graduate Institute of  Biomedical Materials and Tissue  engineering, 4research center for  Biomedical Implants and Microsurgery  Devices, Taipei Medical University,   Taipei, TaiwanAbstract:  Being endowed with an ability of capturing and releasing oxygen, the ceria surface  conventionally assumes the role of catalyzing redox reactions in chemistry.",Non-OADS,/arxiv_data1/oa_pdf/f5/f5/ijn-11-2531.PMC4898043.pdf
"correspondence: Tzu-sen Yang graduate Institute of Biomedical  Materials and Tissue engineering, Taipei  Medical University, 250 Wu-hsing street,  Taipei city 110, Taiwan Tel +886 2 2736 1661 5206 email tsyang@tmu.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Tsai et al Running head recto: Disinfection effects of undoped and silver-doped ceria nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S103760",Non-OADS,/arxiv_data1/oa_pdf/f5/f5/ijn-11-2531.PMC4898043.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f5/f5/ijn-11-2531.PMC4898043.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/f5/ijn-11-2531.PMC4898043.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/13/8b/copd-11-1161.PMC4898045.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1161–1169International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1161OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9125 3Can a supported self-management program  for COPD upon hospital discharge reduce  readmissions?",Non-OADS,/arxiv_data1/oa_pdf/13/8b/copd-11-1161.PMC4898045.pdf
"Additionally, patients report that they want more information Correspondence: s singh Centre for exercise and rehabilitation  science, leicester respiratory  Biomedical Research Unit, Glenfield  hospital, University hospitals of  leicester nhs Trust, groby road,  leicester le3 9QP, UK Tel +44 116 258 3652 Fax +44 116 250 2743 email vicki.johnson@uhl-tr.nhs.u k Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Johnson-Warrington et al Running head recto: SPACE for COPD at discharge DOI: http://dx.doi.org/10.2147/COPD.S91253",Non-OADS,/arxiv_data1/oa_pdf/13/8b/copd-11-1161.PMC4898045.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/13/8b/copd-11-1161.PMC4898045.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/8b/copd-11-1161.PMC4898045.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c6/29/dddt-10-1837.PMC4898046.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1837–1846Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1837Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10224 1Nelfinavir is effective against human cervical  cancer cells in vivo: a potential treatment  modality in resource-limited settings Mitzie-ann Davis* Joe r Delaney* chandni B Patel ryan storgard Dwayne g stupack Division of Gynecologic Oncology,   Department of Reproductive  Medicine, rebecca and John U csD  Moores cancer center, la Jolla,   ca, Usa *These authors contributed equally  to this workObjective:  The standard treatment for cervical cancer in developed countries includes surgery  and chemoradiation, with standard of care lagging in developing countries.",Non-OADS,/arxiv_data1/oa_pdf/c6/29/dddt-10-1837.PMC4898046.pdf
"This problem is compounded by poverty and correspondence: Dwayne g stupack Division of Gynecologic Oncology,  Department of Reproductive Medicine,  rebecca and John UcsD Moores cancer  center, 3855 health sciences Drive,  Mc 0803, la Jolla, ca 92037-0803, Usa Tel +1 858 822 1150 Fax +1 858 822 2630 email dstupack@ucsd.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Davis et al Running head recto: Nelfinavir is effective against human cervical cancer cells in vivo DOI: http://dx.doi.org/10.2147/DDDT.S102241",Non-OADS,/arxiv_data1/oa_pdf/c6/29/dddt-10-1837.PMC4898046.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c6/29/dddt-10-1837.PMC4898046.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/29/dddt-10-1837.PMC4898046.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License.© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica Ltd Solitary sellar plasmacytoma A Soejbjerg and others The solitary sellar plasmacytoma:   a diagnostic challenge Anne Soejbjerg1, Suzan Dyve2, Steen Baerentzen3, Georg Thorsell4, Per L Poulsen5,  Jens O L Jorgensen5 and Ulla Kampmann5 1Department of Internal Medicine, Silkeborg Regional Hospital, Silkeborg, Denmark, 2Department of  Neurosurgery, 3Department of Pathology, 4Department of Hematology and 5Department of   Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, DenmarkID: 16-0031; XXX 2016 DOI: 10.1530/EDM-16-003110.1530/EDM-16-0031ID: 15-0028; March 2016 Summary Solitary sellar plasmacytomas are exceedingly rare and difficult to distinguish from other pituitary tumors.",Non-OADS,/arxiv_data1/oa_pdf/20/63/edmcr-2016-160031.PMC4898066.pdf
A Soejbjerg and others Solitary sellar plasmacytomaID: 16-0031; XXX 2016 DOI: 10.1530/EDM-16-0031 http://www.edmcasereports.com 2right temporal region.,OADS,/arxiv_data1/oa_pdf/20/63/edmcr-2016-160031.PMC4898066.pdf
A Soejbjerg and othersID: 16-0031; XXX 2016 DOI: 10.1530/EDM-16-0031 Solitary sellar plasmacytoma http://www.edmcasereports.com 3was performed 5 months later (Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/63/edmcr-2016-160031.PMC4898066.pdf
A Soejbjerg and others Solitary sellar plasmacytomaID: 16-0031; XXX 2016 DOI: 10.1530/EDM-16-0031 http://www.edmcasereports.com 4extramedullary plasmacytomas are less common than  solitary bone plasmacytomas.,Non-OADS,/arxiv_data1/oa_pdf/20/63/edmcr-2016-160031.PMC4898066.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License.© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica Ltd Treatment of prolactinoma  with aripiprazoleI C A Bakker and others Successful treatment of a prolactinoma with  the antipsychotic drug aripiprazole Ilse C A Bakker1, Chris D Schubart2 and Pierre M J Zelissen1 1Department of Internal Medicine, Section of Endocrinology, University Medical Center Utrecht,  Utrecht, The Netherlands and 2Department of Psychiatry, Tergooi Hospital, Hilversum, The NetherlandsID: 16-0028; June 2016 DOI: 10.1530/EDM-16-002810.1530/EDM-16-0028ID: 15-0028; March 2016 Summary In this report, we describe a female patient with both prolactinoma and psychotic disorder who was successfully treated  with aripiprazole, a partial dopamine 2 receptor agonist.",Non-OADS,/arxiv_data1/oa_pdf/75/2f/edmcr-2016-160028.PMC4898067.pdf
"I C A Bakker and others Treatment of prolactinoma  with aripiprazoleID: 16-0028; June 2016 DOI: 10.1530/EDM-16-0028 http://www.edmcasereports.com  2Because of the long ­ time follow ­ up of more than 10 years,  the effect of recurrent initiation and interruption of  aripiprazole on prolactin levels are well illustrated.",Non-OADS,/arxiv_data1/oa_pdf/75/2f/edmcr-2016-160028.PMC4898067.pdf
"I C A Bakker and othersID: 16-0028; June 2016 DOI: 10.1530/EDM-16-0028 Treatment of prolactinoma  with aripiprazole http://www.edmcasereports.com  3overview of the prolactin levels, medications used and  episodes of pregnancy between 2004 and 2014.",Non-OADS,/arxiv_data1/oa_pdf/75/2f/edmcr-2016-160028.PMC4898067.pdf
I C A Bakker and others Treatment of prolactinoma  with aripiprazoleID: 16-0028; June 2016 DOI: 10.1530/EDM-16-0028 http://www.edmcasereports.com  4of the anterior pituitary gland.,Non-OADS,/arxiv_data1/oa_pdf/75/2f/edmcr-2016-160028.PMC4898067.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License.© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica Ltd GNRH agonist-induced  pituitary apoplexyF Keane and others Gonadotropin-releasing hormone   agonist-induced pituitary apoplexy Fergus Keane1, Aoife M Egan1,3, Patrick Navin2, Francesca Brett4 and   Michael C Dennedy1,3 1Department of Endocrinology, 2Department of Radiology, University Hospital Galway, Newcastle,  Galway, Ireland, 3School of Medicine, National University of Ireland Galway, Newcastle, Galway,   Ireland and 4Department of Pathology, Beaumont Hospital, Beaumont Road, Dublin 9, IrelandID: 16-0021; June 2016 DOI: 10.1530/EDM-16-002110.1530/EDM-16-0021ID: 15-0028; March 2016 Correspondence   should be addressed   to A Egan   Email   aoife.egan@gmail.com Summary Pituitary apoplexy represents an uncommon endocrine emergency with potentially life-threatening consequences.",Non-OADS,/arxiv_data1/oa_pdf/29/96/edmcr-2016-160021.PMC4898068.pdf
"F Keane and others GNRH agonist-induced  pituitary apoplexyID: 16-0021; June 2016 DOI: 10.1530/EDM-16-0021 http://www.edmcasereports.com  2Usually, apoplexy occurs in patients without a known  diagnosis of a pituitary adenoma but may also occur in patients who have known functioning or non-functioning tumour ( 1 ).",Non-OADS,/arxiv_data1/oa_pdf/29/96/edmcr-2016-160021.PMC4898068.pdf
"F Keane and othersID: 16-0021; June 2016 DOI: 10.1530/EDM-16-0021 GNRH agonist-induced  pituitary apoplexy http://www.edmcasereports.com  3the neurosurgical team, it was decided that on the basis  of severe visual compromise, debulking of the pituitary adenoma by endoscopic transphenoidal hypophysectomy was indicated.",Non-OADS,/arxiv_data1/oa_pdf/29/96/edmcr-2016-160021.PMC4898068.pdf
"F Keane and others GNRH agonist-induced  pituitary apoplexyID: 16-0021; June 2016 DOI: 10.1530/EDM-16-0021 http://www.edmcasereports.com 4also occurred in non-functioning gonadotropinomas   (2, 7, 8, 9).",Non-OADS,/arxiv_data1/oa_pdf/29/96/edmcr-2016-160021.PMC4898068.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License.© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica Ltd Antibody negative EGO A Tabasum and others Thyroid antibody-negative euthyroid   Graves’ ophthalmopathy Arshiya Tabasum1, Ishrat Khan1, Peter Taylor1,2, Gautam Das1 and   Onyebuchi E Okosieme1,2 1Department of Diabetes and Endocrinology, Prince Charles Hospital, Cwm Taf Health Board, Merthyr  Tydfil, UK and 2Thyroid Research Group, Institute of Molecular and Experimental Medicine, Cardiff  University School of Medicine, Cardiff, UKID: 16-0008; XXX 2016 DOI: 10.1530/EDM-16-000810.1530/EDM-16-0008ID: 15-0028; March 2016 Summary TSH receptor antibodies (TRAbs) are the pathological hallmark of Graves’ disease, present in nearly all patients with the  disease.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/edmcr-2016-160008.PMC4898069.pdf
A Tabasum and others Antibody negative EGOID: 16-0008; XXX 2016 DOI: 10.1530/EDM-16-0008 http://www.edmcasereports.com 2(TRAbs).,Non-OADS,/arxiv_data1/oa_pdf/07/d1/edmcr-2016-160008.PMC4898069.pdf
A Tabasum and othersID: 16-0008; XXX 2016 DOI: 10.1530/EDM-16-0008 Antibody negative EGO http://www.edmcasereports.com 3Treatment She was treated symptomatically in the regional  multidisciplinary Thyroid Eye Disease clinic with topical  lubricants and fitted with a corrective prism.,Non-OADS,/arxiv_data1/oa_pdf/07/d1/edmcr-2016-160008.PMC4898069.pdf
A Tabasum and others Antibody negative EGOID: 16-0008; XXX 2016 DOI: 10.1530/EDM-16-0008 http://www.edmcasereports.com 4The pathological explanation for negative TRAbs in our  patient is unclear.,Non-OADS,/arxiv_data1/oa_pdf/07/d1/edmcr-2016-160008.PMC4898069.pdf
"A Tabasum and othersID: 16-0008; XXX 2016 DOI: 10.1530/EDM-16-0008 Antibody negative EGO http://www.edmcasereports.com 5Funding This work did not receive any specific grant from any funding agency in  the public, commercial, or not-for-profit sector.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/edmcr-2016-160008.PMC4898069.pdf
Mayo Foundation; 2009 [updated 8 JAN 2009; cited 2009 5 APR2 009]; Available from: http://www.utdol.com/online/content/topic.do?topicKey=gen_pedi/18246&selectedTitle=6~100&source=search_result.,OADS,/arxiv_data1/oa_pdf/07/95/main.PMC4898071.pdf
http://www.cachnet.org/managing_recomp3.html#Section%20XVI,Non-OADS,/arxiv_data1/oa_pdf/56/a9/main.PMC4898072.pdf
"(2007) Available at: http://www.emedicine.com/emerg/topic136.htm Accessed March 15, 2008 16. de la Rocha AG, Creel RJ, Mulligan GW, Burns  CM.",Non-OADS,/arxiv_data1/oa_pdf/58/18/main.PMC4898079.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/25/copd-11-1151.PMC4898082.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1151–1160International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1151OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10480 1 Can patients with moderate to severe acute  respiratory failure from COPD be treated  safely with noninvasive mechanical ventilation  on the ward?",Non-OADS,/arxiv_data1/oa_pdf/d1/25/copd-11-1151.PMC4898082.pdf
"Furthermore, NIMV can  have a very high failure rate and a delay in ICU transfer or tracheal intubation should Correspondence: Murat Yalcinsoy Department of Pulmonary Medicine,  Inonu University Medical Faculty, Turgut  Ozal Medical Center, elazig Yolu 15 km,  Malatya 44069, Turkey Tel +90 532 569 2130 Fax +90 216 421 4110 email mrtyalcinsoy@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y alcinsoy et al Running head recto: Severe ARF treatment with NIMV on the ward DOI: http://dx.doi.org/10.2147/COPD.S104801",Non-OADS,/arxiv_data1/oa_pdf/d1/25/copd-11-1151.PMC4898082.pdf
"Available from: http://www.goldcopd.org/uploads/users/files/GOLD_ Report_2011_Feb21.pd f. Accessed October 8, 2012.",OADS,/arxiv_data1/oa_pdf/d1/25/copd-11-1151.PMC4898082.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/d1/25/copd-11-1151.PMC4898082.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/25/copd-11-1151.PMC4898082.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.,Non-OADS,/arxiv_data1/oa_pdf/06/9a/SJG-22-215.PMC4898091.pdf
Available from: http://www.ars‑grin.gov/cgi‑bin/npgs/ html/taxon.pl?90031.,Non-OADS,/arxiv_data1/oa_pdf/1a/59/SJG-22-226.PMC4898093.pdf
"E-mail: hylin@vghtpe.gov.tw Accepted 21 September 2015304 Scand J Rheumatol 2016;45:304 –311 © 2016 Informa Healthcare on license from Scandinavian Rheumatology Research Foundation This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/7d/ce/irhe-45-304.PMC4898137.pdf
"http://informahealthcare.com/amy ISSN: 1350-6129 (print), 1744-2818 (electronic) Amyloid, 2016; 23(2): 119–123 !2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/35/e7/iamy-23-119.PMC4898138.pdf
"E-mail:Chris.larsen@nephropath.com This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-com-mercial re-use, distribution, and reproduction in any medium, providedthe original work is properly cited, and is not altered, transformed, orbuilt upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/35/e7/iamy-23-119.PMC4898138.pdf
"3, 309 –315 http://dx.doi.org/10.3109/13561820.2016.1143457 © 2016 T. Hellman, I. Jensen, G. Bergström, E. Björk Brämberg.",Non-OADS,/arxiv_data1/oa_pdf/02/8d/ijic-30-309.PMC4898142.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/02/8d/ijic-30-309.PMC4898142.pdf
"Retrieved February 16, 2016, from http://www.psychiatry .org/ﬁle%20library/about-apa/organization-documents-policies/policies/position-2005-recovery-concept.pdf American Psychiatric Association.",Non-OADS,/arxiv_data1/oa_pdf/62/95/imhn-37-372.PMC4898146.pdf
"Retrieved February 12, 2016, from http://www.apna.org/i4a/pages/ index.cfm?pageID =4606 Chien, W. T., Leung, S. F., Yeung, F. K., & Wong, W. K. (2013).",Non-OADS,/arxiv_data1/oa_pdf/62/95/imhn-37-372.PMC4898146.pdf
"Re- trieved November 04, 2014, from http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml Offord, S., Lin, J., Mirski, D., & Wong, B.",Non-OADS,/arxiv_data1/oa_pdf/62/95/imhn-37-372.PMC4898146.pdf
"Retrieved March 18, 2015, from http://media.samhsa.gov/consumersurvivor/sdm/StartHere.html Townsend, W., & Glasser, N. (2003).",Non-OADS,/arxiv_data1/oa_pdf/62/95/imhn-37-372.PMC4898146.pdf
"3, 125 –129 http://dx.doi.org/10.3109/01658107.2016.1148744 © 2016 Yoshiaki Shimada and Masayuki Horiguchi.",Non-OADS,/arxiv_data1/oa_pdf/44/b3/ioph-40-03-1148744.PMC4898147.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/44/b3/ioph-40-03-1148744.PMC4898147.pdf
"ORCID Yoshiaki Shimada http://orcid.org/0000-0001-5277-7768 Masayuki Horiguchi http://orcid.org/0000-0003-2937-2169 References [1] Yen MY, Wei YH.",Non-OADS,/arxiv_data1/oa_pdf/44/b3/ioph-40-03-1148744.PMC4898147.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any me dium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/c5/a0/irab-92-312.PMC4898148.pdf
"6, 312–320http://dx.doi.org/10.3109/09553002.2016.1152414",Non-OADS,/arxiv_data1/oa_pdf/c5/a0/irab-92-312.PMC4898148.pdf
"4, 308–312http://dx.doi.org/10.3109/15563650.2016.1146740",Non-OADS,/arxiv_data1/oa_pdf/53/5c/ictx-54-308.PMC4898153.pdf
Available from: http://www.eatdrinkpolitics.com/wp-content/ uploads/AEDReportSimon2007.pdf .,Non-OADS,/arxiv_data1/oa_pdf/53/5c/ictx-54-308.PMC4898153.pdf
"Available from the Instituteof Medicine: http://www.google.com/url?sa ¼t&rct¼j&q¼&esrc¼s& source¼web&cd ¼10&ved ¼0CF4QFjAJahUKEwjs89ayktLIAhVM4mM KHUIbBjQ&url ¼http%3A%2F%2Fiom.nationalacademies.org%2F /C24% 2Fmedia%2FFiles%2FActivity%2520Files%2FNutrition%2FPotentialEffectsofCaffeine%2FCaffeine-Items%2520Submitted%2520to%2520Committee%25202.pdf&usg ¼AFQjCNF8Iu0b8nd4lpuNmXH1wSx for7Upg&bvm ¼bv.105454873,d.cGc .",Non-OADS,/arxiv_data1/oa_pdf/53/5c/ictx-54-308.PMC4898153.pdf
Available from: https://iom.nationalacademies.org/Reports/2001/Caffeine-for-the-Sustainment-of-Mental-Task-Performance-Formulations-for-Military-Operations.aspx .,Non-OADS,/arxiv_data1/oa_pdf/53/5c/ictx-54-308.PMC4898153.pdf
"4, 393 –405 http://dx.doi.org/10.1517/14728222.2016.1151002 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ce/ab/iett-20-393.PMC4898154.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/ce/ab/iett-20-393.PMC4898154.pdf
"http://informahealthcare.com/mor ISSN 1439-7595 (print), 1439-7609 (online) Mod Rheumatol, 2016; 26(4):473–480 /C2232015 Japan College of Rheumatology DOI: 10.3109/14397595.2015.1109182 ORIGINAL ARTICLE Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis Tsutomu Takeuchi1, Kazuhiko Yamamoto2, Hisashi Yamanaka3, Naoki Ishiguro4, Yoshiya Tanaka5, Katsumi Eguchi6, Akira Watanabe7, Hideki Origasa8, Mariko Kobayashi9, Toshiharu Shoji9, Osamu Togo9, Nobuyuki Miyasaka10, and Takao Koike11 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan,2Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan,3Institute of Rheumatology, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan,4Department of Orthopedic Surgery, Nagoya University Graduate School and Faculty of Medicine, Nagoya, Aichi, Japan,5The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan,6Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Nagasaki, Japan,7Research Division for Development of Anti-Infectious Agents, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan,8Division of Biostatistics and Clinical Epidemiology, The University of Toyama Graduate School of Medicine, Toyama, Japan,9UCB Pharma, Shinjuku-ku, Tokyo, Japan,10Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan, and11Sapporo Medical Center NTT EC, Sapporo, Hokkaido, Japan Abstract Objectives : To compare the efficacy and safety of certolizumab pegol (CZP) with and without loading dose (LD) in a post-hoc analysis of two Japanese clinical studies.",Non-OADS,/arxiv_data1/oa_pdf/d1/47/imor-26-473.PMC4898155.pdf
Available from: http://www.cimzia.com/assets/pdf/MedicationGuide.pdf [lastaccessed 21 Jul 2015].,Non-OADS,/arxiv_data1/oa_pdf/d1/47/imor-26-473.PMC4898155.pdf
Available from: http://www.remicade.com/shared/product/remicade/prescribing-information.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d1/47/imor-26-473.PMC4898155.pdf
"8, 1043 –1053 http://dx.doi.org/10.1080/14656566.2016.1174692 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d0/7f/ieop-17-1043.PMC4898156.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/d0/7f/ieop-17-1043.PMC4898156.pdf
Available at: http://psychiatryonline.org/pb/assets/raw/site wide/practice_guidelines/guidelines/schizophrenia.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/ieop-17-1043.PMC4898156.pdf
Available at: https://www.nice.org.uk/guidance/cg178 9.,Non-OADS,/arxiv_data1/oa_pdf/d0/7f/ieop-17-1043.PMC4898156.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution- NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu tion, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/cd/2c/imte-38-504.PMC4898157.pdf
"5, 504–509 http://dx.doi.org/10.3109/0142159X.2016.1150990",Non-OADS,/arxiv_data1/oa_pdf/cd/2c/imte-38-504.PMC4898157.pdf
"Available from: http://www.hl7.org/documentcenter/public_temp_EA65B543-1C23-BA17-0C3C6ACD0D1FFF9D/pressrelea ses/HL7_PRESS_20141204.pdf Published December 4, 2014.",Non-OADS,/arxiv_data1/oa_pdf/cd/2c/imte-38-504.PMC4898157.pdf
Available from: http://www.cdc.gov/nchs/data/databriefs/db143.pdf Institute of Medicine.,OADS,/arxiv_data1/oa_pdf/cd/2c/imte-38-504.PMC4898157.pdf
Available from: http://healthit.gov/sites/default/files/ ptp13-700hhs_white.pdf Kierkegaard P. 2011.,OADS,/arxiv_data1/oa_pdf/cd/2c/imte-38-504.PMC4898157.pdf
Available from: http://www.technologyreview.com/article/400038/ melding-mind-and-machine/ .,Non-OADS,/arxiv_data1/oa_pdf/cd/2c/imte-38-504.PMC4898157.pdf
Available from: http://healthit.gov/sites/default/files/ONC10yearInteroperabilityConceptPaper.pdf?utm_source ¼ govdelivery .,OADS,/arxiv_data1/oa_pdf/cd/2c/imte-38-504.PMC4898157.pdf
"http://informahealthcare.com/mor ISSN 1439-7595 (print), 1439-7609 (online) Mod Rheumatol, 2016; 26(4):491–498 /C2232016 Japan College of Rheumatology DOI: 10.3109/14397595.2015.1123211 ORIGINAL ARTICLE Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis Masayoshi Harigai1, Naoki Ishiguro2, Shigeko Inokuma3, Tsuneyo Mimori4, Junnosuke Ryu5, Syuji Takei6, Tsutomu Takeuchi7, Yoshiya Tanaka8, Yoshinari Takasaki9, Hisashi Yamanaka10, Masahiko Watanabe11, Hiroshi Tamada11, and Takao Koike12,13 1Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan,2Graduate School & Faculty of Medicine, Nagoya University, Nagoya, Japan,3Chiba Central Medical Center, Chiba, Japan,4Kyoto University Graduate School of Medicine, Kyoto, Japan, 5Nihon University School of Medicine, Tokyo, Japan,6Faculty of Medicine, School of Health Sciences, Kagoshima University, Kagoshima, Japan, 7Keio University School of Medicine, Tokyo, Japan,8University of Occupational and Environmental Health, Fukuoka, Japan,9Juntendo University School of Medicine, Tokyo, Japan,10Tokyo Women’s Medical University, Tokyo, Japan,11Bristol-Myers K.K., Tokyo, Japan,12NTT Sapporo Medical Center Minami, Sapporo, Japan, and13Hokkaido University Graduate School of Medicine, Sapporo, Japan Abstract Objective : To perform a postmarketing surveillance study evaluating the safety and effective- ness of abatacept in Japanese patients with rheumatoid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/c3/b8/imor-26-491.PMC4898160.pdf
Please see Corrigendum (http://dx.doi.org/10.3109/14397595.2015.1173986).,Non-OADS,/arxiv_data1/oa_pdf/c3/b8/imor-26-491.PMC4898160.pdf
Available from: http://www.ryumachi-jp.com/info/guideline_abatacept.html[Japanese] [last accessed 16 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/c3/b8/imor-26-491.PMC4898160.pdf
"7, 709 /C0718, http://dx.doi.org/10.1080/13607863.2015.1063102",Non-OADS,/arxiv_data1/oa_pdf/97/1d/camh-20-709.PMC4898161.pdf
http://www.mhra.gov.uk/ Safetyinformation/DrugSafetyUpdate/CON152729 accessed16/04/14 National Care Forum.,Non-OADS,/arxiv_data1/oa_pdf/97/1d/camh-20-709.PMC4898161.pdf
"http://informahealthcare.com/amy ISSN: 1350-6129 (print), 1744-2818 (electronic) Amyloid, 2016; 23(2): 109–118 !2016 Informa UK Limited, trading as Taylor & Francis Group.",Non-OADS,/arxiv_data1/oa_pdf/c5/70/iamy-23-109.PMC4898164.pdf
"To date, over 100 suchmutations have been characterized (http://amyloidosismutations.com) [20].",Non-OADS,/arxiv_data1/oa_pdf/c5/70/iamy-23-109.PMC4898164.pdf
"http://informahealthcare.com/mor ISSN 1439-7595 (print), 1439-7609 (online) Mod Rheumatol, 2016; 26(4):507–516 !2016 Japan College of Rheumatology.",Non-OADS,/arxiv_data1/oa_pdf/cf/6d/imor-26-507.PMC4898165.pdf
"In the present study, we hypothesized that NFKBIE may play a role in regulating the expression levels of MTX pathway genes (i.e.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-com-mercial re-use, distribution, and reproduction in any medium, providedthe original work is properly cited, and is not altered, transformed, or builtupon in any way.Correspondence to: Shohei Mitani, Department of Physiology, TokyoWomen’s Medical University School of Medicine, 8-1, Kawada-cho,Shinjuku-ku, Tokyo, 162-8666, Japan.",Non-OADS,/arxiv_data1/oa_pdf/cf/6d/imor-26-507.PMC4898165.pdf
"This is an Open Access articledistributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu-tion, and reproduction in any medium, provided the original work isproperly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/51/fa/iiht-28-324.PMC4898166.pdf
"An additional sample of whole blood ( /C241.0 mL) was also collected into an Eppendorf tube (Sarstedt, S.A.,Barcelona, Spain) for serum nicotine/cotinine determinationby standard LC–MS/MS methods at Analytisch-biologischesForschungslabor GmbH (Mu ¨nchen, Germany; http://www.abf- lab.com).",Non-OADS,/arxiv_data1/oa_pdf/51/fa/iiht-28-324.PMC4898166.pdf
Available from: https://www.boe.es/diario_boe/txt.php?id=BOE-A- 2013-1337.,Non-OADS,/arxiv_data1/oa_pdf/51/fa/iiht-28-324.PMC4898166.pdf
Available from: http://www.iso.org/iso/catalogue_de- tail.htm?csnumber=28324.,Non-OADS,/arxiv_data1/oa_pdf/51/fa/iiht-28-324.PMC4898166.pdf
Available from: http://www.iso.org/iso/iso_catalogue/cat-alogue_ics/catalogue_detail_ics.htm?csnumber=28325.,Non-OADS,/arxiv_data1/oa_pdf/51/fa/iiht-28-324.PMC4898166.pdf
Available from:http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_de-tail.htm?csnumber=28323.,OADS,/arxiv_data1/oa_pdf/51/fa/iiht-28-324.PMC4898166.pdf
Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/315800/in_vivo_testing_of_genotoxicity_of_chemicals.pdf.,OADS,/arxiv_data1/oa_pdf/51/fa/iiht-28-324.PMC4898166.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/ed/jjm-09-04-35237.PMC4898167.pdf
Available from: http://s-provencher.com/pages/lcm-manual.shtml.,Non-OADS,/arxiv_data1/oa_pdf/eb/0c/main.PMC4898175.pdf
Avail-able from http://www.ankletightrope.com /  16.,Non-OADS,/arxiv_data1/oa_pdf/7b/db/main.PMC4898177.pdf
JIAS 1994; 7 (2):106-110. url: http://docs.google.com/gview?a=v&q=cache:T_sJ4uJbd70J:www.medicaljournal-ias.org/7_2/Lawrence.pdf+Tumoral+Calcinosis+in+Chronic+Renal+Failure+:+Two+Case+Reports&hl=en&gl=us Last access 9/7/09  14.,Non-OADS,/arxiv_data1/oa_pdf/05/a0/main.PMC4898181.pdf
"Image panels were created with ImageJ (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/37/2d/i1552-5783-57-7-2942.PMC4898200.pdf
Stimuli were presented using a CRT monitor ;70 cm from the observer with MATLAB and PsychToolbox (http://psychtoolbox.org).,Non-OADS,/arxiv_data1/oa_pdf/41/9a/i1534-7362-16-8-1.PMC4898202.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/f7/jjm-09-04-30763.PMC4898205.pdf
"October 22, 2009. http://emedicine.medscape.com/article/323120-overview.",Non-OADS,/arxiv_data1/oa_pdf/88/46/main.PMC4898213.pdf
Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=sotos.,Non-OADS,/arxiv_data1/oa_pdf/6a/df/main.PMC4898217.pdf
Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp .,Non-OADS,/arxiv_data1/oa_pdf/6a/df/main.PMC4898217.pdf
http://www.emedicine.com.,Non-OADS,/arxiv_data1/oa_pdf/e6/d8/main.PMC4898224.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/jpr-9-337.PMC4898257.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The relationship between pain severity and  patient-reported outcomes among patients with  chronic low back pain in Japan William Montgomery1 Jeffrey Vietri2 Jing Shi3 Kei Ogawa4 Sawako Kariyasu4 Levent Alev4 Masaya Nakamura5 1Eli Lilly Australia Pty Ltd., Sydney,   NSW, Australia; 2Health Outcomes  Practice, Kantar Health, Horsham,   PA, 3Health Outcomes Practice,   Kantar Health, Princeton, NJ, USA;   4Eli Lilly Japan K.K., Kobe, Japan;   5Department of Orthopedic Surgery,   Keio University School of Medicine,   T okyo, Japan Correspondence: Jeffrey Vietri   Health Outcomes Practice, Kantar Health,  700 Horsham Road, Horsham, PA 19044,  USA  T el +1 908 887 3535   Fax +1 609 987 5514   Email Jeffrey.vietri@kantarhealth.co mObjective:  The aim of this study was to quantify the impact of pain severity on patient-reported  outcomes among individuals diagnosed with chronic low back pain in Japan.",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/jpr-9-337.PMC4898257.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/jpr-9-337.PMC4898257.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/d9/jpr-9-337.PMC4898257.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Specific proteins of the trapezius muscle correlate  with pain intensity and sensitivity – an explorative  multivariate proteomic study of the trapezius  muscle in women with chronic widespread pain Patrik Olausson Bijar Ghafouri Nazdar Ghafouri Björn Gerdle Pain and Rehabilitation Centre,   Department of Medical and Health  Sciences, Linköping University,   Linköping, Sweden Correspondence: Patrik Olausson   Pain and Rehabilitation Centre,  Department of Medical and Health  Sciences, Linköping University, SE 581 85  Linköping, Sweden   T el +46 10 103 4155   Email patrik.olausson@liu.s eAbstract:  Chronic widespread pain (CWP) including fibromyalgia syndrome (FMS) has a  high prevalence and is associated with prominent negative consequences.",Non-OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
Effect sizes (Cohen’ s d) were calculated using  a calculator available on the internet ( http://www.uccs.,OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
The proteins were divided based on UniProt database ( http://web.expasy.or g) definition on biological process in different groups (labeled type).,OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
The proteins were divided based on UniProt database ( http://web.expasy.or g) definition on biological process in different groups (labeled type).,OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
The proteins were divided based on UniProt database ( http://web.expasy.or g) definition on biological process in different groups  (labeled type).,OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/82/jpr-9-345.PMC4898258.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a7/f0/jpr-9-319.PMC4898259.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a7/f0/jpr-9-319.PMC4898259.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 319–323Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  319 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S108500Does intrauterine tobacco exposure increase the  pain perception of newborns?",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/jpr-9-319.PMC4898259.pdf
"While the increase in sensitivity to pain caused by smoking has not been fully explained pathophysiologically, it is thought that it affects the central nervous system, especially at the level of Correspondence: Şule Yıldırım Department of Pediatrics, Faculty of Medicine, Çanakkale Onsekiz Mart University Hospital, Cumhuriyet Mahallesi, 5 Sahil Yolu, Kepez, Çanakkale, 17100 TurkeyTel +90 286 263 5950Fax +90 286 263 5956Email sule.yildirim@yahoo.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Tekin et alRunning head recto: Smoking and neonatal painDOI: http://dx.doi.org/10.2147/JPR.S108500",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/jpr-9-319.PMC4898259.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/jpr-9-319.PMC4898259.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 323 Smoking and neonatal pain  8.,Non-OADS,/arxiv_data1/oa_pdf/a7/f0/jpr-9-319.PMC4898259.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/a6/jpr-9-325.PMC4898260.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/5f/a6/jpr-9-325.PMC4898260.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain Research 2016:9 325–336Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  325ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S10004 3Progression of fibromyalgia: results from a 2-year  observational fibromyalgia and chronic pain study  in the Us edgar h adams1 Heather J McElroy2 Margarita Udall3 Elizabeth T Masters3 Rachael M Mann4 caroline P schaefer1 Joseph c cappelleri5 andrew g clair3 Markay Hopps3 shoshana R Daniel6 Philip Mease7,8 stuart l silverman9,10 Roland staud11 1covance Market access services inc,   Gaithersburg, MD, USA; 2covance  (Asia) Pte Ltd, Singapore, Singapore;   3Pfizer inc, new Y ork, nY, 4covance  Market access services inc, san  Diego, ca, 5Pfizer inc, groton, cT,   6covance Market access services  inc, conshohocken, P a, 7Division of  Rheumatology Research, Swedish  Medical center, seattle, W a,   8Department of Rheumatology,   University of Washington, Seattle,   Wa, 9Department of Medicine,    Division of Rheumatology, Cedars- sinai Medical center, los angeles,   ca, 10Department of Medicine,   University of California, Los Angeles,   ca,11Department of Medicine,   University of Florida, Gainesville, FL,   Usa Correspondence: Markay Hopps   Pfizer Inc, 235 East 42nd Street,  new Y ork, nY 10017, Usa   T el +1 212 733 0717   email Markay.Hopps@pfizer.co mBackground:  A previous fibromyalgia (FM) research reports that 20%–47% of diagnosed  patients may not meet the study definition of FM 1–2 years after diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/5f/a6/jpr-9-325.PMC4898260.pdf
"Available from: http://www.mdanderson.org/ education-and-research/departments-programs-and-labs/departments- and- divisions/symptom-research/symptom-assessment-tools/BPI_  UserGuide.pd f. Accessed July 05, 2011.",Non-OADS,/arxiv_data1/oa_pdf/5f/a6/jpr-9-325.PMC4898260.pdf
"Available from: http://www.census.gov/2010census/data/2010- census-briefs.ph p. Accessed June 26, 2012.",OADS,/arxiv_data1/oa_pdf/5f/a6/jpr-9-325.PMC4898260.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/5f/a6/jpr-9-325.PMC4898260.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/a6/jpr-9-325.PMC4898260.pdf
"Re- trieved from http://www.R-project.org Song, S., & Levi, D. M. (2010).",Non-OADS,/arxiv_data1/oa_pdf/a1/46/i1534-7362-16-6-8.PMC4898270.pdf
"fMRI data preprocessing All data were analyzed using the Analysis of Functional NeuroImages (AFNI) software package (Cox, 1996, http://afni.nimh.nih.gov/afni).",OADS,/arxiv_data1/oa_pdf/45/69/i1534-7362-16-6-14.PMC4898275.pdf
Surface reconstruc-tions of the gray and white matter boundary of individual participant hemispheres were made using the Freesurfer4 autorecon script http://surfer.nmr.,OADS,/arxiv_data1/oa_pdf/45/69/i1534-7362-16-6-14.PMC4898275.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12670430 Haxby,J.V.,Hoffman,E.A.,&Gobbini,M.I.",OADS,/arxiv_data1/oa_pdf/45/69/i1534-7362-16-6-14.PMC4898275.pdf
"NF-κB  is a transcription factor that plays an important role in the Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> Received 8 December 2015 | Accepted 7 June 2016 | Published 9 June 2016© 2016 Molecular Vision 599Zingiber officinale  attenuates retinal microvascular changes  in diabetic rats via anti-inflammatory and antiangiogenic  mechanisms Shirish Dongare,1 Suresh K. Gupta,1 Rajani Mathur,1 Rohit Saxena,2 Sandeep Mathur,3 Renu Agarwal,4 Tapas  C. Nag,5 Sushma Srivastava,1 Pankaj Kumar5 1Ocular Pharmacology Laboratory, Department of Pharmacology, Delhi Institute of Pharmaceutical Sciences and Research,  New Delhi, India; 2Dr.",Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
"Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  600development of DR via transcriptional regulation of proin - flammatory cytokines [ 14,15].",Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
"Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  601Inflammatory and angiogenic parameters:  For the estimation  of TNF-a α and VEGF, isolated retinas were homogenized in  ice cold phosphate buffer saline (PBS; pH 7.4).",Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  602RESULTS Bodyweight and blood glucose:  The mean bodyweight of the  rats in three groups was comparable at the start of the study  (p>0.05).,Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
"Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  603membrane in the DC group and a reduction in the thickness  after treatment with 6-G (Figure 5A).Immunohistochemistry:  The retinas in the DC group showed  intense expression indicating higher expression of NF-kB in  the nerve fiber layer (NFL), inner plexiform layer (IPL), and  Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  604 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  605inner nuclear layer (INL).,Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  606changes in the 6-G-treated group by reducing the polyol  accumulation.,Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
"Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  607TNF-α, NF-κB, and VEGF.",Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
"Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  608expression, microglial activation, and caspase-3 activation  in a rodent model of diabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
Molecular Vision  2016; 22:599-609 <http://www.molvis.org/molvis/v 22/599> © 2016 Molecular Vision  609experimental diabetic retinopathy.,Non-OADS,/arxiv_data1/oa_pdf/a6/8b/mv-v22-599.PMC4898299.pdf
"Predictions of the functional impact of identified coding variants were assessed by different in silico anal- ysis programs (PolyPhen2, http://genetics.bwh.harvard.edu/ pph2/ and MutationTaster, http://www.mutationtaster.org) using the GRIN1 transcript number ENST00000371561 (table e-2).",OADS,/arxiv_data1/oa_pdf/aa/62/NEUROLOGY2015694455.PMC4898312.pdf
"Variants were compared to 60,706 controls of the ExAC browser (http://exac.broadinstitute.org/).",OADS,/arxiv_data1/oa_pdf/aa/62/NEUROLOGY2015694455.PMC4898312.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/ © C Peters1 et al.",Non-OADS,/arxiv_data1/oa_pdf/77/d8/mto201616.PMC4898404.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © DJ Palmer et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/39/mtm201639.PMC4898405.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/  © H Fu et al.",Non-OADS,/arxiv_data1/oa_pdf/84/85/mtm201636.PMC4898406.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm),Non-OADS,/arxiv_data1/oa_pdf/84/85/mtm201636.PMC4898406.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7f/dc/imcrj-9-135.PMC4898409.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/dc/imcrj-9-135.PMC4898409.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Medical Case Reports Journal International Medical Case Reports Journal 2016:9 135–137Dove press submit your manuscript | www.dovepress.co m Dove press  Case Repo Rtopen access to scientific and medical research open access Full text article 135 http: //dx.doi.org/10.2147/IMCRJ.S10064 8Chronic biliary colic associated with ketamine  abuse ahmed al-Nowfal Yahya a al-abed Department of surgery, southend  University Hospital, prittlewell Chase,   Westcliff-on-sea, essex, UK Correspondence: ahmed al-Nowfal   Department of surgery, southend  University Hospital, prittlewell Chase,  Westcliff-on-sea, essex ss0 0RY, UK   tel +44 17 0243 5555   email alnowfal@gmail.co mIntroduction:  Biliary colic is a common clinical presentation, with the majority of cases being  related to gallstone disease.",Non-OADS,/arxiv_data1/oa_pdf/7f/dc/imcrj-9-135.PMC4898409.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/7f/dc/imcrj-9-135.PMC4898409.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/dc/imcrj-9-135.PMC4898409.pdf
"Available  from: http://www.globaldrugsurvey.com/facts-figures/the-global-drug- survey-2014-finding s. Accessed October 18, 2015.",OADS,/arxiv_data1/oa_pdf/7f/dc/imcrj-9-135.PMC4898409.pdf
"Available from: http://www.drugabuse.gov/publications/research- reports/hallucinogens-dissociative-drugs/what-are-effects-common- dissociative-drugs-brain-bod y. Accessed October 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7f/dc/imcrj-9-135.PMC4898409.pdf
"Available from: http://www.drugs.com/illicit/ ketamine.htm l. Accessed October 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7f/dc/imcrj-9-135.PMC4898409.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3353–3357OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3353Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10162 8acc interleukin-10 gene promoter haplotype  as a breast cancer risk factor predictor among  Jordanian females Manar Fayiz atoum Department of Medical laboratory  sciences, Faculty of allied health  sciences, The hashemite University,   Zarqa, JordanIntroduction:  Interleukin-10 (IL-10) is a multifactorial cytokine with a complex biological  role in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
"IL-10 sup - presses macrophage and proinflammatory Th17 T-cell responses by inhibiting the  inflammatory cytokines IL-6 and IL-12/23.2 IL-10 inhibits proinflammatory cytokine correspondence: Manar Fayiz atoum Department of Medical laboratory  sciences, Faculty of allied health  sciences, The hashemite University,   PO Box 330127, Zarqa, 13133, Jordan Tel +962 5 390 3333 ext 5351 Fax +962 5 382 6613 email manar@hu.edu.j o Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Atoum Running head recto: IL-10 polymorphism among Jordanian breast cancer females DOI: http://dx.doi.org/10.2147/OTT.S101628",Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK611 7.,Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
"Available from: http://www.wcrf.org/int/ cancer-facts-figures/data-specific-cancers/breast-cancer-statistic s.  Accessed November 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
"Available from: http://www.jbcp.j o. Accessed November 28,  2015.",Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
Available from: http://www.cancer.gov/ cancertopics/pdq/treatment/breast/healthprofessional/page 3.,Non-OADS,/arxiv_data1/oa_pdf/33/1c/ott-9-3353.PMC4898410.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/39/opth-10-1023.PMC4898411.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1023–1029Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1023Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10445 9 Grid laser with modified pro re nata injection of  bevacizumab and ranibizumab in macular edema  due to branch retinal vein occlusion: Mar Vel  report no 2 Raja Narayanan1 Bhavik Panchal1 Michael W stewart2 Taraprasad Das1 Jay Chhablani1 subhadra Jalali1 Mohd hasnat ali3 On behalf of MARVEL  study group 1Smt.",Non-OADS,/arxiv_data1/oa_pdf/67/39/opth-10-1023.PMC4898411.pdf
"Kanuri Santhamma Centre for  Vitreo retinal Diseases, l V Prasad eye  Institute, L V Prasad Marg, Banjara Hills,  hyderabad, Telangana, 500 034, india email narayanan@lvpei.or g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Narayanan et al Running head recto: Grid laser combined with intravitreal bevacizumab or ranibizumab DOI: http://dx.doi.org/10.2147/OPTH.S104459",Non-OADS,/arxiv_data1/oa_pdf/67/39/opth-10-1023.PMC4898411.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/67/39/opth-10-1023.PMC4898411.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/39/opth-10-1023.PMC4898411.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/63/opth-10-1007.PMC4898412.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1007–1013submit your manuscript | www.dovepress.co m Dove press  1007 http: //dx.doi.org/10.2147/OPTH.S10231 5Clinical Ophthalmology Dove press Original researChopen access to scientific and medical research Open access Full T ext article Changing indications and techniques for corneal  transplantations at a tertiary referral center in  T urkey, from 1995 to 2014 Yesim altay ayse Burcu gozde aksoy evin singar Ozdemir Firdevs Ornek Department of Ophthalmology,   ankara Training and research  hospital, ankara, T urkeyBackground:  Indications for corneal transplantation in developed and developing nations  differ according to the different spectrum of corneal disease in each country.",Non-OADS,/arxiv_data1/oa_pdf/ae/63/opth-10-1007.PMC4898412.pdf
"Studies  from USA and Canada have documented that pseudophakic bullous keratopathy  (PBK) and regraft are the leading indications for keratoplasty.3–7 Reports from Iran,  New Zealand, and Israel suggest that keratoconus is the most frequent indication for  corneal transplantation,8–11 while in India and the People’s Republic of China, postin - fectious corneal scar and traumatic corneal scar are the major indications.12–14Correspondence: Yesim altay Department of Ophthalmology, ankara  Training and research hospital,  48, Cadde no 33/31 Cukurambar,  06520 ankara, Turkey Tel +90 532 490 2298 email altayye@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Altay et al Running head recto: Indications and techniques for corneal transplantations DOI: http://dx.doi.org/10.2147/OPTH.S102315",Non-OADS,/arxiv_data1/oa_pdf/ae/63/opth-10-1007.PMC4898412.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ae/63/opth-10-1007.PMC4898412.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/63/opth-10-1007.PMC4898412.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e4/df/ijgm-9-173.PMC4898413.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e4/df/ijgm-9-173.PMC4898413.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine International Journal of General Medicine 2016:9 173Dovepress submit your manuscript | www.dovepress.com Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/e4/df/ijgm-9-173.PMC4898413.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 173 RETRACTION open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S112659Post-dural puncture headache [Retraction]Journal name: International Journal of General Medicine Article Designation: RETRACTIONY ear: 2016V olume: 9Running head verso: Dove Medical PressRunning head recto: Post-dural puncture headache [Retraction]DOI: http://dx.doi.org/10.2147/IJGM.S112659 A reader has highlighted the extensive similarities between: 1) Ahmed Ghaleb, Arjang Khorasani, and Devanand Mangar.",Non-OADS,/arxiv_data1/oa_pdf/e4/df/ijgm-9-173.PMC4898413.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/58/ott-9-3291.PMC4898414.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3291–3297OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3291Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10377 1Clinical significance of B7-H6 protein expression  in astrocytoma Jian-gui Guo1,* Cheng-cheng Guo2,* Zhen-qiang He2 Zhi-gang Liu3 Yang Wang2 Y ong-gao Mou2 1Department of Radiation Oncology,   2Department of Neurosurgery, Sun  Yat-sen University Cancer Center,   State Key Laboratory of Oncology  in south china, collaborative  Innovation Center for Cancer  Medicine, Guangzhou, People’s  Republic of China; 3Department of  radiation Oncology, Key laboratory  of Translational Radiation Oncology,   Hunan Cancer Hospital, The Affiliated  Cancer Hospital of Xiangya School of  Medicine, Central South University,   Changsha, People’s Republic of China *These authors have contributed  equally to this workAbstract:  Currently, immunotherapy by blocking the immune checkpoint inhibitors, such as  anti-PD-1, has been carried out in many clinical studies on recurrent glioma, and the preliminary  results are satisfactory, which provides a rationale for the exploration of immune checkpoint  inhibitors in glioma.",Non-OADS,/arxiv_data1/oa_pdf/5a/58/ott-9-3291.PMC4898414.pdf
"B7-H6 is Correspondence: Yong-gao Mou Department of Neurosurgery, State Key  Laboratory of Oncology in South China,  Sun Yat-sen University Cancer Center,  651 Dongfeng East Road, Guangzhou  510060, People’s Republic of China Tel +86 020 8734 3899 email mouyg@sysucc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Guo et al Running head recto: Clinical significance of B7-H6 in astrocytoma DOI: http://dx.doi.org/10.2147/OTT.S103771",Non-OADS,/arxiv_data1/oa_pdf/5a/58/ott-9-3291.PMC4898414.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5a/58/ott-9-3291.PMC4898414.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/58/ott-9-3291.PMC4898414.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/9c/tcrm-12-883.PMC4898415.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 883–886Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  883Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9821 7Herpetic esophagitis following bendamustine- containing regimen Hiromichi Yamane1 Yasumasa Monobe2 T omohiro Tanikawa3 Nobuaki ochi1 Y oshihiro Honda1 Hirofumi Kawamoto3 Nagio Takigawa1 1Department of General Internal  Medicine 4, 2Department of p athology,   3Department of General Internal  Medicine 2, Kawasaki Medical school,   Kita-ku, okayama, JapanAbstract:  A 76-year-old Japanese woman presented to our hospital with anorexia.",Non-OADS,/arxiv_data1/oa_pdf/0a/9c/tcrm-12-883.PMC4898415.pdf
"Seventeen months before presentation, she  was diagnosed with a follicular lymphoma that transformed to a diffuse large B-cell Correspondence: Hiromichi Yamane Department of General Internal  Medicine 4, Kawasaki Medical school,  2-1-80 Nakasange, okayama 700-8505,  Japan Tel +81 86 225 2111 Fax +81 86 232 8343 email hiromichi.ya@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Y amane et al Running head recto: Herpetic esophagitis due to bendamustine DOI: http://dx.doi.org/10.2147/TCRM.S98217",Non-OADS,/arxiv_data1/oa_pdf/0a/9c/tcrm-12-883.PMC4898415.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/0a/9c/tcrm-12-883.PMC4898415.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/tcrm-12-883.PMC4898415.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/ijn-11-2451.PMC4898416.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2451–2461International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2451OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10519 5 annihilation of Leishmania  by daylight responsive  ZnO nanoparticles: a temporal relationship  of reactive oxygen species-induced lipid  and protein oxidation akhtar Nadhman1–3 Malik Ihsanullah Khan1,2 samina Nazir4 Momin Khan1,5 gul shahnaz6 abida raza2 Dilawar Farhan shams7 Masoom Yasinzai1,3 1Department of Biotechnology,   Faculty of Biological sciences,   Quaid-i-azam University, 2Nuclear  Medicine Oncology and radiotherapy  Institute, 3centre for Interdisciplinary  research in Basic sciences (cIrBs),   International Islamic University,   4Nanosciences and catalysis Division,   National centre for Physics, Quaid-i- azam University campus, Islamabad,   5Department of Microbiology,   Institute of Basic Medical sciences,   Khyber Medical University, Peshawar,   6Department of Pharmacy, Faculty  of Biological sciences, Quaid-i- azam  University, Islamabad, 7Department  of environmental sciences, abdul  Wali Khan University Mardan,   Mardan, PakistanAbstract:  Lipid and protein oxidation are well-known manifestations of free radical activity  and oxidative stress.",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/ijn-11-2451.PMC4898416.pdf
"Hydroper - oxides are highly unstable and are further converted to malondialdehydes (MDAs),  hydroxynonenals (HNEs), and hydroxyhexenals in the presence of reduced metal.5  Proteins, attacked by ROS, are normally oxidized to carbonyls on the chiral carbon or correspondence: akhtar Nadhman centre for Interdisciplinary research  in Basic sciences, International Islamic  University, Islamabad 44000, Pakistan Tel +92 333 987 2990 email shamsnazman@gmail.co m Masoom Yasinzai centre for Interdisciplinary research  in Basic sciences, International Islamic  University, Islamabad 44000, Pakistan Tel +92 51 925 8067 email rector@iiu.edu.p k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Nadhman et al Running head recto: Annihilation of Leishmania  by ROS-induced lipid and protein oxidation DOI: http://dx.doi.org/10.2147/IJN.S105195",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/ijn-11-2451.PMC4898416.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/ijn-11-2451.PMC4898416.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/1b/ijn-11-2451.PMC4898416.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/c7/ott-9-3327.PMC4898417.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3327–3333OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3327Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10398 8 synthetic treatment of intracranial peripheral  primitive neuroectodermal tumor with multiple  metastasis: a case report Yang Zhang1,2 Hongsheng Li2 Zongjuan Li3 Ming Liu1,2 Linke Yang2 Liyuan Fan2 Chengsuo Huang2 Baosheng Li2 1school of Medicine and Life sciences,   Jinan University-shandong academy  of Medical sciences, 2Department of  radiation Oncology, shandong Cancer  Hospital affiliated to shandong  University, shandong academy of  Medical sciences, Jinan, shandong,   3Department of radiation Oncology,   The second Hospital of Dalian  Medical University, Dalian, Liaoning,   people’s republic of ChinaAbstract:  Ewing sarcomas (ES) and peripheral primitive neuroectodermal tumors (pPNET)  are now thought to belong to the same tumor family.",Non-OADS,/arxiv_data1/oa_pdf/5a/c7/ott-9-3327.PMC4898417.pdf
"Correspondence: Baosheng Li Department of radiation Oncology,  Shandong Cancer Hospital Affiliated  to shandong University, shandong  academy of Medical sciences, No 440,  Jiyan road, Jinan, shandong 250117,  people’s republic of China Tel +86 531 6762 6162 Fax +86 531 8798 4079 email baoshli1963@163.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Synthetic treatment of intracranial pPNET with multiple metastasis DOI: http://dx.doi.org/10.2147/OTT.S103988",Non-OADS,/arxiv_data1/oa_pdf/5a/c7/ott-9-3327.PMC4898417.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5a/c7/ott-9-3327.PMC4898417.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/c7/ott-9-3327.PMC4898417.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/7b/jbm-7-111.PMC4898418.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e2/7b/jbm-7-111.PMC4898418.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2016:7 111–119Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  111 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S103967Clinical association of baseline levels of  conjugated dienes in low-density lipoprotein   and nitric oxide with aggressive B-cell   non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio Mustapha Haddouche1,2  Warda Meziane1,2  Zeyneb Hadjidj1,2  Naima Mesli3  Mourad Aribi1,2 1Laboratory of Applied Molecular  Biology and Immunology, 2Department  of Biology, University of Tlemcen,   3Hematology Department, Tlemcen  Medical Centre University, Tlemcen,   AlgeriaObjective: The aim of this study was to highlight the clinical association of baseline lev- els of conjugated dienes in low-density lipoprotein (LDL-BCD) and nitric oxide (NO) with  immunoglobulins (Igs) and T helper (Th)1/Th2 ratio in patients with newly diagnosed B-cell  non-Hodgkin lymphoma (NHL).",Non-OADS,/arxiv_data1/oa_pdf/e2/7b/jbm-7-111.PMC4898418.pdf
"Keywords: aggressive B-cell non-Hodgkin lymphoma, LDL-BCD, NO production Introduction Non-Hodgkin lymphoma (NHL) is a nonspecific term that includes a spectrum of  lymphoproliferative malignant diseases with different clinical and histological appear - ances.1 Two clinical forms of NHL can be distinguished on the basis of their growth Correspondence: Mourad Aribi Laboratory of Applied Molecular Biology and Immunology, University of Tlemcen, Imama-Mansourah, Rocade # 2, PO Box 262, Tlemcen 13000, AlgeriaTel +213 5 5628 1751Fax +213 43 21 5534Email m_aribi@mail.univ-tlemcen.dzJournal name: Journal of Blood Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Haddouche et alRunning head recto: LDL-BCD and NO production in B-cell NHLDOI: http://dx.doi.org/10.2147/JBM.S103967",Non-OADS,/arxiv_data1/oa_pdf/e2/7b/jbm-7-111.PMC4898418.pdf
"Journal of Blood Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/e2/7b/jbm-7-111.PMC4898418.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 119 LDL-BCD and NO production in B-cell NHL,Non-OADS,/arxiv_data1/oa_pdf/e2/7b/jbm-7-111.PMC4898418.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/64/ott-9-3299.PMC4898419.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3299–3305OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3299Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10235 1sequential measurements of serum matrix  metalloproteinase 9 to monitor chemotherapy  responses in patients with advanced non-small-cell  lung cancer Xiaojuan Qiao,1–3,*  Xiaoran Zhai,1,2,*  Jinghui Wang,4  Xiaoting  Zhao,1,2  Xinjie Yang,4 Jialin lv,4  li Ma,1,2 lina Zhang,1,2  Yue Wang,1,2 shucai Zhang,4  Wentao Yue1,2 1Department of cellular and Molecular  Biology, Beijing chest hospital, capital  Medical University, 2Department of  cellular and Molecular Biology, Beijing  Tuberculosis and Thoracic Tumor  research institute, Beijing, 3health care  Ward, The First hospital affiliated to  inner Mongolia Medical University,   hohhot, 4Department of Medical  Oncology, Beijing chest hospital, capital  Medical University, Beijing, People’s  republic of china *These authors contributed equally  to this workBackground:  Matrix metalloproteinase 9 (MMP-9) plays an important role in tumor invasion  and metastasis, including lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/7e/64/ott-9-3299.PMC4898419.pdf
"Matrix metalloproteinase 9  (MMP-9), a member of the MMP family, is closely correlated with tumor cell invasion  and metastasis.2 Downregulation of MMP-9 expression by RNA interference or the use  of DNAzymes inhibits cell migration and invasion.2–5 Previous  studies have demonstrated correspondence: Wentao Yue Department of cellular and Molecular  Biology, Beijing chest hospital,  capital Medical University, 97 Beimachang,  Tongzhou, Beijing 101149, People’s  republic of china Tel +86 10 8950 9372 Fax +86 10 8050 7349 email yuewt2000@yahoo.co m  shucai Zhang Department of Medical Oncology, Beijing  chest hospital, capital Medical University,  97 Beimachang, Tongzhou, Beijing 101149,  People’s republic of china email sczhang6304@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Qiao et al Running head recto: Serum MMP-9 to monitor chemotherapy responses in NSCLC patients DOI: http://dx.doi.org/10.2147/OTT.S102351",Non-OADS,/arxiv_data1/oa_pdf/7e/64/ott-9-3299.PMC4898419.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7e/64/ott-9-3299.PMC4898419.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/64/ott-9-3299.PMC4898419.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/92/ott-9-3281.PMC4898420.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3281–3289OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3281Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8718 3Mir-502-3P suppresses cell proliferation,  migration, and invasion in hepatocellular  carcinoma by targeting SET haosheng Jin* Min Yu* Ye lin Baohua hou Zhongshi Wu Zhide li Jian sun Department of general surgery,   guangdong general hospital,   guangdong academy of Medical  sciences, guangzhou, guangdong,   People’s republic of china *These authors contributed equally  to this workBackground/aim:  Increasing evidences show that microRNAs are engaged in hepatocellular  carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/6e/92/ott-9-3281.PMC4898420.pdf
"Further analysis indicated that downexpression of miR-502-3P was associated with  postoperative recurrence and Edmonson grade.14 However, the function of miR-502-3P correspondence: Jian sun Department of general surgery,  guangdong general hospital,  guangdong academy of Medical  sciences, 106 Zhongshang er road,  guangzhou, guangdong, 51000,  People’s republic of china email sunyat1877@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jin et al Running head recto: MiR-502-3P suppresses cell proliferation, migration, and invasion in HCC DOI: http://dx.doi.org/10.2147/OTT.S87183",Non-OADS,/arxiv_data1/oa_pdf/6e/92/ott-9-3281.PMC4898420.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6e/92/ott-9-3281.PMC4898420.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/92/ott-9-3281.PMC4898420.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6a/bd/opth-10-1031.PMC4898421.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1031–1038Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1031Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10664 6 Optical bench performance of a novel trifocal  intraocular lens compared with a multifocal  intraocular lens shinwook lee Myoung Choi Zaiwei Xu Zeyu Zhao elsinore alexander Yueai liu alcon research, ltd., Fort Worth,   TX, UsaPurpose:  The purpose of this study is to compare the optical characteristics of the novel PanOptix  presbyopia-correcting trifocal intraocular lens (IOL) and the multifocal ReSTOR +3.0 D IOL,  through in vitro bench investigations.",Non-OADS,/arxiv_data1/oa_pdf/6a/bd/opth-10-1031.PMC4898421.pdf
"The ongoing need for spectacle use after surgery has, in turn, decreased Correspondence: shinwook lee alcon research, ltd.,  6201 south Freeway, Fort Worth,  TX 76134-2001, Usa Tel +1 817 615 5075 email shinwook.lee@alcon.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lee et al Running head recto: Optical bench performance of a novel trifocal IOL DOI: http://dx.doi.org/10.2147/OPTH.S106646",Non-OADS,/arxiv_data1/oa_pdf/6a/bd/opth-10-1031.PMC4898421.pdf
"Available from: https://www.osha.gov/ Publications /osha3092.pd f. Accessed August 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6a/bd/opth-10-1031.PMC4898421.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6a/bd/opth-10-1031.PMC4898421.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/bd/opth-10-1031.PMC4898421.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/74/ott-9-3313.PMC4898422.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3313–3325OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3313Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9891 0 Filtered selection coupled with support vector  machines generate a functionally relevant  prediction model for colorectal cancer Musa nur gabere1 Mohamed aly hussein1 Mohammad azhar aziz2 1Department of Bioinformatics,   King abdullah international Medical  research center/King saud bin  abdulaziz University for health  sciences, riyadh, saudi arabia;   2colorectal cancer research  Program, Department of Medical  genomics, King abdullah international  Medical research center, riyadh,   saudi arabiaPurpose:  There has been considerable interest in using whole-genome expression profiles for  the classification of colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/9f/74/ott-9-3313.PMC4898422.pdf
"In certain cancers, preventive  screening is changing the trends in reported incidence, and colorectal cancer (CRC)  management has benefited immensely from this strategy.2 In the past 10 years, the  rate of CRC-associated mortality has decreased by 20%, owing to a combination  of advances in its diagnosis and treatment.3 CRC is one of the most lethal types of  cancer and is ranked first and third among all cancer incidences in men and women  in Saudi Arabia, respectively.4correspondence: Mohammad azhar aziz colorectal cancer research Program,  Department of Medical genomics,  Ministry of national guard health affairs,  King abdullah international Medical  research center/King saud bin abdulaziz  University for health sciences, PO Box  22490, Mail code 2216, King abdul aziz  Medical city, riyadh, saudi arabia Tel +966 11 801 6030 email azizmo@ngha.med.s a Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Gabere et al Running head recto: Functionally relevant prediction model for colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S98910",Non-OADS,/arxiv_data1/oa_pdf/9f/74/ott-9-3313.PMC4898422.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9f/74/ott-9-3313.PMC4898422.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/74/ott-9-3313.PMC4898422.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/04/ijn-11-2471.PMC4898423.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2471–2480International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2471OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10568 1The spherical nanoparticle-encapsulated  chlorhexidine enhances anti-biofilm efficiency  through an effective releasing mode and close  microbial interactions Xuan li1 chi-hin Wong2 Tsz-Wing Ng2 cheng-Fei Zhang1 Ken cham-Fai leung2 lijian Jin1 1Faculty of Dentistry, The University  of Hong Kong, 2Department of  Chemistry, Institute of Creativity  and Partner State Key Laboratory of  Environmental and Biological Analysis,   Hong Kong Baptist University, Hong  Kong SAR, People’s Republic of ChinaAbstract:  We reported two forms (sphere and wire) of newly fabricated chlorhexidine  (CHX)-loaded mesoporous silica nanoparticles (MSNs), and investigated their releasing capacities  and anti-biofilm efficiencies.",Non-OADS,/arxiv_data1/oa_pdf/dc/04/ijn-11-2471.PMC4898423.pdf
"Among different types of inorganic  nanomaterials, the mesoporous silica nanoparticles (MSNs) exhibit many unique fea - tures, such as large surface area, high pore volume, stable physicochemical property,  and flexible surface modification, which make MSN a potential drug delivery vehicle.1  Previous in vitro and in vivo studies have reported the promising capacity of MSNs as  anticancer and antibacterial drug delivery systems.2–6 Moreover, our group has recently  successfully encapsulated the most commonly used antimicrobial agent in dentistry,  chlorhexidine (CHX), into commercial MSNs (MCM-41), and further confirmed their  antibacterial and anti-biofilm efficiencies via an effective releasing mode.7 There are plenty of studies on how the nanoparticle morphology, size, and surface  modifications affect their interactions with the mammal cells.8,9 Currently, there are correspondence: lijian Jin Faculty of Dentistry, The University of  Hong Kong, 34 Hospital Road, Hong  Kong SAR, People’s Republic of China Tel +852 2859 0302 Fax +852 2858 7874 email ljjin@hku.h k  Ken cham-Fai leung Department of Chemistry, Institute  of Creativity and Partner State Key  Laboratory of Environmental and  Biological Analysis, Hong Kong Baptist  University, Kowloon Tong, Hong Kong  SAR, People’s Republic of China Tel +852 3411 2319 Fax +852 3411 7348 email cfleung@hkbu.edu.h k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Li et al Running head recto: Effect of spherical nano-chlorhexidine DOI: http://dx.doi.org/10.2147/IJN.S105681",Non-OADS,/arxiv_data1/oa_pdf/dc/04/ijn-11-2471.PMC4898423.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/dc/04/ijn-11-2471.PMC4898423.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/04/ijn-11-2471.PMC4898423.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijn-11-2463.PMC4898424.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2463–2469International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2463OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10188 1Duality of β-glucan microparticles: antigen carrier  and immunostimulants Kim Baert1 Bruno g De geest2 henri De greve3,4 eric cox1,* Bert Devriendt1,* 1Department of Virology, Parasitology  and Immunology, 2Department of  Pharmaceutics, ghent University,   Merelbeke, ghent, Belgium;   3structural Biology research centre,   VIB, Brussels, Belgium; 4structural  Biology Brussels, Vrije Universiteit  Brussel, Brussels, Belgium *These authors contributed equally  to this workAbstract:  Designing efficient recombinant mucosal vaccines against enteric diseases is still a  major challenge.",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijn-11-2463.PMC4898424.pdf
"However, the development of effective mucosal vaccine subunits  encounters multiple challenges, such as antigen damaging and limited immunogenicity.1–4  The encapsulation of antigens in microparticles is a promising approach to overcome  these problems, as they can protect the antigens against degradation as well as carry  potent adjuvants or immune modulators to enhance the immunogenicity.5–7 Frequently  used particle systems for oral immunization are those based on poly(lactic- co-glycolic  acid); however, low antigen encapsulation efficiency and antigen degradation during  their formation limit their use in commercial vaccines.8 On the contrary, β-glucan  microparticles (GPs) are emerging microparticles known for their safety, immunoge - nicity, and high antigen encapsulation efficiency.9–18 These promising antigen carriers  are derived from the cell wall of Saccharomyces cerevisiae  (Baker’s yeast) and are  composed of .85% β-1,3-d-glucan polymers ( β-glucans), ~2% chitin, and ,1% lipids  and proteins, with the rest being mostly ash and moisture.15 The main component of these  particles, the β-glucans, is a “microbe-associated molecular pattern”, which is very inter - esting in vaccine development for its immunostimulating characteristics.19,20 We have  previously reported that particulate β-glucans are mainly recognized by complement  receptor 3 (CR3) on porcine innate immune cells and require the signaling molecule correspondence: Bert Devriendt laboratory of Immunology, Department  of Virology, Parasitology and Immunology,  ghent University, salisburylaan 133,  9820 Merelbeke, ghent, Belgium Tel +32 9 264 7343 email b.devriendt@ugent.b e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Baert et al Running head recto: Duality of β-glucan microparticles DOI: http://dx.doi.org/10.2147/IJN.S101881",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijn-11-2463.PMC4898424.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijn-11-2463.PMC4898424.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijn-11-2463.PMC4898424.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a4/c6/rmhp-9-101.PMC4898425.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a4/c6/rmhp-9-101.PMC4898425.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2016:9 101–112Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 101 ORIGINAL RESEARCH   open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S104311 Insecticide-treated net ownership and utilization  and factors that influence their use in Itang,  Gambella region, Ethiopia: cross-sectional study Aklilu Habte Watiro1 Worku Awoke2 1Médecins Sans Frontières OCA  (MSF Holland) Ethiopia Mission, Addis  Ababa, 2Department of Epidemiology,   School of Public Health, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, EthiopiaBackground: Malaria remains a major public health problem in Ethiopia.",Non-OADS,/arxiv_data1/oa_pdf/a4/c6/rmhp-9-101.PMC4898425.pdf
"4,5Correspondence: Aklilu Habte Watiro PO Box 34357, Yeka, Addis Ababa, EthiopiaTel +251 91 318 0806Email akwa1.2000@gmail.comJournal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCH Y ear: 2016V olume: 9Running head verso: Watiro and AwokeRunning head recto: ITN ownership and use in Ethiopia DOI: http://dx.doi.org/10.2147/RMHP .S104311",Non-OADS,/arxiv_data1/oa_pdf/a4/c6/rmhp-9-101.PMC4898425.pdf
Available from: http://www.who.int/malaria/publications/world_malaria_report_2014/report/en.,Non-OADS,/arxiv_data1/oa_pdf/a4/c6/rmhp-9-101.PMC4898425.pdf
"Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/a4/c6/rmhp-9-101.PMC4898425.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 112 Watiro and Awoke 17.,Non-OADS,/arxiv_data1/oa_pdf/a4/c6/rmhp-9-101.PMC4898425.pdf
Available from: http://etd.aau.edu.et/handle/123456789/3133.,Non-OADS,/arxiv_data1/oa_pdf/a4/c6/rmhp-9-101.PMC4898425.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/15/7f/tcrm-12-873.PMC4898426.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 873–881Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  873Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7006 8 Growth hormone therapy for Prader–willi  syndrome: challenges and solutions Graziano Grugni1,2 Alessandro Sartorio1,2 Antonino Crinò3 1Division of Auxology, 2experimental  Laboratory for Auxo-endocrinological  Research, San Giuseppe Hospital,   istituto Auxologico italiano, verbania,   3Autoimmune endocrine Diseases  Unit, Bambino Gesù Children’s  Hospital, Rome, italyAbstract:  Prader–Willi syndrome (PWS) is characterized by a dysregulation of growth hormone  (GH)/insulin-like growth factor I axis, as the consequence of a complex hypothalamic involve - ment.",Non-OADS,/arxiv_data1/oa_pdf/15/7f/tcrm-12-873.PMC4898426.pdf
"Three main genetic mechanisms  are responsible for PWS: deletion of the paternal chromosome 15 (del15q11-q13),  maternal uniparental disomy of chromosome 15 (UPD15), and imprinting defects.2  Individuals with del15q11-q13 can be further grouped in two classes, the larger type I  deletion and the smaller type II deletion.1,2 The syndrome affects multiple body systems, and the major clinical manifestations  are hyperphagia and early onset of severe obesity with its comorbidities (if uncon - trolled), musculoskeletal issues, dysmorphic features, multiple hormonal abnormali - ties, and cognitive, behavioral, and psychiatric disturbances.3 Endocrine issues include Correspondence: Graziano Grugni Division of Auxology, San Giuseppe  Hospital, istituto Auxologico italiano,  Corso Mameli 199, 28921 verbania, italy Tel +39 323 51 4247 Fax +39 323 51 4230 email g.grugni@auxologico.i t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Grugni et al Running head recto: GH therapy for PWS DOI: http://dx.doi.org/10.2147/TCRM.S70068",Non-OADS,/arxiv_data1/oa_pdf/15/7f/tcrm-12-873.PMC4898426.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/15/7f/tcrm-12-873.PMC4898426.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/7f/tcrm-12-873.PMC4898426.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a6/1e/sar-7-071.PMC4898427.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Identifying and assessing the risk of opioid abuse  in patients with cancer: an integrative review Ashley-Nicole Carmichael1 Laura Morgan1 Egidio Del Fabbro2 1School of Pharmacy, 2Division of  Hematology, Oncology, and Palliative  Care, Virginia Commonwealth  University, Richmond, VA, USA Correspondence: Egidio Del Fabbro   Division of Hematology, Oncology, and  Palliative Care, Virginia Commonwealth  University, 1101 East Marshall Street,  Box 980230, Richmond, VA 23298, USA   T el +1 804 828 9909   Fax +1 824 828 8079   Email Egidio.DelFabbro@vcuhealth.or gBackground:  The misuse and abuse of opioid medications in many developed nations is a  health crisis, leading to increased health-system utilization, emergency department visits, and  overdose deaths.",Non-OADS,/arxiv_data1/oa_pdf/a6/1e/sar-7-071.PMC4898427.pdf
Or use: http://youtu.be/9FKYPR-J_5 U,Non-OADS,/arxiv_data1/oa_pdf/a6/1e/sar-7-071.PMC4898427.pdf
"Available from: http://www.cdc.gov/nchs/ deaths.ht m. Accessed March 18, 2016.",OADS,/arxiv_data1/oa_pdf/a6/1e/sar-7-071.PMC4898427.pdf
"Available from: https://www.cms.gov/Medicare-  Medicaid-Coordination/Fraud-Prevention/Medicaid-Integrity- Education/   Downloads/drugdiversion-drugmonitoring-factsheet.pd f. Accessed  March 18, 2016.",OADS,/arxiv_data1/oa_pdf/a6/1e/sar-7-071.PMC4898427.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/a6/1e/sar-7-071.PMC4898427.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/1e/sar-7-071.PMC4898427.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 257–266Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 257 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S105407Violence against health workers in Family  Medicine Centers Nouf Al-T urki1 Ayman AM Afify1  Mohammed AlAteeq2 1Family Medicine Department,   Prince Sultan Military Medical City,   2Department of Family Medicine and  PHC, King Abdul-Aziz Medical City,   National Guard Health Affairs, Riyadh,  Kingdom of Saudi ArabiaBackground: Health care violence is a significant worldwide problem with negative conse- quences on both the safety and well-being of health care workers as well as workplace activities.",Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
"2 There was no consistent definition of workplace violence found in the literature,  with variable definitions used in different studies.3 The World Health Organization Correspondence: Mohammed AlAteeq Department of Family Medicine and PHC, King Abdul-Aziz Medical City, National Guard Health Affairs, PO Box 22490, Riyadh 11426, Kingdom of Saudi ArabiaTel +966 1 180 1111 ext 49187   Email malateeq@hotmail.comJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Al-Turki et alRunning head recto: Violence against HCWsDOI: http://dx.doi.org/10.2147/JMDH.S105407",Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
Available from: http://www.worksafebc.com/publications/health_and_safety/by_topic/assets/pdf/violhealthcare.pdf?_ga=1.54472365.402846214.1421522511.,Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
Available from: http://www.cdc.gov/niosh/docs/2002-101/pdfs/2002-101.pdf.,OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
Available from: http://www.who.int/violence_injury_prevention/violence/interpersonal/en/WVquestionnaire.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
Available from: http://cdrwww.who.int/violence_injury_prevention/violence/activities/workplace/WVsynthesisreport.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
Available from: http://www.prevention-violence.com/en/intro.asp.,Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
Available from: http://wwwdocs.fce.unsw.edu.au/orgmanagement/WorkingPapers/WP139.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 266 Al-T urki et al,Non-OADS,/arxiv_data1/oa_pdf/0b/bd/jmdh-9-257.PMC4898428.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ott-9-3369.PMC4898429.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3369–3380OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3369Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9751 9normalization of gene expression measurement  of tissue samples obtained by transurethral  resection of bladder tumors laura a Pop,1,* Valentina  Pileczki,1,2,* roxana M  cojocneanu-Petric,1 Bogdan  Petrut,3,4 cornelia Braicu,1  ancuta M Jurj,1 rares Buiga,5  Patriciu achimas-cadariu,6,7  ioana Berindan-n eagoe1,8 1The research center for Functional  genomics, Biomedicine and Translational  Medicine, Iuliu Haţieganu University of  Medicine and Pharmacy, cluj-n apoca,  cluj, romania; 2Department of analytical  Chemistry, Iuliu Haţieganu University of  Medicine and Pharmacy, cluj-n apoca,  cluj, romania; 3Department of surgery  II – Urology, The Oncology Institute  “Prof Dr Ion Chiricuţă”, Cluj-Napoca,  cluj, romania; 4Department of Urology,  Iuliu Haţieganu University of Medicine  and Pharmacy, cluj-n apoca, cluj,  romania; 5Department of Pathology,  The Oncology institute “Prof.",Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ott-9-3369.PMC4898429.pdf
"The most frequently used surgical  approach in urinary bladder cancer treatment is transurethral resection of bladder tumor  (TURBT), having both diagnostic and prognostic value.3,4 It provides important stag - ing information, facilitating treatment employment, and decreases tumor recurrence.5  Although it is an invasive technique that requires general anesthesia,4 TURBT remains  the best strategy to remove all visible lesions from the urinary bladder.6,7 Even though TURBT is important in the management of bladder cancer, it repre - sents a challenge in biological sample processing, with direct influence on downstream correspondence: Bogdan Petrut Department of Surgery II – Urology,  The Oncology institute “Prof Dr ion  Chiricuţă”, Republici Street, No 34–36,  cluj-napoca, cluj, romania Tel +40 723 188 151 email bogdan.petrut@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Pop et al Running head recto: Normalization of gene expression in TURBT tissue DOI: http://dx.doi.org/10.2147/OTT.S97519",Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ott-9-3369.PMC4898429.pdf
Available from:  http://mrcgene.com/wp-content/uploads/2014/06/TRIMay2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ott-9-3369.PMC4898429.pdf
"Available from: http://www.chem.agilent.com/Library/ applications/5989-1165EN.pd f. Accessed on March 14, 2015.",OADS,/arxiv_data1/oa_pdf/a2/2b/ott-9-3369.PMC4898429.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ott-9-3369.PMC4898429.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/2b/ott-9-3369.PMC4898429.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/3f/ijn-11-2407.PMC4898430.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2407–2415International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2407OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10129 9 Schisandrae fructus  enhances myogenic differentiation  and inhibits atrophy through protein synthesis  in human myotubes cy hyun Kim1,2,* Jin-hong shin1,3,* sung Jun hwang1,2 Yung hyun choi4 Dae-seong Kim1,3 cheol Min Kim2,5 1research Institute of convergence  of Biomedical science and T echnology,   Pusan National University Yangsan  hospital, Yangsan, 2center for anti- aging Industry, Pusan National  University, Busan, 3Department  of Neurology, Pusan National  University Yangsan hospital, Yangsan,   4Department of Biochemistry, Dong- eui University college of Korean  Medicine, Busan, 5Department  of Biomedical Informatics, Pusan  National University school of  Medicine, Yangsan, republic of Korea *These authors contributed equally  to this workAbstract:  Schisandrae fructus  (SF) has recently been reported to increase skeletal muscle mass  and inhibit atrophy in mice.",Non-OADS,/arxiv_data1/oa_pdf/5e/3f/ijn-11-2407.PMC4898430.pdf
"Keywords:  Schisandrae fructus, mTOR signaling, human skeletal muscle cells, myotubes Introduction Sarcopenia, a syndrome of progressive and generalized loss of skeletal muscle mass  and strength, poses a huge health care burden in the elderly.1–5 It has raised a great  interest in the search for dietary ingredients that can help increase and maintain skel - etal muscle mass.6–8 The dried Schisandrae fructus  (SF) has been traditionally used  in herbal medicine as the therapy for asthma, night sweats, insomnia, dry coughs, uri - nary disorders, involuntary ejaculation, poor memory, hyperacidity, chronic diarrhea,  hepatitis, diabetes, etc.9–12 Previous studies on SF extract have reported various bio - logical activities as antioxidant, antiviral, antitumor, and anti-inflammatory agent.13–18  Recently, SF has been shown to increase skeletal muscle mass and ameliorate atrophy in  the mouse models of sciatic neurectomy and dexamethasone (DEX) treatment.19–24 Muscle hypertrophy is affected by balancing between protein synthesis and  degradation.25 Several materials, such as leucine and ursolic acid, as well as exercise,  have been known to induce skeletal muscle hypertrophy stimulating v-akt murine  thymoma viral oncogene homolog (Akt) or mammalian target of rapamycin (mTOR)  signaling.26–32 Activation of mTOR generates upregulation of phosphorylated eukaryotic  translation initiation factor 4E-binding protein 1 (p-4E-BP1) or phosphorylated 70 kDa correspondence: cheol Min Kim center for anti-aging Industry, Pusan  National University, 70-16, eomgung-ro,  sasang-gu, Busan 47046, republic  of Korea Tel +82 51 315 7416 Fax +82 51 583 8820 email kimcm@pusan.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kim et al Running head recto: Effect of SF extract on human myotube differentiation DOI: http://dx.doi.org/10.2147/IJN.S101299",Non-OADS,/arxiv_data1/oa_pdf/5e/3f/ijn-11-2407.PMC4898430.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5e/3f/ijn-11-2407.PMC4898430.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/3f/ijn-11-2407.PMC4898430.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/96/d6/ott-9-3359.PMC4898431.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3359–3368OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3359Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10093 6 combination of gambogic acid with cisplatin  enhances the antitumor effects on cisplatin- resistant lung cancer cells by downregulating  MrP2 and lrP expression Wendian Zhang* hechao Zhou* Ying Yu* Jingjing li haiwen li Danxian Jiang Zihong chen Donghong Yang Zumin Xu Zhonghua Yu cancer center, affiliated hospital  of guangdong Medical University,   Zhanjiang, guangdong Province,   People’s republic of china *These authors contributed equally  to this workAbstract:  Cisplatin resistance is a main clinical problem of lung cancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/96/d6/ott-9-3359.PMC4898431.pdf
"Gambogic acid (GA) is a main ingredient of gamboge, the resin secreted from Gar- cinia hanburyi  tree in South-East Asia.4 GA has been used as one of traditional medicine  for centuries and it possesses many kinds of biological effects such as anti-infectious,  anti-oxidant, anti-inflammatory, and antiviral.5 In recent years, many researchers have  found that GA could inhibit the proliferation of a variety of human cancer cells in vitro, correspondence: Zhonghua Yu;  Zumin Xu Cancer Center, Affiliated Hospital  of guangdong Medical University,  57 south renmin road, Zhanjiang 524000,  guangdong Province, People’s republic  of china Tel +86 759 238 7813; +86 759 238 7448 Fax +86 759 238 7813; +86 759 238 7448 email zhonghua_yu@126.co m;  zuminxu@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Gambogic acid enhances antitumor effect of cisplatin DOI: http://dx.doi.org/10.2147/OTT.S100936",Non-OADS,/arxiv_data1/oa_pdf/96/d6/ott-9-3359.PMC4898431.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/96/d6/ott-9-3359.PMC4898431.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/d6/ott-9-3359.PMC4898431.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/3b/ott-9-3307.PMC4898432.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3307–3312OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3307Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10451 1 The prognostic role of serum c-X-c chemokine  receptor type 4 in patients with metastatic or  recurrent colorectal cancer Y oon Ji choi1 Won Jin chang1 sang Won shin1 Kyong hwa Park1 seung Tae Kim2 Yeul hong Kim1 1Division of hematology-Oncology,   Department of internal Medicine,   Korea University college of Medicine,   2Division of hematology-Oncology,   Department of Medicine, samsung  Medical center, sungkyunkwan  University school of Medicine, seoul,   south KoreaBackground:  C-X-C chemokine receptor type 4 (CXCR4) is involved in tumor progression  including angiogenesis, metastasis, and survival.",Non-OADS,/arxiv_data1/oa_pdf/11/3b/ott-9-3307.PMC4898432.pdf
"Target organs produce and release specific chemokines that attract distant cancer  cells carrying specific chemokine receptors.3,4 The C-X-C chemokine receptor type 4  (CXCR4) and its chemokine ligand 12 (CXCL12) are two key factors in the cross  talk between cancer cells and their microenvironment, which makes them promising  targets for cancer therapy.5 CXCR4 overexpression is known to occur in .20 human tumor types, including  ovarian,6 prostate,7 esophageal,8 melanoma,9 and renal cell carcinoma.10 CXCR4 correspondence: seung Tae Kim Division of hematology-Oncology,  Department of Medicine, samsung  Medical center, sungkyunkwan University  school of Medicine, 50 irwon-dong  gangnam-gu, seoul 135-710, south Korea Tel +82 2 3410 0297 Fax +82 2 3410 1754 email seungtae1.kim@samsung.co m  Yeul hong Kim Division of hematology-Oncology,  Department of internal Medicine,  Korea University anam hospital,  Korea University college of Medicine,  126-1, anam-dong 5-ga, seongbuk-gu,  seoul 136-705, south Korea Tel +82 2 920 5569 Fax +82 2 920 6622 email yhk0215@korea.ac.k r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Choi et al Running head recto: Serum CXCR4 in colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S104511",Non-OADS,/arxiv_data1/oa_pdf/11/3b/ott-9-3307.PMC4898432.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/11/3b/ott-9-3307.PMC4898432.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/3b/ott-9-3307.PMC4898432.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9a/a7/jir-9-091.PMC4898433.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/9a/a7/jir-9-091.PMC4898433.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).T oll-like receptor cascade and gene polymorphism  in host–pathogen interaction in Lyme disease Shusmita Rahman1 Maria Shering2 Nicholas H Ogden3 Robbin Lindsay4 Alaa Badawi1 1National Microbiology Laboratory,   Public Health Agency of Canada,   T oronto, 2Faculty of Arts and Science,   University of T oronto, T oronto, ON,   3National Microbiology Laboratory,   Public Health Agency of Canada,   Saint-Hyacinthe, QC, 4National  Microbiology Laboratory, Public  Health Agency of Canada, Winnipeg,   MB, Canada Correspondence: Alaa Badawi   Public Health Risk Science Division,  National Microbiology Laboratory, Public  Health Agency of Canada, 180 Queen  Street West, T oronto, ON M5V 3L7,  Canada   Email alaa.badawi@phac-aspc.gc.c aAbstract:  Lyme disease (LD) risk occurs in North America and Europe where the tick vectors  of the causal agent Borrelia burgdorferi  sensu lato are found.",Non-OADS,/arxiv_data1/oa_pdf/9a/a7/jir-9-091.PMC4898433.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/9a/a7/jir-9-091.PMC4898433.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/a7/jir-9-091.PMC4898433.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b7/59/ott-9-3335.PMC4898434.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3335–3343OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3335Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10719 0 Significant association between long non-coding  rna hOT air polymorphisms and cancer  susceptibility: a meta-analysis Jian Zhang1 Xu liu2 Liang-Hao Y ou1 Rui-Zhi Zhou1 1Department of cell Biology, Key  Laboratory of Cell Biology, Ministry  of Public Health and Key Laboratory  of Medical Cell Biology, Ministry of  Education,  China  Medical University,   Shenyang,  People’s Republic of  china; 2Department of n eurology,   First affiliated hospital of china  Medical University, Shenyang,   People’s Republic of ChinaAbstract:  HOTAIR, a well-known long non-coding RNA, is involved in carcinogenesis and  progression of multiple cancers.",Non-OADS,/arxiv_data1/oa_pdf/b7/59/ott-9-3335.PMC4898434.pdf
"Nowadays, many molecular epidemiological studies have  reported that genetic factors may play an important role in cancer development, and  the genetic predisposition is receiving increasing attention.4,5 Long non-coding RNAs (lncRNAs) are defined as a new group of transcribed RNA  molecules that are longer than 200 nucleotides and have no obvious protein-coding  capacity.6,7 LncRNAs were previously considered as a fake transcriptional noise,8 but  now accumulating evidence suggests that they are crucial players in a wide range of correspondence: Jian Zhang Department of cell Biology, Key  Laboratory of Cell Biology, Ministry  of Public Health and Key Laboratory  of Medical Cell Biology, Ministry of  Education, China Medical University,  no 77 Puhe road, shenyang north area,  shenyang, liaoning 110122, People’s  Republic of China email jiancmu@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: HOTAIR polymorphisms and cancer susceptibility DOI: http://dx.doi.org/10.2147/OTT.S107190",Non-OADS,/arxiv_data1/oa_pdf/b7/59/ott-9-3335.PMC4898434.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b7/59/ott-9-3335.PMC4898434.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/59/ott-9-3335.PMC4898434.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/e1/ott-9-3269.PMC4898435.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3269–3280OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3269Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9998 9 emerging role of sphingosine-1-phosphate signaling  in head and neck squamous cell carcinoma Rajeev Nema1 Supriya vishwakarma1 Rahul Agarwal2 Rajendra Kumar Panday3 Ashok Kumar1 1Department of Biochemistry, All  india institute of Medical Sciences  Bhopal, Bhopal, 2Jawaharlal Nehru  Cancer Hospital & Research Centre,   3Navodaya Cancer Hospital, indrapuri,   Bhopal, indiaAbstract:  Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer  type, with an annual incidence of approximately half a million people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ff/e1/ott-9-3269.PMC4898435.pdf
edu.in Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Nema et al Running head recto: S1P signaling in head and neck cancer DOI: http://dx.doi.org/10.2147/OTT.S99989,Non-OADS,/arxiv_data1/oa_pdf/ff/e1/ott-9-3269.PMC4898435.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ff/e1/ott-9-3269.PMC4898435.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/e1/ott-9-3269.PMC4898435.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/60/67/ndt-12-1287.PMC4898436.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1287–1293Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1287OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10491 7 intravenous administration of adipose tissue- derived stem cells enhances nerve healing and  promotes BDNF expression via the TrkB signaling  in a rat stroke model Xin li1 Wei Zheng2 hongying Bai1 Jin Wang3 ruili Wei1 hongtao Wen3 hanbing Ning3 1Department of Neurology,   2Department of Nursing, The second  affiliated hospital of Zhengzhou  University, 3Department of Digestive  Diseases, The First affiliated hospital  of Zhengzhou University, Zhengzhou,   People’s republic of chinaAbstract:  Previous studies have shown the beneficial effects of adipose-derived stem cells  (ADSCs) transplantation in stroke.",Non-OADS,/arxiv_data1/oa_pdf/60/67/ndt-12-1287.PMC4898436.pdf
"correspondence: hanbing Ning Department of Digestive Diseases,  The First Affiliated Hospital of  Zhengzhou University, No 1 Jianshe  east road, Zhengzhou 450052, henan,  People’s republic of china Tel +86 371 6361 6719 email nhbing419@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Li et al Running head recto: ADSCs promotes BDNF expression and nerve healing DOI: http://dx.doi.org/10.2147/NDT.S104917",Non-OADS,/arxiv_data1/oa_pdf/60/67/ndt-12-1287.PMC4898436.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/60/67/ndt-12-1287.PMC4898436.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/67/ndt-12-1287.PMC4898436.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/4d/ott-9-3345.PMC4898437.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3345–3351OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3345Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10744 3 Fast-track surgery protocol in elderly patients  undergoing laparoscopic radical gastrectomy  for gastric cancer: a randomized controlled trial guozheng liu1 Fengguo Jian2 Xiuqin Wang2 lin chen1 1Department of general surgery,   chinese P la general hospital,   Beijing, People’s republic of china;   2second Department of general  surgery, changyi People’s hospital,   shandong, People’s republic of chinaAim:  To study the efficacy of the fast-track surgery (FTS) program combined with laparoscopic  radical gastrectomy for elderly gastric cancer (GC) patients.",Non-OADS,/arxiv_data1/oa_pdf/74/4d/ott-9-3345.PMC4898437.pdf
"Fast-track surgery (FTS) is defined as the integration of different medical interven - tion actively during perioperative period to accelerate the rehabilitation of patients correspondence: lin chen Department of general surgery, chinese  Pla general hospital, no 28 Fuxing  road, haidian District, Beijing 100853,  People’s republic of china Tel +86 138 0129 0395 email chenlinpayi@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: FTS protocol in elderly GC patients DOI: http://dx.doi.org/10.2147/OTT.S107443",Non-OADS,/arxiv_data1/oa_pdf/74/4d/ott-9-3345.PMC4898437.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/74/4d/ott-9-3345.PMC4898437.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/4d/ott-9-3345.PMC4898437.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/ndt-12-1281.PMC4898438.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1281–1286Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1281Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10753 5 Chronic depression treated successfully with  novel taping therapy: a new approach to the  treatment of depression Chang Hyun Han1,* Hwa soo Hwang2,* Y oung Joon Lee3 sang Nam Lee4 Jane J abanes5 Bong Hyo Lee6 1Clinical research Division, Korea  institute of Oriental Medicine,   Daejeon, 2Chims-saengvit Oriental  Medicine Clinic, seoul, 3Department  of Preventive Korean Medicine,   4Department of Qigong, College  of Korean Medicine, Daegu Haany  University, Gyeongsangbuk-do,   south Korea; 5Daniel K inouye  Graduate school of Nursing,   Uniformed services University of  the Health sciences, Bethesda, MD,   Usa; 6Department of acupuncture,   Moxibustion and acupoint, College  of Korean Medicine, Daegu Haany  University, Daegu, south Korea *These authors contributed equally  to this workIntroduction:  Despite improved research in the treatment, depression remains difficult to  treat.",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/ndt-12-1281.PMC4898438.pdf
"Correspondence: Bong Hyo Lee Department of acupuncture,  Moxibustion and acupoint, College  of Korean Medicine, Daegu Haany  University, 165 sang-dong, suseong-gu,  Daegu 706-828, south Korea Tel +82 53 819 1828 Fax +82 53 819 1850 email dlqhdgy@dhu.ac.k r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case Series Y ear: 2016 Volume: 12 Running head verso: Han et al Running head recto: Novel taping therapy for severe depression DOI: http://dx.doi.org/10.2147/NDT.S107535",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/ndt-12-1281.PMC4898438.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/ndt-12-1281.PMC4898438.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/4d/ndt-12-1281.PMC4898438.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/90/c9/ppa-10-975.PMC4898439.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 975–982Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  975Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8286 6 Mode of administration of dulaglutide: implications  for treatment adherence Ambika Amblee1,2 1Department of internal Medicine,   Division of endocrinology, John  Stroger Hospital of Cook County,   2Rush University Medical Center,   Chicago, iL, USABackground:  Medication complexity/burden can be associated with nonadherence in patients  with type 2 diabetes mellitus (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/90/c9/ppa-10-975.PMC4898439.pdf
"The efficacy and weight loss potential Correspondence: Ambika Amblee Department of internal Medicine,  Division of endocrinology, John Stroger  Hospital of Cook County, 1900  west Polk Street, Suite 806, Chicago,  iL 60612, USA Tel +1 312 864 0543 Fax +1 312 864 9734 email aamblee@cookcountyhhs.or g Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Amblee Running head recto: Dulaglutide: patient adherence and satisfaction DOI: http://dx.doi.org/10.2147/PPA.S82866",Non-OADS,/arxiv_data1/oa_pdf/90/c9/ppa-10-975.PMC4898439.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/90/c9/ppa-10-975.PMC4898439.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/19/opth-10-1015.PMC4898440.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1015–1021Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1015Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9962 0The association of sleep quality with dry eye  disease: the Osaka study Motoko Kawashima1 Miki Uchino1,2 norihiko Y okoi3 Yuichi Uchino1,2 Murat Dogru1 aoi Komuro3 Yukiko sonomura3 hiroaki Kato3 shigeru Kinoshita3 Kazuo Tsubota1 1Department of Ophthalmology,   Keio University school of Medicine,   shinjuku-ku, 2ryogoku eye Clinic,   sumida-ku, T okyo, 3Department of  Ophthalmology, Kyoto Prefectural  University of Medicine, Kyoto, JapanPurpose:  To investigate the association of dry eye disease with sleep quality.",Non-OADS,/arxiv_data1/oa_pdf/1e/19/opth-10-1015.PMC4898440.pdf
"Sleep deficiencies  are considered a public health problem.14,15 Furthermore, mental health maintenance Correspondence: Motoko Kawashima Department of Ophthalmology,  Keio University school of Medicine,  35 shinanomachi, shinjuku-ku,  Tokyo 1608582, Japan Tel +81 3 5363 3866 Fax +81 3 5363 3045 email motoko-k@a3.keio.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kawashima et al Running head recto: Sleep quality with dry eye disease DOI: http://dx.doi.org/10.2147/OPTH.S99620",Non-OADS,/arxiv_data1/oa_pdf/1e/19/opth-10-1015.PMC4898440.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1e/19/opth-10-1015.PMC4898440.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/19/opth-10-1015.PMC4898440.pdf
"METHODS This was a hospital-based, cross-sectional, epidemiological survey and retrospective chart review, in both secondary and tertiary care acrossThailand (http://ClinicalTrials.gov Identi ﬁer: NCT00684151).",Non-OADS,/arxiv_data1/oa_pdf/cc/83/heartasia-2011-010036.PMC4898574.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/a6/bhw066.PMC4898676.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/04/bhw089.PMC4898678.pdf
"Graph Theoretic Measures All graph theoretic metrics and analyses were performed using the Brain Connectivity Toolbox ( https://sites.google.com/site/ bctnet/ ), including degree/strength, modularity, and the rich club coef ﬁcient ( Rubinov and Sporns 2010 ).",OADS,/arxiv_data1/oa_pdf/10/04/bhw089.PMC4898678.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/10/04/bhw089.PMC4898678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/3a/bhw111.PMC4898680.pdf
"The full movies are available at http://ppw.kuleuven.be/home/english/research/lbp/downloads/ratMovies (Last accessed 19 April 2016).3312 |Cerebral Cortex, 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/96/3a/bhw111.PMC4898680.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/11/bhw132.PMC4898681.pdf
Supplementary material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/b5/11/bhw132.PMC4898681.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/3a/ijpbs-10-01-2602.PMC4898745.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7c/11/ijpbs-10-01-3895.PMC4898746.pdf
Available at: http://siteresources.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/7c/11/ijpbs-10-01-3895.PMC4898746.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/63/ijpbs-10-01-4961.PMC4898747.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/3b/ijpbs-10-01-4307.PMC4898748.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/89/ijpbs-10-01-3561.PMC4898749.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fd/4c/ijpbs-10-01-3483.PMC4898750.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/61/ijpbs-10-01-4011.PMC4898751.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d9/d1/ijpbs-10-01-948.PMC4898752.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/27/ijpbs-10-01-2026.PMC4898753.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/9e/evw054.PMC4898790.pdf
"2009 )t os o r t the bam ﬁles, Picard v1.127 ( http://broadinstitute.github.io/ picard , last accessed March 21, 2016) to assign the readgroup information, and GATK v.3.3.0 ( DePristo et al.",OADS,/arxiv_data1/oa_pdf/7f/9e/evw054.PMC4898790.pdf
"We obtained the allele frequency at every site in the genome for each sample using bam read-count 0.7.4 ( https://github.com/genome/bam-readcount ,l a s t accessed March 21, 2016) retaining only alleles with mapping and base quality scores of at least 20 for further analysis.",Non-OADS,/arxiv_data1/oa_pdf/7f/9e/evw054.PMC4898790.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtable S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/7f/9e/evw054.PMC4898790.pdf
Available from: http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/7f/9e/evw054.PMC4898790.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/ab/evw064.PMC4898791.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/evw078.PMC4898795.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/48/evw079.PMC4898796.pdf
"Available from: http://www.repeatmasker.org .Smith CD, Zimin A, et al.",Non-OADS,/arxiv_data1/oa_pdf/25/48/evw079.PMC4898796.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/62/evw080.PMC4898797.pdf
The genome assembly with predicted genes are available for download at http://mbio-serv2.mbioekol.lu.se/Malavi/Downloads .,OADS,/arxiv_data1/oa_pdf/66/6a/evw081.PMC4898798.pdf
The assembled transcripts are available for download at http://mbio-serv2.mbioekol.lu.se/Malavi/Downloads .,OADS,/arxiv_data1/oa_pdf/66/6a/evw081.PMC4898798.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/6a/evw081.PMC4898798.pdf
"A partial genome sequence of the bird malaria parasite Plasmodium gallinaceum is available for download but remains unpublished ( ftp://ftp.sanger.ac.uk/pub/project/ pathogens/Plasmodium/gallinaceum/ ), last accessed April, 2006.",Non-OADS,/arxiv_data1/oa_pdf/66/6a/evw081.PMC4898798.pdf
"Thegenome assembly with predicted genes is available for down-load at http://mbio-serv2.mbioekol.lu.se/Malavi/Downloads , last accessed April, 2016.",OADS,/arxiv_data1/oa_pdf/66/6a/evw081.PMC4898798.pdf
"Transcripts containing translated open reading frames (ORFs) were scanned using TransDecoder (ver-sion rel16JAN2014, http://transdecoder.github.io/ , last accessed April, 2016) with default parame ters.",OADS,/arxiv_data1/oa_pdf/66/6a/evw081.PMC4898798.pdf
"Orthologs were clustered with WU-BLAST (version 2.2.6) which has become a module within the AB-BLAST package ( http://www.advbio- comp.com/ , last accessed April, 2016) and OrthoMCL ( Li et al.",OADS,/arxiv_data1/oa_pdf/66/6a/evw081.PMC4898798.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/00/evw082.PMC4898799.pdf
"0.10.1, http://www.bioinformatics.babra ham.ac.uk/projects/fastqc/ ) to ﬁlter out low-quality reads before de novo assembly with the program SOAPdenovo (ver.",Non-OADS,/arxiv_data1/oa_pdf/54/00/evw082.PMC4898799.pdf
"1.05, http://soap.genomics.org.cn/ )u s i n ga K-mer value of 51.",OADS,/arxiv_data1/oa_pdf/54/00/evw082.PMC4898799.pdf
Supplementary Material Supplementary ﬁgures S1–S4 andtables S1–S17 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/54/00/evw082.PMC4898799.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/a5/evw083.PMC4898800.pdf
Supplementary Material Supplementary ﬁgures S1–S6 and methods are available at Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/36/a5/evw083.PMC4898800.pdf
Available from: http://arxiv.org/abs/1510.08002.,Non-OADS,/arxiv_data1/oa_pdf/36/a5/evw083.PMC4898800.pdf
"Introduction Aphids (Aphididae Latreille, 1802) are a highly diverse group of insects, with over 4,000 species currently organized into 24distinct extant subfamilies ( http://aphid.speciesﬁle.org ,l a s ta c - cessed January 12, 2016).",Non-OADS,/arxiv_data1/oa_pdf/b1/aa/evw085.PMC4898801.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/aa/evw085.PMC4898801.pdf
"Genome Assembly HiSeq2000 paired-end reads were ﬁrst right-tailed trimmed (using a minimum quality threshold of 20) using FASTX- Toolkit v0.0.14 ( http://hannonlab.cshl.edu/fastx_toolkit/ ,l a s t accessed January 12, 2016) and reads shorter than 75 bpwhere removed.",OADS,/arxiv_data1/oa_pdf/b1/aa/evw085.PMC4898801.pdf
"Finally, to correct base errors in the assem- bled consensus sequences and manually check for misas- sembled regions, we used Polisher v2.0.8 (available for academic use from http://jgi.doe.gov/data-and-tools/polisher/ , last accessed January 12, 2016) and Tablet (Milne et al.",OADS,/arxiv_data1/oa_pdf/b1/aa/evw085.PMC4898801.pdf
"The resulting trees were visualized and exported with FigTree v1.4.1 (http://tree.bio.ed.ac.uk/software/ﬁgtree/ , last accessed January 12, 2016) and edited in Inkscape .",OADS,/arxiv_data1/oa_pdf/b1/aa/evw085.PMC4898801.pdf
biorXiv.Available from: http://dx.doi.org/10.1101/042267 .,OADS,/arxiv_data1/oa_pdf/b1/aa/evw085.PMC4898801.pdf
http://www.pubmedcentral.nih.gov/articlerender.,OADS,/arxiv_data1/oa_pdf/b1/aa/evw085.PMC4898801.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/f7/evw086.PMC4898802.pdf
Supplementary Material Supplementary tables S1–S6 andﬁgures S1–S9 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/64/f7/evw086.PMC4898802.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/0c/evw089.PMC4898803.pdf
"Filescontaining all predicted proteins, transcripts, and annotations are available for download at https://sites.google.com/site/col- letotrichumgenome/ (last accessed May 2, 2016).",OADS,/arxiv_data1/oa_pdf/b3/0c/evw089.PMC4898803.pdf
"Likelihood-ratio tests were carried out on PRANK ( http://wasabiapp.org/software/prank/ , last accessed May 2, 2016) nucleotide alignments using thebranch-site model of CodeML using the “cleandata” optionto remove any sites with gaps in at least one sequence ( Yang 2007 ).",OADS,/arxiv_data1/oa_pdf/b3/0c/evw089.PMC4898803.pdf
Supplementary Material Supplementary tables S1–S7 andﬁgures S1–S8 are available atGenome Biology and Evolution online (http://www.gbe.,OADS,/arxiv_data1/oa_pdf/b3/0c/evw089.PMC4898803.pdf
https://CRAN.R-project.org/package=pheatmap .,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/evw089.PMC4898803.pdf
http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/evw089.PMC4898803.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/a5/evw090.PMC4898804.pdf
1994 ) between indi- viduals using the software asd ( http://szpiech.com/software.,OADS,/arxiv_data1/oa_pdf/20/a5/evw090.PMC4898804.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/7c/evw091.PMC4898805.pdf
Available from: http://www.kew.org/cvalues .,Non-OADS,/arxiv_data1/oa_pdf/1e/7c/evw091.PMC4898805.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/df/evw092.PMC4898806.pdf
S1–S5 and tables S1–S9 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/9a/df/evw092.PMC4898806.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/fe/evw093.PMC4898807.pdf
Supplementary Material Supplementary ﬁgures S1 and S2 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.oxfordjour nals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/fe/evw093.PMC4898807.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/29/evw095.PMC4898809.pdf
"To exclude possible contamination, all reads were aligned to bacterial database downloaded from NCBI ( http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/7b/29/evw095.PMC4898809.pdf
"2012 ) and duplicated reads were removed with picard ( https://github.com/broadin- stitute/picard , last accessed April 30, 2016) according to the alignments which mapped the processed reads against theﬁrst assembly.",Non-OADS,/arxiv_data1/oa_pdf/7b/29/evw095.PMC4898809.pdf
"Ka/Ks Ratio To reduce the possible impact of Ka/Ks ratio by wrong annotation, we used only annotations against Swissprot (http://www.ebi.ac.uk/uniprot ), BLASTx alignments with e-value greater than 1e-40 or identity less than 40% were discarded.",Non-OADS,/arxiv_data1/oa_pdf/7b/29/evw095.PMC4898809.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/96/evw096.PMC4898810.pdf
"Bayesian analysis to describe genomic evolution by rearrangement (BADGER), version 1.02 beta, Duquesne University.http://www.badger.duq.edu/ .",Non-OADS,/arxiv_data1/oa_pdf/3b/96/evw096.PMC4898810.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/a1/evw097.PMC4898811.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/6f/evw098.PMC4898812.pdf
"Strains R10SW13, LMG 21861 and LMG 21856 have been obtained from the culture collection ofthe DSMZ ( https://www.dsmz.de/home.html ).",Non-OADS,/arxiv_data1/oa_pdf/25/6f/evw098.PMC4898812.pdf
(http://www.ncbi.nlm.nih.gov/genome/annotation_prok/ ).,OADS,/arxiv_data1/oa_pdf/25/6f/evw098.PMC4898812.pdf
S1–S6 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/25/6f/evw098.PMC4898812.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/69/evw102.PMC4898814.pdf
Supplementary Material Supplementary tables S1 and S2 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.oxfordjour- nals.org /).,Non-OADS,/arxiv_data1/oa_pdf/70/69/evw102.PMC4898814.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/16/evw103.PMC4898815.pdf
"As RTKs are involved in cell proliferation, survival,adhesion, migration, and differentiation and more generally development through regulatory networks, our work provides a baseline for comparative expression and function analysistowards a better understanding of the diversiﬁcation of cellmetabolism and the development complexity in vertebrates.Supplementary Material Supplementary ﬁgures S1–S5 andtable S1 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.",Non-OADS,/arxiv_data1/oa_pdf/8f/16/evw103.PMC4898815.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/13/evw110.PMC4898816.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________ ________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/76/mjiri-30-342.PMC4898833.pdf
Vol.30:342.http://mjiri.iums.ac.irfected by age and gender) are known as a u- ditory elements for speech perception in noise(5).,Non-OADS,/arxiv_data1/oa_pdf/0f/76/mjiri-30-342.PMC4898833.pdf
Vol.30:342. http://mjiri.iums.ac.iryears.,Non-OADS,/arxiv_data1/oa_pdf/0f/76/mjiri-30-342.PMC4898833.pdf
"Vol.30:342.http://mjiri.iums.ac.irDiscussion The main finding of this study was the significant difference between word di s- crimination scores in silence and at 0, +5, and +10dB SNRs in both ears.",Non-OADS,/arxiv_data1/oa_pdf/0f/76/mjiri-30-342.PMC4898833.pdf
Vol.30:342. http://mjiri.iums.ac.irThis finding is in agreement with Wong et al.,OADS,/arxiv_data1/oa_pdf/0f/76/mjiri-30-342.PMC4898833.pdf
"Vol.30:342.http://mjiri.iums.ac.irAcknowledgement We would like to sincerely thank the Eshragh, Andishe, Bahman cultural centers for their extensive cooperation.",Non-OADS,/arxiv_data1/oa_pdf/0f/76/mjiri-30-342.PMC4898833.pdf
Vol.30:342. http://mjiri.iums.ac.ir262-72.,Non-OADS,/arxiv_data1/oa_pdf/0f/76/mjiri-30-342.PMC4898833.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/83/ca/mjiri-30-324.PMC4898834.pdf
Vol.30:324. http://mjiri.iums.ac.irto find nerve fibers in dissections.,Non-OADS,/arxiv_data1/oa_pdf/83/ca/mjiri-30-324.PMC4898834.pdf
"Vol.30:324.  http://mjiri.iums.ac.irnerve lesion, incomplete median nerve l e- sion, evidence of peripheral neuropathy, thenar and palmar area injury, burn injury, electrical shock injury and injury at distal wrist that posed pro blems in stimulation of the median nerve distal to the injury site.",Non-OADS,/arxiv_data1/oa_pdf/83/ca/mjiri-30-324.PMC4898834.pdf
Vol.30:324.http://mjiri.iums.ac.irany response with surface stimulation of the median nerve while the needle was i n- serted to APB and OP was another co n- firmatory clue to ensure that the needle had been placed correctly.,Non-OADS,/arxiv_data1/oa_pdf/83/ca/mjiri-30-324.PMC4898834.pdf
Vol.30:324. http://mjiri.iums.ac.irmedian nerves.,Non-OADS,/arxiv_data1/oa_pdf/83/ca/mjiri-30-324.PMC4898834.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________ _____________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
"Vol.30:344.http://mjiri.iums.ac.irample, how the problems caused by differ- ences between men and women affect their health requirements (3).",Non-OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
"Vol.30:344. http://mjiri.iums.ac.ircators were categorized into three groups of health status indicators, health determ i- nants, and health systems performance (T a- ble 1).The indexes were evaluated using the data of the heal th equity monitoring system of the Iranian Ministry of Health, Multiple-Indicator Demographic and Health Survey 2010 (IrMIDHS) (17), and other data from Ministry of Health (18-21).",OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
"Vol.30:344.http://mjiri.iums.ac.irD2 = Number of men who have an specific characteristic N1 = Total number of women N2= Total number of men Educational indicators (including pre - school coverage, first grade absorption, sustaining to the end of the elementary school and literacy) were analyzed based on the appraisal framework by UNESCO Institute for Statistics (UIS) and I nterna- tional Institute for Education Planning.",OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
"Vol.30:344. http://mjiri.iums.ac.irof infant mortality, under -five mortality, crude death, drug abuse, smoking and the death resulting from cardiac diseases showed gender inequality in favor of f e- males.",Non-OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
Vol.30:344.http://mjiri.iums.ac.ircardiac diseases.,Non-OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
Vol.30:344. http://mjiri.iums.ac.irsignificant achievements of the Iranian Ministry of Health.,Non-OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
"Vol.30:344.http://mjiri.iums.ac.irAs for basic and supplementary insurance coverage, gender inequality was mostly in favor of males in Tehran, but there was gender equality in other three provinces.",Non-OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
Vol.30:344. http://mjiri.iums.ac.irindeprived and relatively deprived pro v- inces.,Non-OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
Vol.30:344.http://mjiri.iums.ac.irRepublic of Iran :Department of Women and Family Affairs; 2015.,Non-OADS,/arxiv_data1/oa_pdf/c0/18/mjiri-30-344.PMC4898835.pdf
Debate Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mjiri-30-346.PMC4898836.pdf
Vol.30:346.http://mjiri.iums.ac.irabout how qualitative researchers promote the quality of their articles and provide a p- plicable and trustworthy outcome.,Non-OADS,/arxiv_data1/oa_pdf/ed/1f/mjiri-30-346.PMC4898836.pdf
Vol.30:346. http://mjiri.iums.ac.irwhich analytical tools were exploited in each stage and how theoretical model or concept came out of raw data.,OADS,/arxiv_data1/oa_pdf/ed/1f/mjiri-30-346.PMC4898836.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/51/mjiri-30-338.PMC4898837.pdf
Vol.30:338. http://mjiri.iums.ac.ir(5).,Non-OADS,/arxiv_data1/oa_pdf/9a/51/mjiri-30-338.PMC4898837.pdf
Vol.30:338. http://mjiri.iums.ac.iris the size of ESRF over the size of patients in stage 5 (Fig .1).,Non-OADS,/arxiv_data1/oa_pdf/9a/51/mjiri-30-338.PMC4898837.pdf
Vol.30:338. http://mjiri.iums.ac.irtime.,Non-OADS,/arxiv_data1/oa_pdf/9a/51/mjiri-30-338.PMC4898837.pdf
Vol.30:338.  http://mjiri.iums.ac.irresults revealed that the estimated prev a- lence was three times more in 2011 co m- pared to 2006.,OADS,/arxiv_data1/oa_pdf/9a/51/mjiri-30-338.PMC4898837.pdf
Vol.30:338.http://mjiri.iums.ac.ireight times higher t han those aged 40 -59.,Non-OADS,/arxiv_data1/oa_pdf/9a/51/mjiri-30-338.PMC4898837.pdf
"Vol.30:338. http://mjiri.iums.ac.ir2.7%(27-28), 7.6-29.6%(10,28), and 23.4 - 38.3%(28-29)in 20-39, and 40 -59 age groups and in population of over 60 years of age, respectively.",Non-OADS,/arxiv_data1/oa_pdf/9a/51/mjiri-30-338.PMC4898837.pdf
"Vol.30:338.http://mjiri.iums.ac.irdrivers in Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/9a/51/mjiri-30-338.PMC4898837.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
Vol.30:325.http://mjiri.iums.ac.irorders(1).,Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
"Vol.30:325. http://mjiri.iums.ac.irStudy Objective The original objective of the present study was to conduct a systematic review to compare efficacy and safety of atomoxetine to methylphenidate however because the trials were not individually powerful enough to detect differences in t he thera- peutic effects of the drugs, a meta -analysis was conducted by extracting and analyzing data from all available clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
"Vol.30:325. http://mjiri.iums.ac.irunder the produced outcomes, and the mean difference was calculated based on the random effects model at the confidence interval of 95%.",OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
Vol.30:325. http://mjiri.iums.ac.irwhen the articles were found relevant to the meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
"Vol.30:325.http://mjiri.iums.ac.ir(18,21), once a day in three studies (23-25), and three times a day in two studies (19,20).",Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
"Vol.30:325.  http://mjiri.iums.ac.irtients with a history of bipolar and psycho- logical disorders, an xiety, convulsion, and Tourette syndrome were excluded.",Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
"Vol.30:325. http://mjiri.iums.ac.iratomoxetine, the effect size was -5% at 95%CI (-0.20, 0.10) and (Z= 68%, p= 0.49) which meant that IR -MPH had no prefe r- ence to atomoxetine.",Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
"Vol.30:325. http://mjiri.iums.ac.iret al., which had lasted three weeks, from their meta -analysis.",OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
Vol.30:325.http://mjiri.iums.ac.irogeneity.,Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
Vol.30:325. http://mjiri.iums.ac.ir26-41.,Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
"Vol.30:325.http://mjiri.iums.ac.irtry, and allied disciplines 2014.",Non-OADS,/arxiv_data1/oa_pdf/96/f0/mjiri-30-325.PMC4898838.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
Vol.30:317.http://mjiri.iums.ac.irIntroduction Prostate cancer is one of the most co m- mon malignant cancers around the world.,Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
"Vol.30:317. http://mjiri.iums.ac.ircate articles, two reviewers inde pendently assessed the titles and abstracts of search results and selected potentially relevant studies according to our main question (T a- ble 1).",Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
"Vol.30:317. http://mjiri.iums.ac.irFrom the 485 remaining papers, 421were excluded by reviewing their titles and a b- stracts.",Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
Vol.30:317.http://mjiri.iums.ac.ir weeks of ADT  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
"Vol.30:317.  http://mjiri.iums.ac.ircant (I2=78%,p= 0.01), we did not pooled data.",OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
"Vol.30:317. http://mjiri.iums.ac.irTestosterone level reduction Two studies (13,18)reported the serum testosterone level ≤0.5ng/ml between 1 -28 days of treatment.",Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
"Vol.30:317.  http://mjiri.iums.ac.irwhereas for goserelin they were −72.2, −93.1 and −93.0%.",OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
"Vol.30:317. http://mjiri.iums.ac.iranalysis results revealed that deagrelix and GnRHagonists are similar in this outcome (OR=1.04, 95% CI: 0.75 to 1.44, p= 0.83) (Fig.9).",OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
Vol.30:317. http://mjiri.iums.ac.irand connective tissue A Es (26% versus 17%; p< 0.05) were more common with leuprolide.,Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
Vol.30:317.http://mjiri.iums.ac.irwhich needs to be addressed.,Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
"Vol.30:317. http://mjiri.iums.ac.irvs leuprolide treatme nt in patients with advanced prostate cancer: PSA failures during a randomised, phase 3 trial (CS21).",Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
Vol.30:317.http://mjiri.iums.ac.irAppendix 1 MEDLINE search strategy 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/e7/mjiri-30-317.PMC4898839.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
"Vol.30:323.http://mjiri.iums.ac.ireases such as heart disease, cancers and d i- abetes and conditions fuelled by tobacco use, unhealthy diets, physical inactivity, and harmful use of alcohol, and 3) Acc i- dents, injuries, road accidents, violence and crime(4).",Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
Vol.30:323. http://mjiri.iums.ac.iring urban services.,Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
"Vol.30:323.http://mjiri.iums.ac.ircluding written correspondence and sen d- ing questionnaires, interview guide, using a familiar interviewer, and confidentiality.",Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
"Vol.30:323. http://mjiri.iums.ac.irhealth councils, recruitment of Sal a- matyaran (community health workers), e d-ucating and empowering the community about prevention particularly by establis h- Table 1.",Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
"Vol.30:323.http://mjiri.iums.ac.iring Faramouz (learner) centers to teach life skills to children and adolescents and pr e- vent high risk behaviors, assessment and announcement of health and equity cond i- tions of residents th roughout regions of Tehran city and identifying problems of each region in 2010 Urban HEART pr o- jects (17), Intersectoral cooperation pa rticu- larly through Neighborhood Health Cou n- cils with participation of the repr esentatives of the Ministry of Education , Police Force (Disciplinary Force), and the NGOs.",Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
"Vol.30:323. http://mjiri.iums.ac.ircils), increasing available financial r e- sources and infrastru ctures, simplification and offering a new definition of health (s o- cial determinants of health approach) f o- cusing on “health for all” through “all for health”, legislating new laws (%3 of total municipal revenues should be spent on health costs and %10 on s ocial expenditure and poverty reduction), presence of Te h- ran’s Strategic Document prior to fo r- mation of General Department of Health and Annual planning, support of WHO, subject-oriented programs (Commemorate the occasions), trust of organizations such asWelfare Organization and also staff co n- tribution.",Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
Vol.30:323.http://mjiri.iums.ac.irattention to effectiveness of plans and the held courses; paying attention to the quant i- ty of programs rather than the quality of performed activities and failure to intr o- duce scientific indices for evaluating health-oriented programs are also among problems and obstacles.,Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
"Vol.30:323. http://mjiri.iums.ac.iring to requirements and circumstances of each city; introduction of health -oriented actions of Tehran Municip ality through: 1) holding health exhibitions in other cities to be visited by their authorities and holding educational workshops, 2) piloting Health Department plans (e.g.",Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
Vol.30:323.http://mjiri.iums.ac.irand child friendly cities.,Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
"Vol.30:323. http://mjiri.iums.ac.irlooks like that the main problem is weak prioritization of resources and then if not enough, more att empts should be made to attract further resources.",Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
Vol.30:323.http://mjiri.iums.ac.iranatomistes 2002;86:35 -37.,Non-OADS,/arxiv_data1/oa_pdf/3b/09/mjiri-30-323.PMC4898840.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339.http://mjiri.iums.ac.ircanal.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339. http://mjiri.iums.ac.irtematic review of the evidences regarding effectiveness of the vertebral column i m- plant systems (i.e.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339. http://mjiri.iums.ac.iries were c ategorized into static and dyna m- ic implants and the pooled index of mean difference values were calculated for each.,OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339. http://mjiri.iums.ac.irstudy and the reasons of their exclusion are mentioned in the annex.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
"Vol.30:339. http://mjiri.iums.ac.irthe pooled index, the weighted mean di f- ference of intended index before and after intervention through the meta -analysis was used.",OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339. http://mjiri.iums.ac.irused.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339.http://mjiri.iums.ac.iradded to the decision -making model.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339.  http://mjiri.iums.ac.ir780.7 US dollars.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339.http://mjiri.iums.ac.irsolute cost -effectiveness of dynamic i m- plants compared with laminectomy (less cost and higher effectiveness) considering 47-50% probability of success for lamine c- tomy which makes the incremental cost - effectiveness of dynamic implants negative.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339. http://mjiri.iums.ac.irimplants are potentially more cost -effective than laminectomy (less complication and cost).,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339.http://mjiri.iums.ac.irof lumbar spinal stenosis with microdecompression and interspinous distraction device insertion.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Vol.30:339. http://mjiri.iums.ac.irspacer versus open decompression: a 2 -year follow - up of clinical outcome and quality of life.,Non-OADS,/arxiv_data1/oa_pdf/10/36/mjiri-30-339.PMC4898842.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/13/mjiri-30-334.PMC4898843.pdf
Vol.30:334.http://mjiri.iums.ac.irIntroduction Excessive secretion of adrenocortic o- trophic hormone (ACTH) by a pituitary corticotroph adenoma is the most prevalent cause of endogenous Cushing's disease.,Non-OADS,/arxiv_data1/oa_pdf/6f/13/mjiri-30-334.PMC4898843.pdf
Vol.30:334. http://mjiri.iums.ac.irrespectively.,Non-OADS,/arxiv_data1/oa_pdf/6f/13/mjiri-30-334.PMC4898843.pdf
"Vol.30:334.  http://mjiri.iums.ac.irnine (64.5%) respondents indicated the use of both serum ACTH and classic high dose dexamethasone suppression test, while 12 (15.8%) respondents selected modified high dose dexamethasone suppression test for localizing the primary lesion (Fig .1-B).",Non-OADS,/arxiv_data1/oa_pdf/6f/13/mjiri-30-334.PMC4898843.pdf
"Vol.30:334.http://mjiri.iums.ac.irConsidering the available treatment o p- tions,the respondents were asked about the rate of success in the treatment of ACTH dependent Cushing's disease in Iran.",Non-OADS,/arxiv_data1/oa_pdf/6f/13/mjiri-30-334.PMC4898843.pdf
Vol.30:334. http://mjiri.iums.ac.irhydroxylase.,Non-OADS,/arxiv_data1/oa_pdf/6f/13/mjiri-30-334.PMC4898843.pdf
Vol.30:334.http://mjiri.iums.ac.irthe need for long -term surveillance.,Non-OADS,/arxiv_data1/oa_pdf/6f/13/mjiri-30-334.PMC4898843.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/63/2d/mjiri-30-350.PMC4898844.pdf
"Vol.30:350.http://mjiri.iums.ac.irsuggested that more than 90 ,000 HIV i n- fectedindividuals are living in Iran (4).",Non-OADS,/arxiv_data1/oa_pdf/63/2d/mjiri-30-350.PMC4898844.pdf
"http://mjiri.iums.ac.irCorp., Armonk, NY, USA) and paired t - tests was used to analyze the results.",OADS,/arxiv_data1/oa_pdf/63/2d/mjiri-30-350.PMC4898844.pdf
Vol.30:350.http://mjiri.iums.ac.irsignificance (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/63/2d/mjiri-30-350.PMC4898844.pdf
Vol.30:350. http://mjiri.iums.ac.irthe normal range (25).Findings of Linne- banket al.,OADS,/arxiv_data1/oa_pdf/63/2d/mjiri-30-350.PMC4898844.pdf
"Vol.30:350.http://mjiri.iums.ac.irnaive in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross -sectional study.",Non-OADS,/arxiv_data1/oa_pdf/63/2d/mjiri-30-350.PMC4898844.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.PhDofHealth Economics, Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of M ed- ical Sciences, Kerman, Iran.",Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Vol.30:330.http://mjiri.iums.ac.irchanges in policy approaches and plans of health systems particularly in developing countries.,Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Vol.30:330. http://mjiri.iums.ac.irand economic consideration s. The econo m- ic considerations imply the economic eva l- uation that is conducted through cost - effectiveness and cost -utility analyses based on the current modeling approaches including the decision tree and Markov model.,Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
"Vol.30:330.http://mjiri.iums.ac.ircomputing the total cost, the process and activities constituting each therapeutic strategy were identified.",OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
"Vol.30:330. http://mjiri.iums.ac.irHere, some required explanations are pr e- sented: 1.There are no comprehensive statistics on the prevalence of major depressive di s- orders in Iran.",Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Vol.30:330. http://mjiri.iums.ac.irsented in Appendices 1 and 2 .,Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Vol.30:330. http://mjiri.iums.ac.ireach strategy.,Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
"Vol.30:330.http://mjiri.iums.ac.irtreatment session costs were lower for rTMS than ECT, the cost for a course of rTMS was not significantly different from that fora course of ECT as more rTMS se s- sions were given per course (18).",Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Vol.30:330. http://mjiri.iums.ac.iramong the Iranian population and the a u- thors used the prevalence ratio that extrac t- ed from a systematic review in 2010 and expert’s opinions.,Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Available: http://www.who.int/healthinfo/global_ burden_disease/2004_report_update/en.,Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Avail a- ble online at http://www.fda.gov/ohrms/dockets/ ac/07/briefing/2007 -4273b1_01 -FDAExecutiveSum mary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Vol.30:330.http://mjiri.iums.ac.irsion: a multicentre pragmatic randomized controlled trial and economic analysis.HealthTechnol Assess 2007;11:24.,Non-OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
"Vol.30:330. http://mjiri.iums.ac.irAppendix Appendix 1.The rTMS strategy costs components and description Costs Monetary value of costsDescription and source Costs related to the device : All costs were based on a self -report of a manager at rTMS private center, except for costs related to the depreciation that are based on tax laws of the country, the annual deprec i- ation rate was 10%.Cost of purchase 90000000 Cost of deployment and commissioning 2000000 The annual cost of repair and service 80000 The annual cost of depreciation 9000000 Cost of special seat 600000 Cost of the noise reduction tool (two) 30000 Cost of cooling 2000000 Total cost of the device 106710000 Costs related to Human Resources: Human resources costs were calculated only for psychi a- trists.According to the Iran Health Insurance Organization, wages and expected earnings for a psychiatrist is equal to 10.5 million in 1392.It is for 250 working days and 6 hours per day.",OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
"Vol.30:330.http://mjiri.iums.ac.ir Appendix 2.The ECT strategy costs components and description Costs Monetary value of costsDescription and source Costs related to the device : Cost of purchase 11000000 The annual cost of depreciation and services 1100000 Totalcost of the device 12100000 Costs related to Human Resources: Wage was calculated for apsychiatrist , an anesthesiologist and a nurse in aprivate center in one year .Annualsalary of a psychiatrist 75000000 Annual salary of an anesthesiologist 36000000 Annual salary of a nurse 15000000 Cost of examination by a psychiatrist 101200 Costs of care by a nurse 3182400 Total cost of Human Resources 129283600 Total cost of physical space About 14 meters of space were allocated to ECT.",OADS,/arxiv_data1/oa_pdf/37/58/mjiri-30-330.PMC4898845.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________ ________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/af/eb/mjiri-30-326.PMC4898846.pdf
29: 326.http://mjiri.iums.ac.ir(USD 548 billion in health expenditure) (10).,Non-OADS,/arxiv_data1/oa_pdf/af/eb/mjiri-30-326.PMC4898846.pdf
"29: 326. http://mjiri.iums.ac.irof cost benefits or cost effectiveness and cost utility analysis; 2), studies which were apprised type 2 diabetes, 3) outcomes were measured as life years gained (LYGs) or quality-adjusted life years (QALYs) gained and cost saving; and 4) Publication in the English occurred between January 2000 and November 2013.",Non-OADS,/arxiv_data1/oa_pdf/af/eb/mjiri-30-326.PMC4898846.pdf
29: 326.http://mjiri.iums.ac.irone of them took 14 years (14)and other one took 50 years analytical horizon (22).,Non-OADS,/arxiv_data1/oa_pdf/af/eb/mjiri-30-326.PMC4898846.pdf
29: 326. http://mjiri.iums.ac.ircosts of screening for type 2 diabetes melli- tus in 4 studies.,Non-OADS,/arxiv_data1/oa_pdf/af/eb/mjiri-30-326.PMC4898846.pdf
29: 326.http://mjiri.iums.ac.ircosts in their mod els.,Non-OADS,/arxiv_data1/oa_pdf/af/eb/mjiri-30-326.PMC4898846.pdf
"29: 326. http://mjiri.iums.ac.irnosis without repetition (5,14), others used the extra tests as diagnosis test and this could rise the screening costs (15,21,22) .",Non-OADS,/arxiv_data1/oa_pdf/af/eb/mjiri-30-326.PMC4898846.pdf
29: 326. http://mjiri.iums.ac.ir24.,Non-OADS,/arxiv_data1/oa_pdf/af/eb/mjiri-30-326.PMC4898846.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
"Vol.30:313.http://mjiri.iums.ac.iras income per capita, age and sex distrib u- tion and urbanization level on healthcare expenditure in different countries (9).",OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
"Vol.30:313. http://mjiri.iums.ac.irlation of less than 20,000, the self - employed and students.",Non-OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
"Vol.30:313.http://mjiri.iums.ac.irwheresare the first difference of vari a- bles,is the draft component, and is a white noise error process.",OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
"Vol.30:313. http://mjiri.iums.ac.irResults Descriptive Statistics The descriptive statistics of variables used in the study indicated that per capita health expenditure (as measured in current US$) increased from $30 in 1978 to $13,600 in 2011.",Non-OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
"Vol.30:313. http://mjiri.iums.ac.ircent, a similar increase in the proportion of the population aged ≥ 65 years reduces HCE by 1 per cent.",Non-OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
Vol.30:313. http://mjiri.iums.ac.irwithin the two critical lines and therefore there is not any structur e break in the mo d- el.,Non-OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
Vol.30:313.http://mjiri.iums.ac.irpenditures in the short -run.,Non-OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
"13.World Bank, [11/2/2014], available at: http://databank.worldbank.org/data.",Non-OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
"Vol.30:313. http://mjiri.iums.ac.ir20.Samadi A, Homaie Rad E. Determinants of Healthcare Expenditure in Economic Cooperation Organization (ECO) Countries: Evidence from Pa n- el Cointegration Test s. Int J Health Policy Manag, 2013, 1(1):63.",Non-OADS,/arxiv_data1/oa_pdf/c6/90/mjiri-30-313.PMC4898847.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.PhD of Health Education and Promotion, Academic Member of Health Education Department, Saveh University of Medical Sciences, Saveh, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
"Vol.30:314. http://mjiri.iums.ac.irtry (2.26% of the adult population), placing Iran among the countries with the highest prevalence worldwide (2,3).",Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
"Vol.30:314. http://mjiri.iums.ac.irnations and screening behaviors in the Asians(15,16).",Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
Vol.30:314.http://mjiri.iums.ac.iritems and scoring.,Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
Vol.30:314. http://mjiri.iums.ac.irpartners.,Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
Vol.30:314.http://mjiri.iums.ac.irHIV/AIDS transmission in drug addicts in Saveh.,Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
Vol.30:314. http://mjiri.iums.ac.irthat AIDS is a dangerous and incurable di s- ease.A study by Adefuye et al.,Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
Vol.30:314.http://mjiri.iums.ac.irDr.,Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
"C. Drug Prevention, Treatment and HIV/AIDS , Situation Analysis 2015 [cited 2015  1/14/2015]; Available from: http://www.unodc.org/islamicrepublicofiran/drug - prevention -treatment -and-hiv-aids.html.",Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
2013  [cited 2015 1/14/2015]; Available from: http://www.unaids.org/en/ regionscountries/countries/islamicrepublicofiran.,Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
2015  [cited 2015 1/14/2015]; Available from: http://www.who.int/ healthy_settings/types/cities/en/.,Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
Vol.30:314. http://mjiri.iums.ac.irAmong Nurses Based on the Health Belief Model Constructs.,Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
"Vol.30:314.http://mjiri.iums.ac.irin Kathmandu, Nepal: a test of perceived severity and susceptibility.",Non-OADS,/arxiv_data1/oa_pdf/b0/1b/mjiri-30-314.PMC4898848.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/mjiri-30-321.PMC4898849.pdf
"Vol.30:321.http://mjiri.iums.ac.irway to utilize them (2,3).",Non-OADS,/arxiv_data1/oa_pdf/b2/96/mjiri-30-321.PMC4898849.pdf
"Vol.30:321. http://mjiri.iums.ac.ir“What do you think about the conducted HTAs in Iran?” Then he would proceed to questions such as, “Why some decision - makers do not credit HTA reports, even those prepared in Iran?”, “What barriers affect the utilization of HTA reports in Iran?”, “Which solution will improve the current state of utilization of HTA results in the country?”, all the inte rviews were re c- orded after obtaining oral permissions from the interviewees.",Non-OADS,/arxiv_data1/oa_pdf/b2/96/mjiri-30-321.PMC4898849.pdf
Vol.30:321.http://mjiri.iums.ac.irTentativeness of the instructions and unsuitably of student admission.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/mjiri-30-321.PMC4898849.pdf
"Vol.30:321. http://mjiri.iums.ac.ircedure goes like this; first doctors start to prescribe a new medicine for people, then, since that new medicine does not exist in the market, demand for that particular me d- icine increases.",Non-OADS,/arxiv_data1/oa_pdf/b2/96/mjiri-30-321.PMC4898849.pdf
Vol.30:321.http://mjiri.iums.ac.irProfessional level There are significant proposals in this category such as making the language of HTAs appropriate for service provi ders and providing clear information on HTA r e- ports by creating open websites all stoc k- holders.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/mjiri-30-321.PMC4898849.pdf
Vol.30:321. http://mjiri.iums.ac.irnature of utilization of HTA is different in each and eve ry country; in some countries such as United Kingdom acting in accor d- ance with HTAs is obligatory while in many others it is only recommended (14).,Non-OADS,/arxiv_data1/oa_pdf/b2/96/mjiri-30-321.PMC4898849.pdf
Vol.30:321.http://mjiri.iums.ac.irmedicine and rehabili tation 1981;62(1):31 -34.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/mjiri-30-321.PMC4898849.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ______________________________________________ ______________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Vol.30:333. http://mjiri.iums.ac.irinterest in different activities.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Vol.30:333.http://mjiri.iums.ac.iritem named “other activities” was added.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Vol.30:333. http://mjiri.iums.ac.irwas performed on 21 parents of th ese chil- dren.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Vol.30:333.http://mjiri.iums.ac.irhow much the parent is satisfied (for the parent-report version) were also reported for all the activities.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Vol.30:333. http://mjiri.iums.ac.irold.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Vol.30:333.http://mjiri.iums.ac.irture on children’s community participation in Israel.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Vol.30:333. http://mjiri.iums.ac.irAppendix Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Vol.30:333.http://mjiri.iums.ac.ir Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/63/4a/mjiri-30-333.PMC4898850.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
"The safety and effectiveness of the current treatment regimen with ... 2 http://mjiri.iums.ac.irCOPDismore common inseventh and eighth decades of lifeandhas alowpreva- lencein people less than 40 years of age .It shows a higher prevalence inthose with low socioeconomic status (SES) ,and it is directlycorrelated with ratesofsmoking andairpollution (9).",Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
"Vol.30:332.http://mjiri.iums.ac.irInclusion and Exclusion Criteria Adults older than 18 years of age with COPD, as defined by the American Thora c- ic Society, European Respiratory Society or GOLD, with an airflow obstruction evident by spirometry, with post -bronchodilator FEV1/FVC ≤ 0.7(20)were included in the study.",Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
"The safety and effectiveness of the current treatment regimen with ... 4 http://mjiri.iums.ac.ir Table4.How to find clinical effectiveness studies Databases Keywords N. finding PubMedCopd or coad or pulmonary disease, chronic obstructive or chronic obstructive pulmonary di s- ease orchronic airway disorder or chronic airway limitation or chronic obstructive respiratory disease or chronic obstructive lung disease or pulmonary disease773252 Roflumilast or daxas or daliresp or phosphodisterase4 or phosphodisterase 4 or pde4 or pde 4 or pde four or ""phosphodisterase 4*"" or ""pde4*""5344 tiotropium or spiriva or fluticasone or flixotide or fluticasone salmeterol or advair or seretide or salmeterol or serevent or ICS or inhaled corticosteroid* or LAMA or long acting muscarinic receptor antagonist or long acting muscarinic antago nist or LABA or long acting* agonist or long acting beta -adrenoceptor agonist or long acting beta agonist or long acting*33302 Randomized controll ed trial or controlled clinical trial or randomized or clinical trial or rando m- ly or trial or systematic review or placebo3011066 Total 81 CochranePulmonary disease or chronic obstructive lung disease or chronic obstructive respiratory disease: ti, ab, kw or chronic airway limitation or chronic airway disorder or chronic obstructive pulm o- nary disease or pulmonary disease, chronic obstructive: ti, ab, kw or Copd or coad: ti, ab, kw (Word variations have been searched)13725 Phosphodisterase4 or phosphodisterase 4 or pde4 or pde 4 or pde four or ""phosphodisterase 4*"" or ""pde4*"":ti, ab, kw or roflumilast or daxas or daliresp: ti, ab, kw (Word variations have been searched)266 Tiotropium or spiriva or fluticasone or flixotide or fluticasone salmeterol or advair or seretide or salmeterol or serevent: ti,ab,kw or ICS or inhaled cor ticosteroid* or LAMA or long acting mu s- carinic receptor antagonist or long acting muscarinic antagonist or LABA or long acting* ag o- nist or long acting beta -adernoceptor agonist or long acting beta agonist or long acting*:ti, ab, kw (Word variations have be en searched)10238 Randomized controlled trial or controlled clinical trial or randomized or clinical trial or rando m- ly or trial or systematic revi ew or placebo500687 Total 20 E.E = 1 CRDCopd or coad or pulmonary disease, chronic obstructive or chronic obstructive pulmonary di s- ease or chronic airway disorder or chronic airway limitation or chronic obstructive respiratory disease or chronic obstructive lung disease or pulmonary dise ase815 Phosphodisterase4 or phosphodisterase 4 or pde4 or pde 4 or pde four or ""phosphodisterase 4*"" or ""pde4*"":ti,ab,kw or roflumilast or daxas o r daliresp:ti,ab,kw (Word variations have been searched)14 Tiotropium or spiriva or fluticasone or flixotide or fluticasone salmeterol or advair o r seretide or salmeterol or serevent:ti,ab,kw or ICS or inhaled corticosteroid* or LAMA or long acting mu s- carinic receptor antagonist or long acting muscarinic antagonist or LABA or long acting* ag o- nist or long acting beta -adernoceptor agonist or long acti ng beta agonist or long acting*:ti,ab,kw (Word variations have been searched)422 Randomized controlled trial or controlled clinical trial or rando mized or clinical trial or rando m- ly or trial or systematic review or placebo44998 Total 3 ClinicalTrials.gov ""Copd"" AND ""roflumilast"" 33 atsjournals.org 21 Controlled trials.",Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
"The safety and effectiveness of the current treatment regimen with ... 6 http://mjiri.iums.ac.irM2- 125PivotalDouble-blind, randomized, pl a- cebocontrolled, parallel group (roflumilast 500 µg once daily); four-week single -blind placebo run-in followed by a treatment period of 52 weeks.",Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
Vol.30:332.http://mjiri.iums.ac.irof 24 weeks.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
"The safety and effectiveness of the current treatment regimen with ... 8 http://mjiri.iums.ac.irde Mey, C 2011 Title: No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subj ects: an open -label, randomized, actively controlled   study Exit reason: Phar macokinetic Study8 Calverley 2007 Title: Effect of 1 -Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease Exit reason: FEV 141%9 The HERO -study M2-1212013 Title: Effects of Roflumilast in Patients With COPD (Chronic Obstruct ive Pulmonary Disease) (BY217/M2 -121) Exit reason: FEV1 ≤65%10 Hui D M2-1192011 Title: Roﬂumilast in Asian patients with  COPD: A randomized placebo -controlled trial [Abstract] Exit reason:  FEV1 30 -80%11 APTA-06 2005 Title: Efficacy and Safety of R oflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA -2217- 06) Exit reason: FEV1 30 -80%12 APTA-08 2005 Title: Long -term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older   Than 40  Yea rs With Chronic Obstructive Pulmonary Disease (APTA -2217-08) Exit reason: FEV1 30 -80%13 Klaus F Rabe 2005 Title: Roflumilast —an oral anti -inflammatory treatment for chronic obstructive pulmonary disease: a randomized controlled trial Exit reason: FEV1 30-80%14 ACROSS 2012 Title: A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast  on Safety and Effectiveness in China, Hong Kong and Singapore Exit reason: The comparison group differed15 M2-110 2003 Title:Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2 -110) Exit reason: : lack of access to the full text16 Two reviewers independently screened the search results to select citations to retrieve the full texts, and they also screened the full -texts of the articles to identify the appropriate studies for inclusion.",Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
The safety and effectiveness of the current treatment regimen with ... 10 http://mjiri.iums.ac.irand quality assessment of the studies are presented in Table 5.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
Vol.30:332.http://mjiri.iums.ac.irSGRQ total score was observed for patients with chronic bronchitis ( p= 0.0265).,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
"The safety and effectiveness of the current treatment regimen with ... 12 http://mjiri.iums.ac.irand in accordance with the FDA Draft Guidance for Industry: “Chronic Obstru c- tive Pulmonary Disease: Development of Drugs for Treatment” (November 2 007) (29), most patients were treated with roflumilast for six months to one year.",Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
Vol.30:332.http://mjiri.iums.ac.irlation.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
"The safety and effectiveness of the current treatment regimen with ... 14 http://mjiri.iums.ac.irprove short -term lung function and reduce exacerbations, but have not been shown to increase life expectancy.",Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
Vol.30:332.http://mjiri.iums.ac.ir1.The importation and/ or production of the drug in the country 2.Drug coverage by insurance 3.Arranging and planning to use the drug information in the preparation of national guidelines Adding this medi cation to the country’s drug list Role of the Funding Source: The sponsor did not place any restrictions on authors about the statements made in the final r e- port.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
"The safety and effectiveness of the current treatment regimen with ... 16 http://mjiri.iums.ac.ir23.Calverley P, Rabe KF, Goehring U -M, Kristiansen S, Fabbri LM, Martinez FJ.",Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
Vol.30:332.http://mjiri.iums.ac.irAppendix The results of a meta-analysisof effectiveness : Analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
The safety and effectiveness of the current treatment regimen with ... 18 http://mjiri.iums.ac.irAnalysis 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
Vol.30:332. http://mjiri.iums.ac.ir Analysis 7.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
The safety and effectiveness of the current treatment regimen with ... 20 http://mjiri.iums.ac.irThe results of a meta-analysis: Analysis 10.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
Vol.30:332.http://mjiri.iums.ac.irAnalysis 14.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
The safety and effectiveness of the current treatment regimen with ... 22 http://mjiri.iums.ac.irAnalysis 17.,Non-OADS,/arxiv_data1/oa_pdf/2b/d5/mjiri-30-332.PMC4898851.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/9a/mjiri-30-322.PMC4898852.pdf
"Vol.30:322.http://mjiri.iums.ac.ircause of cirrhosis (4,5).",Non-OADS,/arxiv_data1/oa_pdf/c6/9a/mjiri-30-322.PMC4898852.pdf
Vol.30:322. http://mjiri.iums.ac.irmercial kits.,Non-OADS,/arxiv_data1/oa_pdf/c6/9a/mjiri-30-322.PMC4898852.pdf
"Vol.30:322.http://mjiri.iums.ac.irand ALT than those without steatosis (p<0.05).However, the AST, ALP, UA, PT, TBIL, DBIL and Hb were not signi ficantly different between both groups ( p>0.05).",Non-OADS,/arxiv_data1/oa_pdf/c6/9a/mjiri-30-322.PMC4898852.pdf
"Vol.30:322. http://mjiri.iums.ac.irwere subdivided into four groups (Table 2): without steatosis in 48 (41.7%) patients, mild in 45 (39.1%), moderate in 19 (16.5%), and severe in 3 (2.6%) .Consider- ing the HAI score, as it is shown in Table 3, there was a significant association between patients with and without steatosis in terms of liver necroinflammation.",Non-OADS,/arxiv_data1/oa_pdf/c6/9a/mjiri-30-322.PMC4898852.pdf
"Vol.30:322.http://mjiri.iums.ac.irIn this study, there was no link between cholesterol level and the presence of steat o- sis.",OADS,/arxiv_data1/oa_pdf/c6/9a/mjiri-30-322.PMC4898852.pdf
Vol.30:322. http://mjiri.iums.ac.irAcknowledgements This research has been supported by Te h- ran University of Medical Sciences & Health Services grant (No.,Non-OADS,/arxiv_data1/oa_pdf/c6/9a/mjiri-30-322.PMC4898852.pdf
Vol.30:322.http://mjiri.iums.ac.irsteatohepatitis: a proposal for grading and staging the histological lesions.,Non-OADS,/arxiv_data1/oa_pdf/c6/9a/mjiri-30-322.PMC4898852.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran(MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
"Vol.30:329.http://mjiri.iums.ac.irWithin the recent years, the use of health technologies for diagnosis and treatment of diseases experienced considerable and a c- celerated growth.",Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
"Vol.30:329. http://mjiri.iums.ac.irphase) were analyzed and synthesized into six main themes as follows: 1) Health ou t- comes; 2) Disease and target population; 3) Technology alternative s; 4) Economic a s- pects; 5) Evidence; 6) Other factors (Table 1,Appendix 2).",Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Vol.30:329.http://mjiri.iums.ac.irmore than 10% (reduction of absolute risk) and improvement of phys ical and mental performance were used (12).,Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
"Vol.30:329. http://mjiri.iums.ac.irFuture In the view of the Canadian people, the potential of technology to detect a cond i- tion, which if treated early, averts costs in the future, was assumed for priority setting (24).",Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Vol.30:329.http://mjiri.iums.ac.irtion size inf luenced by disease was used for decision making in Thailand (19).,OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
"Vol.30:329. http://mjiri.iums.ac.irtions, cost effectiveness (in two states: Cost effectiveness: Incremental cost effectiv e- ness ratio lower than one and more than GDP per capita and without cost effectiv e- ness: Incremental cost effectiveness ratio more than one and more than GDP per ca p- ita)was defined (19).",Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Vol.30:329.http://mjiri.iums.ac.irtions were considered for decision making in health technologies in Germany (14).,Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
"Vol.30:329. http://mjiri.iums.ac.irE.3) Relevance and Validity of Evidence In EVIDEM, relevance and validity of e v- idence, with respect to the need for dec i- sion-making, was used (5).",OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Vol.30:329.http://mjiri.iums.ac.ircan affect the importance of assessment use?” (26).,Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Vol.30:329. http://mjiri.iums.ac.irthe main criteria in priority setting of health technology assessment.,Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Vol.30:329.http://mjiri.iums.ac.irself-assessment accord ing to national criteria for priority setting.,Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Vol.30:329. http://mjiri.iums.ac.iractivities.,Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Vol.30:329.http://mjiri.iums.ac.ir Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/be/83/mjiri-30-329.PMC4898853.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
Vol.30:345.http://mjiri.iums.ac.irpatients’ dissatisfaction.,Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
"Vol.30:345. http://mjiri.iums.ac.irSystematic review of research question What consequences have been off -site sterilization centers in terms of effic acy, effectiveness and costs for the hospitals a p- plying this technology?",Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
Vol.30:345.http://mjiri.iums.ac.irused in order to economic evaluation of off-site sterilization technology.,Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
Vol.30:345. http://mjiri.iums.ac.ir(15) supported by the Atlas.ti 6 Software package.,OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
Vol.30:345. http://mjiri.iums.ac.irsafe and sterile tools in both methods is the same.,Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
"Vol.30:345. http://mjiri.iums.ac.irvestment, less need for personnel in the hospital and saving in fuel and supporting costs of hospital, all are considered as e f- fective factors in the hospital effic acy.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
"Vol.30:345.http://mjiri.iums.ac.irC: The scope of contractor related factors In this scope the view and the satisfa c- tion’s extent of clinical teams with the co n- tractors’ performance, mutual trust, and the existence of valid institute with technical knowledge were the main considered su b- jects by the interviewers.",Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
"Vol.30:345. http://mjiri.iums.ac.irversity experts should propound the stan d- ards, proce dures and policies that the co n- tractor should perform and provide mech a- nism to enforce them (24,25 ,26).",Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
Vol.30:345.http://mjiri.iums.ac.irtors.,Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
Vol.30:345. http://mjiri.iums.ac.irIran2015.,Non-OADS,/arxiv_data1/oa_pdf/85/f9/mjiri-30-345.PMC4898854.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _________________________________ ___________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/46/14/mjiri-30-335.PMC4898855.pdf
29: 335.http://mjiri.iums.ac.irsessments (3).,Non-OADS,/arxiv_data1/oa_pdf/46/14/mjiri-30-335.PMC4898855.pdf
"29: 335. http://mjiri.iums.ac.irmales and 45 females) were literate, aged 20-50 years, right -handed and acquired Persian as their first language.",Non-OADS,/arxiv_data1/oa_pdf/46/14/mjiri-30-335.PMC4898855.pdf
29: 335.http://mjiri.iums.ac.irtest-retest interval was within 14 days (in a subsample of 30 subjects).,Non-OADS,/arxiv_data1/oa_pdf/46/14/mjiri-30-335.PMC4898855.pdf
"29: 335. http://mjiri.iums.ac.irMoreover, when each homophone was e x- cluded from the analysis, the alpha reliabi l- ity of the scale was not improved.",Non-OADS,/arxiv_data1/oa_pdf/46/14/mjiri-30-335.PMC4898855.pdf
29: 335.http://mjiri.iums.ac.irsian HMGT.,Non-OADS,/arxiv_data1/oa_pdf/46/14/mjiri-30-335.PMC4898855.pdf
29: 335. http://mjiri.iums.ac.irmore correlated with semantic clustering than phonemic clustering.,Non-OADS,/arxiv_data1/oa_pdf/46/14/mjiri-30-335.PMC4898855.pdf
29: 335.http://mjiri.iums.ac.irtive analysis.,Non-OADS,/arxiv_data1/oa_pdf/46/14/mjiri-30-335.PMC4898855.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ________________________________ ____________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/47/mjiri-30-319.PMC4898856.pdf
"Vol.30:319.http://mjiri.iums.ac.irone or more foot ulcers, and 15 -25% need amputation at the end (2).",Non-OADS,/arxiv_data1/oa_pdf/f8/47/mjiri-30-319.PMC4898856.pdf
"Vol.30:319. http://mjiri.iums.ac.irsidering the inclusion and exclusion criter i- on, five articles were ultimately included in the final assessment phase, and two studies were removed.",Non-OADS,/arxiv_data1/oa_pdf/f8/47/mjiri-30-319.PMC4898856.pdf
"Vol.30:319.http://mjiri.iums.ac.irstudy was on health technology assessment (7), two articles were related to economic evaluation (8,9), one study was a multice n- ter randomized controlled trial (3)and one study was a systematic review (1).",Non-OADS,/arxiv_data1/oa_pdf/f8/47/mjiri-30-319.PMC4898856.pdf
"Vol.30:319. http://mjiri.iums.ac.irNotwithstanding, quality of the included studies in this review was lower than the appropriate value and there were important differences in the use of other therapies such as compressing that may affect the both debridement and healing between the two groups and inappropriately on the short follow-up times.",Non-OADS,/arxiv_data1/oa_pdf/f8/47/mjiri-30-319.PMC4898856.pdf
"Vol.30:319.http://mjiri.iums.ac.ir1,712 persons that had foot ulcer were screened.",Non-OADS,/arxiv_data1/oa_pdf/f8/47/mjiri-30-319.PMC4898856.pdf
Vol.30:319. http://mjiri.iums.ac.irneeds to be paid to the treatment of patients with common methods.,Non-OADS,/arxiv_data1/oa_pdf/f8/47/mjiri-30-319.PMC4898856.pdf
"Letter to Editor http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ *(Corresponding author )MD, PhD, Adjunct -Professor of Internal Medicine, Armed Forces Hospital and Catholic University, Brasília -DF, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/2a/87/mjiri-30-337.PMC4898857.pdf
"Vol.30:337.http://mjiri.iums.ac.irtions, enhance the risk of death in anicteric leptospirosis, and may lead to higher rates of morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/2a/87/mjiri-30-337.PMC4898857.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/80/52/mjiri-30-340.PMC4898859.pdf
Vol.30:340.http://mjiri.iums.ac.iras with less income and lower sociocultural levels (1-4).,Non-OADS,/arxiv_data1/oa_pdf/80/52/mjiri-30-340.PMC4898859.pdf
Vol.30:340. http://mjiri.iums.ac.irwere calculated for each pe rson per day using the food composition table in the n a- tional consumption survey.,OADS,/arxiv_data1/oa_pdf/80/52/mjiri-30-340.PMC4898859.pdf
"Vol.30:340.http://mjiri.iums.ac.irThe findings revealed that in affluent zones of Tehran (north and center), protein density was the highest along with high l i- pid density, indicating high animal protein intake.",OADS,/arxiv_data1/oa_pdf/80/52/mjiri-30-340.PMC4898859.pdf
"Vol.30:340. http://mjiri.iums.ac.irthat the share and density of carbohydrate was highest in the south and West of Te h- ran, it seems that carbohydrat e sources play a major role in the food pattern of the pe o- ple of the south and west of Tehran.",Non-OADS,/arxiv_data1/oa_pdf/80/52/mjiri-30-340.PMC4898859.pdf
Vol.30:340.http://mjiri.iums.ac.irnians (30 -33).,Non-OADS,/arxiv_data1/oa_pdf/80/52/mjiri-30-340.PMC4898859.pdf
"Vol.30:340. http://mjiri.iums.ac.ir20.Drewnowski A, Fulgoni VL, 3rd.",Non-OADS,/arxiv_data1/oa_pdf/80/52/mjiri-30-340.PMC4898859.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/d0/mjiri-30-328.PMC4898860.pdf
"Vol.30:328. http://mjiri.iums.ac.irgenetic factors, thicker cortex and long d u- ration of BP use, suboptimal 25 -OHD level, and bone densi ty in the non-osteoporotic range might play important roles (6, 9).",Non-OADS,/arxiv_data1/oa_pdf/fc/d0/mjiri-30-328.PMC4898860.pdf
"Vol.30:328.  http://mjiri.iums.ac.irmural shaft were measured in 3.5 and 4 cm of greater trochanter (GT) and 0.5 cm under smaller trochanter (LT)  in  BMD and in 9.5 and 10.5 cm of GT and 1 cm under LT in plain pelvic graphs (Shi madsu, Japan) according to accommodation of size in this Xray of a patient.",OADS,/arxiv_data1/oa_pdf/fc/d0/mjiri-30-328.PMC4898860.pdf
Vol.30:328.http://mjiri.iums.ac.irThe cortical thickness parameters in DXA pelvicX-rayare demonstrated in Table 3.,OADS,/arxiv_data1/oa_pdf/fc/d0/mjiri-30-328.PMC4898860.pdf
Vol.30:328. http://mjiri.iums.ac.irenergy injury due to changes of structural components that reduce mechanical prope r- ties under cyclic loading conditions (12).,Non-OADS,/arxiv_data1/oa_pdf/fc/d0/mjiri-30-328.PMC4898860.pdf
Vol.30:328.http://mjiri.iums.ac.irsubtrochanteric region in BMD or plain pelvic X-ray.,Non-OADS,/arxiv_data1/oa_pdf/fc/d0/mjiri-30-328.PMC4898860.pdf
"Vol.30:328. http://mjiri.iums.ac.irNapoli N, Papapoulos S, et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/d0/mjiri-30-328.PMC4898860.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _________ ___________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/da/f7/mjiri-30-316.PMC4898866.pdf
Vol.30:316.http://mjiri.iums.ac.irproductivity in order to find out how one must combine factors and resources of pr o- duction to provide the required services (1).,Non-OADS,/arxiv_data1/oa_pdf/da/f7/mjiri-30-316.PMC4898866.pdf
Vol.30:316. http://mjiri.iums.ac.irover the period between 2009 and 2014.,Non-OADS,/arxiv_data1/oa_pdf/da/f7/mjiri-30-316.PMC4898866.pdf
"Vol.30:316.http://mjiri.iums.ac.irefficiency indicates that managers’ hard work, effort and scheme of management, personnel’s efforts and the correct combi- nation of production factors have led to i n- creased productivity in hospitals.",Non-OADS,/arxiv_data1/oa_pdf/da/f7/mjiri-30-316.PMC4898866.pdf
"Vol.30:316. http://mjiri.iums.ac.irThe analysis of Malmquist productivity index changes based on separate influen c- ing factors indicates that during the period under review, technical efficiency changes and technological changes have averagely the most and least positive impact on the productivity, respectively.",OADS,/arxiv_data1/oa_pdf/da/f7/mjiri-30-316.PMC4898866.pdf
Vol.30:316.http://mjiri.iums.ac.iryears 2000 and 2006.,Non-OADS,/arxiv_data1/oa_pdf/da/f7/mjiri-30-316.PMC4898866.pdf
"Vol.30:316. http://mjiri.iums.ac.irer implementa tion of the new system of administration of hospitals; establishing appropriate performance -based payment system and reward and punishment system for employees, use of appropriate manag e- ment practices in accordance with the r e- quirements, holding training c ourses for personnel, changing working conditions and personnel motivation methods, impro v- ing systems, laws and regulations, circulars, instructions, methods, technologies, and etc.",Non-OADS,/arxiv_data1/oa_pdf/da/f7/mjiri-30-316.PMC4898866.pdf
Vol.30:316.http://mjiri.iums.ac.irperspectives to measuring productivity.,Non-OADS,/arxiv_data1/oa_pdf/da/f7/mjiri-30-316.PMC4898866.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
"Vol.30:336.http://mjiri.iums.ac.irsystem (CNS) which affects the brain and spinal cord, in which infiltrating lymph o- cytes, predominantly T -cells and macr o- phages lead to damage of the myelin sheath (1-5).",Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
Vol.30:336. http://mjiri.iums.ac.irized controlled trials (Fig.5).,Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
Vol.30:336.http://mjiri.iums.ac.irweight monthly in the study by Fazekas et al.,Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
"Vol.30:336.  http://mjiri.iums.ac.irmeasures included change in burden of di s- ease volume, change in brain parenchymal fraction, ratio and cumulative number of unique newly active lesions (20).",Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
Vol.30:336. http://mjiri.iums.ac.ir1998; Lewanska et al.,Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
"Vol.30:336.  http://mjiri.iums.ac.irmentwith IVIG, or placebo.",Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
Vol.30:336.http://mjiri.iums.ac.irremarkably consistent in the meta -analysis.,Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
Vol.30:336. http://mjiri.iums.ac.irpatients.,Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
Vol.30:336.http://mjiri.iums.ac.irand only two trails compared two different doses of IVIG with placebo ( Lewanska et al.,Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
"Vol.30:336. http://mjiri.iums.ac.ir13.Fernández Liguori N, Rojas JI, Klajn DS, Ciapponi A.",Non-OADS,/arxiv_data1/oa_pdf/f5/ce/mjiri-30-336.PMC4898867.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327.http://mjiri.iums.ac.irtypically without symptoms (5).,Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327. http://mjiri.iums.ac.irthat calculated and compared the cost per symptoms free cases and cost per QALYs for treatment regimens of Helicobacter p y- loriinfection.,OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327.http://mjiri.iums.ac.irthe case for p roton pomp inhibitors.,Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327. http://mjiri.iums.ac.irtwo private laboratories in Tehran.,Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
"Vol.30:327. http://mjiri.iums.ac.irphysician’s cost, is measured by the nee d- ed time to perform each test, or the energy cost is calculated through the KW per hour.",Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
"Vol.30:327. http://mjiri.iums.ac.irregimens), a probabilistic sensitivity anal y- sis was conducted (Fig.",Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
"Vol.30:327.http://mjiri.iums.ac.irTable 2, indicating that in triple treatment regimen, serology based strategy has clear dominancy to 13 CUBT strategy in both aspects of cost per symptoms free and cost per QALY.",Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327. http://mjiri.iums.ac.irThe Monte Carlo simulation result has been presented in Figure3.,OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
"Vol.30:327.http://mjiri.iums.ac.irFinally, the scatter planes of symptoms - freecases in antisecretory treatment when serology was used as the first diagnostic test against t he serology is shown in Fig ure 6.",Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
"Vol.30:327. http://mjiri.iums.ac.irAlthough the carbon -13urea breath is more expensive, it is remarkably effective and can reduce the endoscopy referral burden.",Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327.http://mjiri.iums.ac.ir56:1-9.,Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327. http://mjiri.iums.ac.irbismuth-containing quadruple therapy versus mox i- floxacin-based triple therapy.,Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327.http://mjiri.iums.ac.irAppendix Fig.,Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Vol.30:327. http://mjiri.iums.ac.ir Fig.,Non-OADS,/arxiv_data1/oa_pdf/27/b3/mjiri-30-327.PMC4898868.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
Vol.30:331.http://mjiri.iums.ac.irnologies in this area can impose a signif i- cant financial burden to health system.,Non-OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
Vol.30:331.  http://mjiri.iums.ac.iruncertain conditions.,Non-OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
Vol.30:331.http://mjiri.iums.ac.ir10).,Non-OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
Vol.30:331. http://mjiri.iums.ac.irthe ratio for radiation dose were changed from least emission rate (11) to most ( 1).,OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
"Vol.30:331.http://mjiri.iums.ac.irRecommendations for future research Due to the lack of evidence on clin ical ef- fectiveness of EOS imaging, it is reco m- mended that studies to be conducted with proper design to ensure about additional benefits of this technology.",Non-OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
"4.CriticalAppraisal SkillsProgramme (CASP), 2014, http://www.systematicreviewsjournal.com/ content/supplementary/ 139-3-4053-2046-s8.pdf.Ox ford.",Non-OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
Vol.30:331. http://mjiri.iums.ac.irties.,Non-OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
Vol.30:331.http://mjiri.iums.ac.irJul;65(1):E4 -7.,Non-OADS,/arxiv_data1/oa_pdf/34/02/mjiri-30-331.PMC4898869.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ___________________________________________________________________________________________________________ _________ 1.,Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
Vol.30:318.http://mjiri.iums.ac.irprovement of the quality of life of cancer patients throughout the world (2).,Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
"Vol.30:318. http://mjiri.iums.ac.irrion of study type based on clinical ev i- dences pyramid included systematic review studies and health technology assessment studies, economic evaluation studies, health technologies horizon scanning studies were included in the stud y.",Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
"Vol.30:318.http://mjiri.iums.ac.ir1-1.Toxicity Rate: In general image - guided radiotherapy, regardless of its ima g- ing technique, is not associated with a m a- jor toxicity; and in one of the studies, it wasproved that the prescribed dose is not ass o- ciated with toxicity consequences.",Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
Vol.30:318. http://mjiri.iums.ac.iraspects of IGRT is its additional radiation dose(2).,Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
Vol.30:318.http://mjiri.iums.ac.ir3.Economic Evaluation Results obtained for economic evaluation of this technology was analyzed in the the r- apeutic costs subgroup: 3-1.Treatment Costs :Daily use of IGRT and 3D imaging for controlling the p a- tient’s position in prostate cancer therapy results in a significant addit ional cost in comparison to 2D imaging and weekly co n- trol(10).,Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
Vol.30:318. http://mjiri.iums.ac.irfirmed that may be due to cost impacts of IGRT.,Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
Available: http://sunshineaffiliate.com/subodh/wp1/list -of- test/radiation -therapy-oncology/ .,Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
"Vol.30:318.http://mjiri.iums.ac.irAppendix 1 In this study, two search strategies were used: Search strategy for Cochrane library #1) Image near/2 guide* 365 #2) radiation near/2 therapy 3999 #3) #1 and #2 45 #4) IGRT 13 #5) #3 or #4 51 Search strategy for Medline via PubMed #1)Search""image guided radiation therapy"" 460 #2)Search ""image -guided radiation ther a- py""460 #3) Search ((#1 or #2)) 460",Non-OADS,/arxiv_data1/oa_pdf/29/6c/mjiri-30-318.PMC4898870.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences __________________________________________________________________________________________________________________ __ 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
Health technology assessment of non -invasive weight loss intervention 2 http://mjiri.iums.ac.irorder and the main risk factor for chronic and non-infectious diseases worldwide (2).,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
"Vol.30:348. http://mjiri.iums.ac.irMethods Literature Review In thepresent study, a systematic review and search were done in different databases to find the evidence for the outcome of the mentioned technologies.",OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
Health technology assessment of non -invasive weight loss intervention 4 http://mjiri.iums.ac.irdiofrequency .,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
Vol.30:348. http://mjiri.iums.ac.irand clinics.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
Health technology assessment of non -invasive weight loss intervention 8 http://mjiri.iums.ac.irTable 3.Characteristics of included Studies on Systematic Review for Lipolysis Lipolysis NAuthor YearNo.Problem Sex Intervention TechnologySystem Follow-upClinical Outcome 1Mulholland [17]201267Cellulite Female Lipolysis Zerona Laser2 weeks The mean difference of tissue circumference and reduced size of cellulite in the patients were 2.8 inch at the end of intervention.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
Vol.30:348.  http://mjiri.iums.ac.ir Fig.1.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
Health technology assessment of non -invasive weight loss intervention 12 http://mjiri.iums.ac.irhighest and lowest influence on the ou t- come of each intervention was defined based on the outcomes.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
"Health technology assessment of non -invasive weight loss intervention 14 http://mjiri.iums.ac.irtellvíA, Bonet R, Palomer X, et al.TheEffects of Liposuction Removal of Subcutaneous Abdominal Fat on Lipid Metabolism are Independent of Insulin Sensitivity in Normal -Overweight Individuals.Obesity Surgery April 2008 ;18(4):408-414.",Non-OADS,/arxiv_data1/oa_pdf/a8/9b/mjiri-30-348.PMC4898871.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/6a/e7/mjiri-30-320.PMC4898872.pdf
Vol.30:320.http://mjiri.iums.ac.irstimulates IL -6 and IL-8 and may be ass o- ciated with oxidative stress parameters.,Non-OADS,/arxiv_data1/oa_pdf/6a/e7/mjiri-30-320.PMC4898872.pdf
Vol.30:320. http://mjiri.iums.ac.irdisease-free controls were enrolled.,Non-OADS,/arxiv_data1/oa_pdf/6a/e7/mjiri-30-320.PMC4898872.pdf
"Vol.30:320.http://mjiri.iums.ac.irrelationship between obesity, BMI and s e- rum levels of visfatin has also been doc u- mented(2,6).Although the visfatin level had a significant relation with the BMI va l- ue in our adenoma patients, we found no statistical significant relation in the healthy controls.",Non-OADS,/arxiv_data1/oa_pdf/6a/e7/mjiri-30-320.PMC4898872.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/58/a4/mjiri-30-341.PMC4898873.pdf
"Vol.30:341.http://mjiri.iums.ac.irand appropriate socket for the patient r e- quires correct and detailed casting (6,7).",Non-OADS,/arxiv_data1/oa_pdf/58/a4/mjiri-30-341.PMC4898873.pdf
"Vol.30:341.  http://mjiri.iums.ac.irNegative and Positive Casts Preparation In the next step, the participants were chosen randomly for providing cast with two different methods with 30 -minute in- terval between each casting process.",Non-OADS,/arxiv_data1/oa_pdf/58/a4/mjiri-30-341.PMC4898873.pdf
Vol.30:341.http://mjiri.iums.ac.irminutes was considered before walking tr i- al with other prosthesis (13).,Non-OADS,/arxiv_data1/oa_pdf/58/a4/mjiri-30-341.PMC4898873.pdf
"Vol.30:341.  http://mjiri.iums.ac.irDiscussion In this study, two sockets with two diffe r- ent casting methods (weight bearing and air pressure methods) were prepared for 15 transtibial amputees (totally 30 sockets).",OADS,/arxiv_data1/oa_pdf/58/a4/mjiri-30-341.PMC4898873.pdf
Vol.30:341.http://mjiri.iums.ac.irmethod.,Non-OADS,/arxiv_data1/oa_pdf/58/a4/mjiri-30-341.PMC4898873.pdf
Vol.30:341. http://mjiri.iums.ac.irFuture researches are recommended to compare air pressure casting method which has triggered greater satisfaction among the amputees in this study with hydrostatic casting methods that water is used as a fluid instead of air.,Non-OADS,/arxiv_data1/oa_pdf/58/a4/mjiri-30-341.PMC4898873.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ________________________________ ____________________________________________________________________________________ 1.PhD Health Service Management, Associate Professor, Health Human Resource Research Center, School of Management and Medical I n- formation ,Shiraz University of Medical Sciences, Shiraz, Iran .zhr.kavosi@gmail.com 2.MScof Health Economics, Student Research Committee, School of Management and Medical Information, Shiraz University of Medical Sciences, Shiraz, Iran .maryamsarikhani@yahoo.com 3.PhD of Pharmacoeconomics an d Pharmaceutical Administration, Assistant Professor ,Department of Health Economic and Health Human Resource Research Center, School of Management and Medical Information, Shiraz University of Medical Sciences, Shiraz, Iran .",Non-OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
"Vol.30:347.http://mjiri.iums.ac.irIntroduction End-stage renal disease (ESRD) is a cli n- ical condition with uremic syndrome which has a very poor prognosis for patients (1).It isone of the most important life - threatening diseases in the world, incurring considerable social and economic burden on patients, their families and society (2).",Non-OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
"Vol.30:347. http://mjiri.iums.ac.ir2)According to the systematic review, taurolidine -citrate is safer than heparin - gentamicin in the prevention of catheter - related infections in hemodialysis patients.",Non-OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
Vol.30:347.http://mjiri.iums.ac.irsidered as accep table in terms of quality.,Non-OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
Vol.30:347.  http://mjiri.iums.ac.irCRB Episode: The outcome of CRB ep i- sode was investigated in all studies.,Non-OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
"Vol.30:347. http://mjiri.iums.ac.irratio was most sensitive to the effectiveness oftaurolidine -citrate, and least sensitive to the cost of taurolidine -citrate compared to heparin, (Fig.",Non-OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
Vol.30:347.http://mjiri.iums.ac.irperformance compared to heparin.,OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
Vol.30:347. http://mjiri.iums.ac.iraccess care among hemodialysis patients.,Non-OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
"Vol.30:347.http://mjiri.iums.ac.irAppendix Search Strategies Data Base Years Search Strategies References Identified PubMed 1996-2013 1)“Taurolock” OR “Taurolidin citrate” 2)“Catheter -related Infection” OR “Cath e- ter-related sepsis” 3)Hemodilysis 4)Heparin lock 5)“1” AND “2” 6)“1” AND “3” 7)“1” AND “4”231 Scopus 235 Web of knowledge ISI 647 Cochrane 44 Total 1157 What are these studies and their design, aims and results?",Non-OADS,/arxiv_data1/oa_pdf/a9/93/mjiri-30-347.PMC4898874.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
Vol.30:315.http://mjiri.iums.ac.irthe perspective of equity and financial risk protection is considered as the worst poss i- ble way of debt financing and exposes i n- dividuals with a lot of risks (2).,Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
Vol.30:315. http://mjiri.iums.ac.irthat 31% of respondents stated that they had at least one -time informal payment.,Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
Vol.30:315.http://mjiri.iums.ac.irused  Chi -square test.,Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
"Vol.30:315. http://mjiri.iums.ac.irceiving  requests  for informal payment (from doctors and other staff), is reported in Table 1.",Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
Vol.30:315.http://mjiri.iums.ac.irran and the rest in o ther cities or villages.,Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
Vol.30:315. http://mjiri.iums.ac.irments to medical or administrative staff.,Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
Vol.30:315.http://mjiri.iums.ac.irleagues’ findings.,Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
"Vol.30:315. http://mjiri.iums.ac.irlevels, improving quantity and quality of health services and trying to change the opinions which believe informal paymen ts are necessary (changing the culture) can be effective in controlling such payments.",Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
Vol.30:315.http://mjiri.iums.ac.irstudy from Turkey.,Non-OADS,/arxiv_data1/oa_pdf/91/89/mjiri-30-315.PMC4898875.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/04/15/mjiri-30-312.PMC4898876.pdf
Vol.30:312.http://mjiri.iums.ac.irterms.,Non-OADS,/arxiv_data1/oa_pdf/04/15/mjiri-30-312.PMC4898876.pdf
"Vol.30:312. http://mjiri.iums.ac.iradding neurons to the middle layer, a pe r- ceptron ANN with similar variables were developed.",OADS,/arxiv_data1/oa_pdf/04/15/mjiri-30-312.PMC4898876.pdf
Vol.30:312.http://mjiri.iums.ac.irANN method has more precision in concurrent affliction to hypertension and diabetes than the joint LR.,Non-OADS,/arxiv_data1/oa_pdf/04/15/mjiri-30-312.PMC4898876.pdf
Vol.30:312. http://mjiri.iums.ac.irIt is suggested to use some new variables such as stress and smoking to find better predictions.,Non-OADS,/arxiv_data1/oa_pdf/04/15/mjiri-30-312.PMC4898876.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________________________________ _____________ 1.,Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
Vol.30:349.http://mjiri.iums.ac.irty.,Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
Vol.30:349. http://mjiri.iums.ac.irwere selected randomly (100 girls in the intervention group and 100 girls in the co n- trol group).,Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
"Vol.30:349.http://mjiri.iums.ac.irdiabetes and its importance, complications, types, and risk factors (attitude) (sessions one and two),  significance of improving and protecting the adolescents’ health, and expectations of society, family and friends from the adolescents to protect their health (subjective norm) (sessions three and four), importance of changing lifestyle to prevent diabetes (the perceiv ed behavioral control) and healthy nutrition to prevent diabetes (sessions five and six) (21,22).According to the program schedule, after determining the purposes of each educational session, an educational content was presented via a short lecture, and t hen the scenarios based on the problem -solving design were pre- sented to the adolescents.",Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
Vol.30:349. http://mjiri.iums.ac.ircates that there is a significant increase in the mean of the score of the theory comp o- nents within the control group before and after the educational program (p<001).,Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
"Vol.30:349.http://mjiri.iums.ac.irmight suffer from type -2 diabetes in the adolescence or adulthood, as a result of i g- noring the risk factors of the ty pe-2 diabe- tes.",Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
"Vol.30:349. http://mjiri.iums.ac.irnot involvement of friends and families were the causes of their failure, however, Baker’s study of the adolescents with the purpose of predicting nutrition and beha v- ior patterns based on the TPB also failed modify the adolescents’ subjective norms (28).",Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
"Vol.30:349.http://mjiri.iums.ac.irAcknowledgment We would like to appreciate Vice - chancellery for research of Tehran Unive r- sity of Medical Sciences, which provided financial support.",Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
Vol.30:349. http://mjiri.iums.ac.irNationalcenter for statistics of Iran; 2011.,Non-OADS,/arxiv_data1/oa_pdf/42/e7/mjiri-30-349.PMC4898877.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Repub lic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
Vol.30:343.http://mjiri.iums.ac.ir5.,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
Vol.30:343. http://mjiri.iums.ac.irunsafe behaviors from the students; suffer from some limitations in choosing the me n- tioned methods (17-19).,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
Vol.30:343. http://mjiri.iums.ac.irTotal Risk Estimation5=% 100RPNin 1  MRN ni (5) Where RPNi= Risk priority number for each po s- sible hazard (cause) N= Number of hazards (causes)in each project or laboratory MRN= Maximum risk number upon calculating risk.,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
Vol.30:343.  http://mjiri.iums.ac.irtems in the site outlet.,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
"Vol.30:343.http://mjiri.iums.ac.irThe evaluation and comparison of resid u- al and initial risks among the total health, safety and environmental hazards revealed that the mitigated risk was equal to 65% ofthe total risk post -intervention.",OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
Vol.30:343. http://mjiri.iums.ac.irinherent risks (in addition to 3% risk which was deemed to be negligible) at the tested research complexes.,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
Vol.30:343.http://mjiri.iums.ac.ircan be rooted in the large number an d vari- ety of machinery with a long working life (press machine and elevators).,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
"5.http://www.directives.doe.gov ,Office of Health, Safety and Security , DOEG 414.1-1C.",Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
"6.http://www.epa.gov/oppfead1/trac/science/cum ulative_guidance.pdf, 2002 .",OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
"7.http://www.hc -sc.gc.ca/ewh -semt/air/out -ext/re search-recherche -eng.php.2012, 8.Goyal RK.",OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
Vol.30:343. http://mjiri.iums.ac.ir2010:215 -225.,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
edition (http://www.machine build- ing.net/n/n2306.htm ) 15.U.S.,Non-OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
"Planning and Scoping .Science Policy Cou n- cil, 20460 July 3, 1997.http://www.epa.gov/sites/ production/files/2014 -11/documents/frmwrk_cum_ risk_assmnt.pdf.",OADS,/arxiv_data1/oa_pdf/78/4b/mjiri-30-343.PMC4898878.pdf
"Journal of  Preventive Medicine  & Public Health 165 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:165-175    •  http://dx.doi.org/10.3961/jpmph.16.022 Risk Factors for Preterm Birth and Low Birth Weight  Among Pregnant Indian Women: A Hospital-based   Prospective Study Chaitanya Tellapragada1, Vandana Kalwaje Eshwara2, Parvati Bhat3, Shashidhar Acharya4, Asha Kamath5,   Shashikala Bhat3, Chythra Rao5, Sathisha Nayak3, Chiranjay Mukhopadhyay2 1Directorate of Research (Health Sciences), Manipal University, Manipal; 2Department of Microbiology, Kasturba Medical College,   Manipal University, Manipal; 3Department of Obstetrics and Gynecology, Melaka Manipal Medical College, Manipal University, Manipal;  4Department of Community Dentistry, Manipal College of Dental Sciences, Manipal University, Manipal; 5Department of Community Medicine,  Kasturba Medical College, Manipal University, Manipal, IndiaOriginal Article Objectives: The present study was undertaken to study the maternal risk factors for preterm birth (PTB) and low birth weight (LBW)  with a special emphasis on assessing the proportions of maternal genitourinary and periodontal infections among Indian women and  their association with adverse pregnancy outcomes.",Non-OADS,/arxiv_data1/oa_pdf/c7/52/jpmph-49-3-165.PMC4898897.pdf
"Key words:  Bacteriuria, Bacterial vaginosis, Intermediate vaginal flora, Low birth weight, Periodontitis, Premature birth  Received:  February 22, 2016 Accepted:  May 19, 2016 Corresponding author:  Vandana Kalwaje Eshwara, MD  Manipal, Karnataka 576104, India  Tel: +91-820-2923171, Fax:  +91-820-2593214 E-mail:  vandanake@gmail.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Preterm birth (PTB) is an obstetric complication of complex  etiology associated with significant neonatal mortality and  morbidity worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c7/52/jpmph-49-3-165.PMC4898897.pdf
ORCID Chaitanya Tellapragada http://orcid.org/0000-0002-0117- 5369 Vandana Kalwaje Eshwara http://orcid.org/0000-0001-7561- 4435,Non-OADS,/arxiv_data1/oa_pdf/c7/52/jpmph-49-3-165.PMC4898897.pdf
Available from: http://www.unicef.,Non-OADS,/arxiv_data1/oa_pdf/c7/52/jpmph-49-3-165.PMC4898897.pdf
"Journal of  Preventive Medicine  & Public Health 143 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:143-152    •  http://dx.doi.org/10.3961/jpmph.16.021 Metabolic Risk Profile and Cancer in Korean Men and  Women  Seulki Ko1, Seok-Jun Yoon1, Dongwoo Kim1, A-Rim Kim2, Eun-Jung Kim3*, Hye-Young Seo2 1Department of Preventive Medicine, Korea University College of Medicine, Seoul; 2Department of Public Health, Graduate School of Korea   University, Seoul; 3Department of Economics, Economic Research Institute, Korea University, Seoul, KoreaOriginal Article Objectives: Metabolic syndrome is a cluster of risk factors for type 2 diabetes mellitus and cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/0a/3b/jpmph-49-3-143.PMC4898898.pdf
"Key words:  Metabolic syndrome, Risk factors, Neoplasms, Cohort studies  Received:  February 22, 2016 Accepted:  April 5, 2016 Corresponding author:  Seok-Jun Yoon, MD, PhD 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea Tel: +82-2-2286-1412, Fax:  +82-2-927-7220   E-mail:  yoonsj02@korea.ac.kr * Current affiliation: Department of Nursing, Pyeongtaek University, Pyeongtaek,  Korea This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Metabolic syndrome is defined as a cluster of risk factor for  type 2 diabetes mellitus and cardiovascular disease [1,2].",Non-OADS,/arxiv_data1/oa_pdf/0a/3b/jpmph-49-3-143.PMC4898898.pdf
151Metabolic Syndrome and Cancer in Korea ORCID  Seulki Ko http://orcid.org/0000-0003-0346-2035 Seok-Jun Yoon http://orcid.org/0000-0003-3297-0071 Dongwoo Kim http://orcid.org/0000-0001-7731-4081 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/3b/jpmph-49-3-143.PMC4898898.pdf
Available from:  http://www.wpro.who.,Non-OADS,/arxiv_data1/oa_pdf/0a/3b/jpmph-49-3-143.PMC4898898.pdf
"Journal of  Preventive Medicine  & Public Health 153 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:153-164    •  http://dx.doi.org/10.3961/jpmph.16.014 Blood Triglycerides Levels and Dietary Carbohydrate   Indices in Healthy Koreans Hye Sook Min1, Ji Yeon Kang2, Joohon Sung1, Mi Kyung Kim2 1Department of Preventive Medicine, Graduate School of Public Health, Seoul National University, Seoul; 2Department of Preventive Medicine,   Hanyang University College of Medicine, Seoul, KoreaOriginal Article Objectives: Previous studies have obtained conflicting findings regarding possible associations between indices measuring carbohy - drate intake and dyslipidemia, which is an established risk factor of coronary heart disease.",Non-OADS,/arxiv_data1/oa_pdf/de/ac/jpmph-49-3-153.PMC4898899.pdf
"Key words:  Carbohydrate, Glycemic index, Glycemic load, Dyslipidemias, Triglycerides Received:  February 2, 2016 Accepted:  April 22, 2016 Corresponding author:  Mi Kyung Kim, PhD 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea Tel: +82-2-2220-0667,  Fax:  +82-2-2293-0660 E-mail:  kmkkim@hanyang.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION  The glycemic index (GI) is a relative ranking of the post- prandial blood glucose level for each carbohydrate-containing  food when compared to 50 g of glucose or a reference food,  such as white bread, and the glycemic load (GL) of a food is a  measure of the quantity (g) of a carbohydrate in addition to its  quality (GI).",Non-OADS,/arxiv_data1/oa_pdf/de/ac/jpmph-49-3-153.PMC4898899.pdf
ORCID  Hye Sook Min http://orcid.org/ 0000-0003-0029-5163 Joohon Sung http://orcid.org/0000-0001-9948-0160 Mi Kyung Kim  http://orcid.org/0000-0001-8503-2631 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/de/ac/jpmph-49-3-153.PMC4898899.pdf
"Journal of  Preventive Medicine  & Public Health 176 Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:176-182    •  http://dx.doi.org/10.3961/jpmph.16.012 Depressive Symptoms on the Geriatric Depression Scale  and Suicide Deaths in Older Middle-aged Men:   A Prospective Cohort Study Sang-Wook Yi1,2 1 Department of Preventive Medicine and Public Health, Catholic Kwandong University College of Medicine, Gangneung; 2Institute for Clinical and  Translational Research, Catholic Kwandong University, Gangneung, KoreaBrief Report Objectives: Prospective evaluations of the associations between depressive symptoms and suicide deaths have been mainly per - formed in high-risk populations, such as individuals with psychiatric disorders or histories of self-harm.",Non-OADS,/arxiv_data1/oa_pdf/cf/d6/jpmph-49-3-176.PMC4898900.pdf
"Key words:  Asia, Cohort studies, Depression, Men, Suicide  Received:  January 26, 2016 Accepted:  April 1, 2016 Corresponding author:  Sang-Wook Yi, MD, PhD 24 Beomil-ro 579beon-gil, Gangneung 25601, Korea Tel: +82-33-649-7468, Fax:  +82-33-641-1074 E-mail:  flyhigh@cku.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Korea had the highest rate of suicide deaths among the Or - ganization for Economic Cooperation and Development coun - tries from 2003 to 2012 (26 to 34 per 100 000) [1], with over 10  000 people per year dying by suicide.",Non-OADS,/arxiv_data1/oa_pdf/cf/d6/jpmph-49-3-176.PMC4898900.pdf
ORCID Sang-Wook Yi  http://orcid.org/0000-0002-6656-6205 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/d6/jpmph-49-3-176.PMC4898900.pdf
Available from: http://www.oecd.org/ health/health-systems/OECD-Health-Statistics-2015-Fre - quently-Requested-Data.xls.,OADS,/arxiv_data1/oa_pdf/cf/d6/jpmph-49-3-176.PMC4898900.pdf
"RESULTS Patient Population Baseline demographic and clinical characteristics for the 3 pooled study populations were well matched across treatment groups (Supplementary Table 1, Supplemental Digital Content 1, http://links.lww.com/JCP/A339).",Non-OADS,/arxiv_data1/oa_pdf/f4/72/jcp-35-706.PMC4898901.pdf
"Data for quetiapine XR and placebo aregiven in Supplementary Table 1, Supplemental Digital Content 1,http://links.lww.com/JCP/A339 and Supplementary Table 2, Supplemental Digital Content 2, http://links.lww.com/JCP/A340.",OADS,/arxiv_data1/oa_pdf/f4/72/jcp-35-706.PMC4898901.pdf
"Predictive Value of Early Improvement in Response to Placebo Therapy For the adjunctive placebo plus antidepressant therapy popu- lation, the Yule ’s Q coefficient for the predictive value of 15% or more improvement on MADRS at 2 weeks for eventual MADRS response at 6 weeks was lower than the corresponding predic-tive value for quetiapine XR; the Yule ’s Q coefficient ranged from 0.72 to 0.76 (Supplementary Tabl e 2, Supplemental Digital Content 2, http://links.lww.com/JCP/A340 and Supplementary Table 3,Supplemental Digital Content 3, http://links.lww.com/JCP/A341).Remission (MADRS total score ≤12) at 6 weeks was most effi- ciently predicted by a 30% improvement on MADRS at 2 weeksin this group.",Non-OADS,/arxiv_data1/oa_pdf/f4/72/jcp-35-706.PMC4898901.pdf
"However, in the flexible-dose placebo population, a greater level of early improve-ment did not seem to correspond to greater predictivity for re- sponse or remission (lower Yule ’sQf o r2 5 % –30% improvement on MADRS at 2 weeks compared with 15% –20% improvement at 2 weeks; Supplementary Table 2, Supplemental Digital Content 2,http://links.lww.com/JCP/A340 and Supplementary Table 3, Sup- plemental Digital Content 3, http://links.lww.com/JCP/A341).",Non-OADS,/arxiv_data1/oa_pdf/f4/72/jcp-35-706.PMC4898901.pdf
Available at: http://www.psychiatryonline.com/pracGuide/pracGuideTopic_7.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f4/72/jcp-35-706.PMC4898901.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cervical cancer Mesonephric carcinoma Mesonephric adenocarcinomaAdenocarcinoma cervix 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/a3/main.PMC4898911.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.05.002 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/a3/main.PMC4898911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/a3/main.PMC4898911.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/a8/main.PMC4898912.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.05.033 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/a8/main.PMC4898912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/c9/main.PMC4898913.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/c9/main.PMC4898913.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.017Urology Case Reports 8 (2016) 1 e3,Non-OADS,/arxiv_data1/oa_pdf/4d/c9/main.PMC4898913.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: OvarySarcomaPregnancyChemotherapy Adnexal mass in pregnancy is an uncommon, but not rare occur- rence with approximately 1 in 600 pregnancies being affected.",Non-OADS,/arxiv_data1/oa_pdf/ac/e4/main.PMC4898914.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.05.008 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/e4/main.PMC4898914.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/e4/main.PMC4898914.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/d8/main.PMC4898915.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/d8/main.PMC4898915.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.007Urology Case Reports 8 (2016) 4 e6,Non-OADS,/arxiv_data1/oa_pdf/c1/d8/main.PMC4898915.pdf
http://dx.doi.org/10.1186/S12894-015-0064-Z .S.,Non-OADS,/arxiv_data1/oa_pdf/c1/d8/main.PMC4898915.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Müllerian origin Umbilical metastasis 1.,Non-OADS,/arxiv_data1/oa_pdf/eb/93/main.PMC4898916.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.05.005 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/93/main.PMC4898916.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/93/main.PMC4898916.pdf
Available at: http://www.apa.org/news/press/releases/2007/10/stress.aspx.,Non-OADS,/arxiv_data1/oa_pdf/bb/fb/OBY-24-794.PMC4898945.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
These studies report aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.05.005 2213-2317/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).☆To distinguish between genes and their proteins, gene names are typed in italics.",Non-OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
32 (2000) 798 –804 [Online] 〈http://www.ncbi.nlm.nih.gov/ pubmed/10845667 〉.,Non-OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
64 (2002) 1019 –1026 [Online] 〈http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
"(2014) , http://dx.doi.org/10.3109/ 00365521.2014.964757 .",Non-OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
Med 26 (1999) 34 –41 〈http://www.ncbi.nlm.nih.gov/pubmed/ 9890638 〉.Å.,Non-OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
46 (2008) 209 –214 [Online] 〈http://www.ncbi.nlm.nih.gov/ pubmed/18334086 〉.,Non-OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
798 (2003) 343 –349 [Online] 〈 http://www.ncbi.nlm.nih.gov/pubmed/ 14643515 〉.,Non-OADS,/arxiv_data1/oa_pdf/82/42/main.PMC4898964.pdf
"targetscan.org/), PicTar (http://pictar.mdc-berlin.de/), miRanda  (http://www.microrna.org/) and DIANA LAB TarBase 5.0  (http://diana.imis.athena-innovation.gr/DianaTools/index.php).",OADS,/arxiv_data1/oa_pdf/5b/be/ijmm-38-01-0113.PMC4899011.pdf
"To  explore the mechanisms responsible for the growth inhibitory  effects of miR -1, we used 4 miRNA target prediction programs ,  TargetScan (http://www.targetscan.org/), PicTar (http://pictar.",OADS,/arxiv_data1/oa_pdf/5b/be/ijmm-38-01-0113.PMC4899011.pdf
"mdc-berlin.de/), miRanda (http://www.microrna.org/) and  DIANA LAB TarBase 5.0 ( http://diana.imis.athena-innovation.",Non-OADS,/arxiv_data1/oa_pdf/5b/be/ijmm-38-01-0113.PMC4899011.pdf
http://www.mirbase.org/.,Non-OADS,/arxiv_data1/oa_pdf/59/c2/ijmm-38-01-0131.PMC4899017.pdf
The bands from western blot analysis  were quantified using ImageJ2x software (http://imagej.net/ ImageJ2).,OADS,/arxiv_data1/oa_pdf/dc/9b/ijmm-38-01-0105.PMC4899026.pdf
The primers for maspin  promoter methylation analysis by PCR were designed by MethPrimer (http://www.urogene.org/methprimer/).,Non-OADS,/arxiv_data1/oa_pdf/dd/fc/or-36-01-0057.PMC4899031.pdf
DNA CpG islands of the maspin  promoter were analyzed by EMBOSS Cpgplot (http://www.ebi.ac.uk/).,OADS,/arxiv_data1/oa_pdf/dd/fc/or-36-01-0057.PMC4899031.pdf
Gene sequences of maspin were analyzed using EMBOSS Cpgplot (http://www.ebi.ac.uk/).,OADS,/arxiv_data1/oa_pdf/dd/fc/or-36-01-0057.PMC4899031.pdf
1 http://repository.edm-forum.org/egems/vol4/iss3/1 DOI: 10.13063/2327-9214.1231,Non-OADS,/arxiv_data1/oa_pdf/7d/68/egems1231.PMC4899050.pdf
1 http://repository.edm-forum.org/egems/vol4/iss3/1 DOI: 10.13063/2327-9214.1231,Non-OADS,/arxiv_data1/oa_pdf/7d/68/egems1231.PMC4899050.pdf
1 http://repository.edm-forum.org/egems/vol4/iss3/1 DOI: 10.13063/2327-9214.1231,Non-OADS,/arxiv_data1/oa_pdf/7d/68/egems1231.PMC4899050.pdf
1 http://repository.edm-forum.org/egems/vol4/iss3/1 DOI: 10.13063/2327-9214.1231,Non-OADS,/arxiv_data1/oa_pdf/7d/68/egems1231.PMC4899050.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Malignant peritoneal mesotheliomaOvarian neoplasmAsbestos 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/02/main.PMC4899076.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.04.003 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/02/main.PMC4899076.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/02/main.PMC4899076.pdf
http://dx.doi.org/10.1007/s10552-009-9328-9 (Aug).,Non-OADS,/arxiv_data1/oa_pdf/1e/02/main.PMC4899076.pdf
"Best Regards, Theodore M. Brasky David E. Cohn Brittany M. BernardoGynecologic Oncology Reports 17 (2016) 1 –2 http://dx.doi.org/10.1016/j.gore.2016.04.007 2352-5789/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e4/62/main.PMC4899077.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/62/main.PMC4899077.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.05.001 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/6b/main.PMC4899078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/6b/main.PMC4899078.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.04.004 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
http://dx.doi.org/10.1038/ modpathol.2012.83 .,OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
"Histopathology 64, 2 –11.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
"2014, 1 –4.http://dx.doi.org/10.1155/2014/216340 .",Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
http://dx.doi.org/10.1007/s00595-003-2559-6 .,Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
http://dx.doi.org/10.1002/cncr.26098 .,Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
http://dx.doi.org/10.1007/ s11605-007-0099-x .,Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
"5, 63. http://dx.doi.org/10.1186/1477-7819-5-63 .",Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
http://dx.doi.org/10.9738/INTSURG-D-14-00141.1 .,OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
http://dx.doi.org/10.1245/s10434-013- 3242-9 .,Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
http://dx.doi.org/10.3748/ wjg.v18.i44.6515 .,Non-OADS,/arxiv_data1/oa_pdf/6f/58/main.PMC4899079.pdf
E-mail address: kawada@nms.ac.jp 5 April 2016Gynecologic Oncology Reports 17 (2016) 12 http://dx.doi.org/10.1016/j.gore.2016.04.008 2352-5789/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/ce/ed/main.PMC4899080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/ed/main.PMC4899080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/c9/main.PMC4899081.pdf
Some critical limitations associated with using soluble NO do- nors that need to be recognized include: (1) the NO donor's ana- lytical concentration does not equal to NO level that cells or tissues experience; (2) NO level that cells actually experience is in ﬂu- enced by species present within the buffer solutions and culture media and by cells and tissues; (3) the NO donor treatment time may not represent the true NO exposure time; (4) NO donor'sContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.05.002 2213-2317/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/c9/main.PMC4899081.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/c9/main.PMC4899081.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Endometrial cancerChemotherapy Tumor grade TreatmentDisease responseResistance 1.,Non-OADS,/arxiv_data1/oa_pdf/da/04/main.PMC4899082.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.04.006 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/da/04/main.PMC4899082.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/04/main.PMC4899082.pdf
1.1:[Available from:) http://www.recist.com/recist-in- practice/01.html .,Non-OADS,/arxiv_data1/oa_pdf/da/04/main.PMC4899082.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/91/main.PMC4899312.pdf
Cut  sections  of  the  mass  showed  gray  tan  surface  with http://dx.doi.org/10.1016/j.ijscr.2016.05.037 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/cf/91/main.PMC4899312.pdf
"31 (January–February  (1))  (2008)  107–111,  Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/18419060.",Non-OADS,/arxiv_data1/oa_pdf/cf/91/main.PMC4899312.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Lymphangioma circumscriptum Vulvar pain LymphaticsCervical cancerGenital wart 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/1b/main.PMC4899408.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.03.006 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/1b/main.PMC4899408.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/1b/main.PMC4899408.pdf
Her symptoms improved after Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.01.006 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/1b/main.PMC4899409.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/1b/main.PMC4899409.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gynecologic mucosal melanoma Vaginal melanomaCervical melanomaIpilimumabImmunotherapyRadiation therapy 1.,Non-OADS,/arxiv_data1/oa_pdf/75/62/main.PMC4899413.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.04.001 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/75/62/main.PMC4899413.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/62/main.PMC4899413.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.03.003 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/36/main.PMC4899414.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/36/main.PMC4899414.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Carcinoma of unknown primary HPV positiveSquamous cell carcinomaChemoradiationp16 positivePelvis and retroperitoneum 1.,Non-OADS,/arxiv_data1/oa_pdf/6c/8a/main.PMC4899416.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.01.005 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/8a/main.PMC4899416.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/8a/main.PMC4899416.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Malignant melanomaMature teratomaDermoidPrognosisTreatmentsLiterature review 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/26/main.PMC4899417.pdf
http://dx.doi.org/10.1016/j.gore.2016.04.005 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/26/main.PMC4899417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/26/main.PMC4899417.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.03.002 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/7d/main.PMC4899419.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/7d/main.PMC4899419.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.03.007 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/b7/main.PMC4899421.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/b7/main.PMC4899421.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gynecologic malignancyClear cell pathologyAcute abdomenOvarian cancerSurgical emergencyTumor capsule rupture 1.,Non-OADS,/arxiv_data1/oa_pdf/49/f3/main.PMC4899427.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.01.003 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/f3/main.PMC4899427.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/f3/main.PMC4899427.pdf
http://dx.doi.org/10.1016/S1470- 2045(14)71028-9 (Mar).,OADS,/arxiv_data1/oa_pdf/96/bc/main.PMC4899481.pdf
http://dx.doi.org/10.1002/jso.24174 (Jan 21).,OADS,/arxiv_data1/oa_pdf/96/bc/main.PMC4899481.pdf
http://dx.doi.org/10.1007/s00404-015-3956-y .,Non-OADS,/arxiv_data1/oa_pdf/96/bc/main.PMC4899481.pdf
http://dx.doi.org/10.1016/j.gore.2016.03.004 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/96/bc/main.PMC4899481.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/bc/main.PMC4899481.pdf
"[http://dx.doi.org/10.1212/WNL.39.4.481] [PMID: 2648186 ] [3] Halmagyi GM, Lessell I, Curthoys IS, Lessell S, Hoyt WF.",OADS,/arxiv_data1/oa_pdf/1b/f5/TOOPHTJ-10-126.PMC4899508.pdf
"[http://dx.doi.org/10.1016/0002-9394(89)90265-1 ] [PMID: 2499196 ] [4] Akdal G, Yener GG, Ada E, Halmagyi GM.",OADS,/arxiv_data1/oa_pdf/1b/f5/TOOPHTJ-10-126.PMC4899508.pdf
"[http://dx.doi.org/10.1111/j.1468-1331.2007.01824.x] [PMID: 17880572] [5] Mayfrank L, Thoden  U. Downbeat nystagmus indicates cerebellar or brain-stem lesions in vitamin B12 deficiency.",Non-OADS,/arxiv_data1/oa_pdf/1b/f5/TOOPHTJ-10-126.PMC4899508.pdf
"[http://dx.doi.org/10.1007/BF00314420 ] [PMID: 3487624] [6] Suzuki  Y,  Matsuda  T,  Washio  N,  Ohtsuka  K.  Transition  from  upbeat  to  downbeat  nystagmus  observed  in  a  patient  with  Wernicke’s encephalopathy.",Non-OADS,/arxiv_data1/oa_pdf/1b/f5/TOOPHTJ-10-126.PMC4899508.pdf
"[http://dx.doi.org/10.1007/s10384-004-0182-8 ] [PMID: 15944827] [7] Barata PC, Morgado J, Sousa AP, et al.",OADS,/arxiv_data1/oa_pdf/1b/f5/TOOPHTJ-10-126.PMC4899508.pdf
"[http://dx.doi.org/10.1159/000345692] [PMID: 23275775] [8] Alkawi A, Kattah JC, Wyman K. Downbeat nystagmus as a result of lamotrigine toxicity.",Non-OADS,/arxiv_data1/oa_pdf/1b/f5/TOOPHTJ-10-126.PMC4899508.pdf
"[http://dx.doi.org/10.1016/j.eplepsyres.2004.11.004 ] [PMID: 15716057 ] [9] Leight RJ, Zee DS.",OADS,/arxiv_data1/oa_pdf/1b/f5/TOOPHTJ-10-126.PMC4899508.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/f5/TOOPHTJ-10-126.PMC4899508.pdf
[http://dx.doi.org/10.1001/archopht.120.6.701 ] [PMID: 12049574 ] [3] The  Advanced  Glaucoma  Intervention  Study  (AGIS):  7.,Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1016/S0002-9394(00)00538-9 ] [PMID: 11024415 ] [4] Maxey KM, Johnson JL, LaBrecque J.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1016/S0039-6257(02)00323-5 ] [PMID: 12204699 ] [5] Davies SS, Ju WK, Neufeld AH, Abran D, Chemtob S, Roberts LJ II.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1089/108076803762718105 ] [PMID: 12648303 ] [6] Camras CB, Toris CB, Sjöquist B, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
[http://dx.doi.org/10.1016/j.ophtha.2004.06.028 ] [PMID: 15582073 ] [7] Stjernschantz  JW.,OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1016/S0039-6257(02)00293-X ] [PMID: 12204698 ] [9] Woodward DF, Krauss AH, Chen J, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1016/S0039-6257(01)00224-7 ] [PMID: 11434936 ] [10] Takagi Y, Nakajima T, Shimazaki A, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
[http://dx.doi.org/10.1016/j.exer.2003.12.007 ] [PMID: 15037111 ] [11] Holló G. The side effects of the prostaglandin analogues.,Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1517/14740338.6.1.45 ] [PMID: 17181451 ] [12] Sharif NA, Kelly CR, Crider JY, Williams GW, Xu SX.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1089/108076803322660422 ] [PMID: 14733708 ] [13] Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1016/j.preteyeres.2010.03.001 ] [PMID: 20302969 ] [14] De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1167/iovs.03-1067 ] [PMID: 15111589 ] [16] Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1097/01.ico.0000116526.57227.82 ] [PMID: 15220734 ] [17] Kahook MY, Noecker RJ.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
[http://dx.doi.org/10.1097/ICO.0b013e31815cf651 ] [PMID: 18362664 ] [18] Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.,Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1111/j.1755-3768.2008.01250.x ] [PMID: 18537937 ] [19] Liang H, Baudouin C, Pauly A, Brignole-Baudouin F. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1136/bjo.2008.138768 ] [PMID: 18723745 ] [20] Tressler CS, Beatty R, Lemp MA.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1016/S1542-0124(11)70024-6 ] [PMID: 21791189 ] [21] Liang H, Pauly A, Riancho L, Baudouin C, Brignole-Baudouin F. Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1136/bjo.2010.189449 ] [PMID: 21429894 ] [22] Pauly A, Roubeix C, Liang H, Brignole-Baudouin F, Baudouin C. In vitro  and in vivo  comparative toxicological study of a new preservative- free latanoprost formulation.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1167/iovs.12-10766 ] [PMID: 23150620 ] [23] Pellinen P, Huhtala A, Tolonen A, Lokkila J, Mäenpä J, Uusitalo H. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro  and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.3109/02713683.2011.626909 ] [PMID: 22049909 ] [24] Stalmans I, Sunaric Mégevand G, Cordeiro MF, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.5301/ejo.5000270 ] [PMID: 23483513 ] [25] Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1136/bjo.86.4.418 ] [PMID: 11914211 ] [26] Jaenen N, Baudouin C, Pouliquen P, Manni G, Figueiredo A, Zeyen T. Ocular symptoms and signs with preserved and preservative-free glaucoma medications.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e31815c5f4f ] [PMID: 18703943 ] [28] Uusitalo H, Chen E, Pfeiffer N, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1111/j.1755-3768.2010.01907.x ] [PMID: 20546237 ] [29] Crichton AC, Vold S, Williams JM, Hollander DA.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
[http://dx.doi.org/10.1007/s12325-013-0014-7 ] [PMID: 23475405 ] [30] Brandt JD.,Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1001/archopht.121.6.892 ] [PMID: 12796264 ] [31] Boimer C, Birt CM.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e31825af67d ] [PMID: 23524856 ] [32] Uusitalo H, Kaarniranta K, Ropo A. Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1111/j.1755-3768.2008.01380.x ] [PMID: 18752509 ] [33] Hamacher T, Airaksinen J, Saarela V, Liinamaa MJ, Richter U, Ropo A. Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1111/j.1755-3768.2008.01381.x ] [PMID: 18752510 ] [34] Konstas AG, Quaranta L, Katsanos A, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1136/bjophthalmol-2012-303026 ] [PMID: 23681371 ] [35] Day DG, Walters TR, Schwartz GF, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1136/bjophthalmol-2012-303040 ] [PMID: 23743437 ] [36] Rouland JF, Traverso CE, Stalmans I, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1136/bjophthalmol-2012-302121 ] [PMID: 23203707 ] [37] Lewis RA, Katz GJ, Weiss MJ, et al.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1097/01.ijg.0000212274.50229.c6 ] [PMID: 17224758 ] [38] Choy CK, Cho P, Boost MV.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1111/j.1444-0938.2011.00687.x ] [PMID: 22233282 ] [39] Choy CK, Cho P, Boost MV, Benzie IF.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1097/OPX.0b013e31819fa422 ] [PMID: 19319011 ] [40] Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1016/j.arr.2007.09.002 ] [PMID: 17964225 ] [41] Ammar  DA,  Noecker  RJ,  Kahook  MY.",OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1007/s12325-010-0070-1 ] [PMID: 20931366 ] [42] Paimela T, Ryhänen T, Kauppinen A, Marttila L, Salminen A, Kaarniranta K. The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1089/jop.2013.0002 ] [PMID: 23905770 ] [44] Smedowski  A,  Paterno  JJ,  Toropainen  E,  Sinha  D,  Wylegala  E,  Kaarniranta  K.  Excipients  of  preservative-free  latanoprost  induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
[http://dx.doi.org/10.1111/j.1755-3768.2013.S008.x ] [46] McDonald T. Shadduck J.,Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2011.03.038 ] [PMID: 21507487 ] [50] Denis P. Adverse effects, adherence and cost-benefits in glaucoma treatment.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
[http://dx.doi.org/10.17925/EOR.2011.05.02.116 ] [51] Parsi K. Interaction of detergent sclerosants with cell membranes.,Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
[http://dx.doi.org/10.1177/0268355514534648 ] [PMID: 24827732 ] © Esaki et al.,Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
"This  is  an  open  access  article  licensed  under  the  terms  of  the  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/c5/TOOPHTJ-10-146.PMC4899509.pdf
[http://dx.doi.org/10.1097/00055735-200102000-00009 ] [PMID: 11150081 ],Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/S0161-6420(02)02000-6 ] [PMID: 12689913 ] [3] Agarwal  A,  Kumar  DA,  Jacob  S,  Baid  C,  Agarwal  A,  Srinivasan  S.  Fibrin  glue-assisted  sutureless  posterior  chamber  intraocular  lens implantation in eyes with deficient posterior capsules.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2008.04.040 ] [PMID: 18721701 ] [4] Dadeya  S,  Kamlesh  K,  Kumari  SP.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2013.03.004 ] [PMID: 23726133 ] [6] Mohr A, Hengerer F, Eckardt C. Retropupillary fixation of the iris claw lens in aphakia.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1007/s00347-001-0563-z ] [PMID: 12148307 ] [7] Menezo JL, Martinez MC, Cisneros AL.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/S0886-3350(96)80151-9 ] [PMID: 9051506 ] [8] Hsing YE, Lee GA. Retropupillary iris claw intraocular lens for aphakia.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1111/j.1442-9071.2012.02808.x ] [PMID: 22594520 ] [9] Güell JL, Velasco F, Malecaze F, Vázquez M, Gris O, Manero F. Secondary Artisan-Verysise aphakic lens implantation.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2005.06.047 ] [PMID: 16473216 ] [10] Baykara M, Ozcetin H, Yilmaz S, Timuçin OB.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.ajo.2007.06.009 ] [PMID: 17692274 ] [11] Gonnermann  J,  Klamann  MK,  Maier  AK,  et  al.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2012.07.035 ] [PMID: 23036355 ] [12] De Silva SR, Arun K, Anandan M, Glover N, Patel CK, Rosen P. Iris-claw intraocular lenses to correct aphakia in the absence of capsule support.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2011.03.051 ] [PMID: 21855764 ] [13] Rao R, Sasidharan A. Iris claw intraocular lens: a viable option in monocular surgical aphakia.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.4103/0301-4738.107198 ] [PMID: 23412525 ] [14] Lett KS, Chaudhuri PR.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1038/eye.2010.146 ] [PMID: 20948556 ] [15] Gonnermann J, Torun N, Klamann MK, et al.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.ajo.2013.03.002 ] [PMID: 23721944 ] [16] Pattnaik L, Almozawak K, Binder S. Pars plana vitrectomy and artisan iris fixated intraocular lens for aphakia in complicated vitreoretinal referrals.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/S2221-6189(13)60109-2 ] [17] Patil KB, Meleth P, Shanker MP.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.4103/0301-4738.86321 ] [PMID: 22011497 ] [18] Anglada R, Castellví J, Parera A, Sabala A. Inverted implantation of posterior iris-fixated intraocular lens with 23G transconjunctival vitrectomy in the management of secondary implant-Technique and stability, astigmatism and endothelial loss outcomes.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1097/01.iae.0000250005.38037.da ] [PMID: 17031292 ] [20] van der Meulen IJ, Gunning FP, Vermeulen MG, de Smet MD.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2004.04.050 ] [PMID: 15617928 ] [21] Riazi M, Moghimi S, Najmi Z, Ghaffari R. Secondary Artisan-Verysise intraocular lens implantation for aphakic correction in post-traumatic vitrectomized eye.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
[http://dx.doi.org/10.1038/eye.2008.271 ] [PMID: 18756286 ],OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1097/IAE.0b013e3181b32eef ] [PMID: 19834354 ] [23] Català-Mora J, Díaz-Cascajosa J, Ferreruela-Sanfeliu G, Castany-Aregall M, Prat-Bartomeu J, García-Arumí J.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1097/IAE.0b013e31824d4f06 ] [PMID: 22643806 ] [24] Farrahi F, Feghhi M, Haghi F, Kasiri A, Afkari A, Latifi M. Iris claw versus  scleral fixation intraocular lens implantation during pars plana vitrectomy.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1111/j.1600-0420.2005.00573.x ] [PMID: 16637836 ] [26] Gonnermann J, Torun N, Klamann MK, et al.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1007/s00417-012-2226-y ] [PMID: 23250481 ] [27] Rüfer F, Saeger M, Nölle B, Roider J. Implantation of retropupillar iris claw lenses with and without combined penetrating keratoplasty.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1007/s00417-008-0940-2 ] [PMID: 18787833 ] [28] Koçak-Altintas AG, Koçak-Midillioglu I, Dengisik F, Duman S. Implantation of scleral-sutured posterior chamber intraocular lenses during penetrating keratoplasty.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/S0002-9394(14)76783-2 ] [PMID: 2039047 ] [30] Soong HK, Musch DC, Kowal V, Sugar A, Meyer RF.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1001/archopht.1989.01070010678026 ] [PMID: 2655567 ] [31] Schein  OD,  Kenyon  KR,  Steinert  RF,  et  al.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/S0161-6420(93)31458-2 ] [PMID: 8414402 ] [32] Price MO, Price FW Jr, Werner L, Berlie C, Mamalis N. Late dislocation of scleral-sutured posterior chamber intraocular lenses.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2004.12.060 ] [PMID: 16105601 ] [33] Gicquel JJ, Guigou S, Bejjani RA, Briat B, Ellies P, Dighiero P. Ultrasound biomicroscopy study of the Verisyse aphakic intraocular lens combined with penetrating keratoplasty in pseudophakic bullous keratopathy.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2006.11.017 ] [PMID: 17321397 ] [34] Rubinstein A, Salmon JF.",OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
[http://dx.doi.org/10.1038/sj.eye.6702476 ] [PMID: 16763651 ] © Ganesh et al.,Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/0b/TOOPHTJ-10-111.PMC4899510.pdf
"[http://dx.doi.org/10.1034/j.1600-0420.2003.00021.x ] [PMID: 12631014 ] [4] Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1001/archopht.126.8.1030 ] [PMID: 18695095 ] [5] Gordon MO, Beiser JA, Brandt JD, et al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1001/archopht.120.6.714 ] [PMID: 12049575 ] [6] Chauhan BC, Mikelberg FS, Artes PH, et al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"Risk Factors for Primary Open Angle Glaucoma The Open Ophthalmology Journal, 2016, Volume 10    137 [http://dx.doi.org/10.1001/archophthalmol.2010.196 ] [PMID: 20696979 ] [7] Paoli D. Glaucoma Management System Seconda Versione: proceedings of XX AISG Associazione Italiana Studio del Glaucoma, Turin 11-12 March 2005; Edizioni Minerva Medica, Torino (Italia); 2005.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1167/iovs.02-0814 ] [PMID: 12766063 ] [10] Nelder J, Wedderburn R. Generalized linear models.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
[http://dx.doi.org/10.1001/jama.2014.3192 ] [PMID: 24825645 ] [15] Barnshaw HD.,Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1097/00004397-197901910-00003 ] [PMID: 376471 ] [16] Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
[http://dx.doi.org/10.1001/archopht.121.1.48 ] [PMID: 12523884 ] [17] The  Advanced  Glaucoma  Intervention  Study  (AGIS):  7.,Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/S0002-9394(00)00538-9 ] [PMID: 11024415 ] [18] Hollows FC, Graham PA. Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1136/bjo.50.10.570 ] [PMID: 5954089 ] [19] Bankes JL, Perkins ES, Tsolakis S, Wright JE.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1136/bjo.65.1.46 ] [PMID: 6969603 ] [21] Mitchell P, Smith W, Attebo K, Healey PR.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/S0161-6420(96)30449-1 ] [PMID: 8874440 ] [22] Giuffrè G, Giammanco R, Dardanoni G, Ponte F. Prevalence of glaucoma and distribution of intraocular pressure in a population.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1111/j.1600-0420.1995.tb00272.x ] [PMID: 7493232 ] [23] Kahn HA, Leibowitz HM, Ganley JP, et al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1001/jama.1991.03470030069026 ] [PMID: 2056646 ] [25] Cedrone C, Culasso F, Cesareo M, Zapelloni A, Cedrone P, Cerulli L. Prevalence of glaucoma in Ponza, Italy: a comparison with other studies.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.3109/09286589709057098 ] [PMID: 9243650 ] [26] Coleman AL, Miglior S. Risk factors for glaucoma onset and progression.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.survophthal.2008.08.006 ] [PMID: 19038621 ] [27] Armaly MF, Krueger DE, Maunder L, et al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1001/archopht.1980.01020041015002 ] [PMID: 7447768 ] [28] Rivera JL, Bell NP, Feldman RM.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1097/ICU.0b013e3282f493b3 ] [PMID: 18301282 ] [29] Bron A, Chaine G, Villain M, et al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
[http://dx.doi.org/10.1016/S0181-5512(08)71443-8 ] [PMID: 18563046 ],OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1001/jama.1991.03470030069026 ] [PMID: 2056646 ] [33] Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1001/archopht.116.12.1640 ] [PMID: 9869795 ] [34] Wu J, Hewitt AW, Green CM, et al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1001/archopht.124.7.950 ] [PMID: 16832017 ] [35] Weih LM, Nanjan M, McCarty CA, Taylor HR.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/S0161-6420(01)00799-0 ] [PMID: 11713063 ] [36] Actis AG, Dall’Orto L, Penna R, Brogliatti B, Rolle T. An internal medicine perspective review of risk factors for assessing and progression of primary open angle glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1167/iovs.08-2956 ] [PMID: 20089880 ] [38] Leske MC, Wu SY, Nemesure B, Hennis A.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1001/archopht.120.7.954 ] [PMID: 12096967 ] [39] Werne A, Harris A, Moore D, BenZion I, Siesky B.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.survophthal.2008.08.021 ] [PMID: 19026319 ] [40] Joe SG, Choi J, Sung KR, et al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
[http://dx.doi.org/10.3341/kjo.2009.23.1.32 ] [PMID: 19337477 ] [41] Gugleta K. Vascular risk factors in glaucoma - diagnostics.,Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1024/1661-8157.98.4.201 ] [PMID: 19224488 ] [42] Doughty MJ, Gillis N, MacGill J, Montgomery DM.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
[http://dx.doi.org/10.1111/j.1475-1313.2008.00596.x ] [PMID: 19076558 ] [43] Kotecha A.,OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.survophthal.2007.08.004 ] [PMID: 17998034 ] [44] Iester M, Mete M, Figus M, Frezzotti P. Incorporating corneal pachymetry into the management of glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.jcrs.2009.05.015 ] [PMID: 19683164 ] [45] Smith KD, Arthurs BP, Saheb N. An association between hypothyroidism and primary open-angle glaucoma.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/S0161-6420(93)31441-7 ] [PMID: 8414419 ] [46] Smith KD, Tevaarwerk GJ, Allen LH.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2004.05.026 ] [PMID: 15350317 ] [49] Cross JM, Girkin CA, Owsley C, McGwin G Jr.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1136/bjo.2008.147165 ] [PMID: 18927223 ] [50] Haefliger IO, von Arx G, Pimentel AR.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
[http://dx.doi.org/10.1055/s-0029-1245199 ] [PMID: 20408077 ],Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1176/appi.neuropsych.12020030 ] [PMID: 24026713 ] [53] Zhou C, Qian S, Wu P, Qiu C. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.jpsychores.2013.03.005 ] [PMID: 23751243 ] [54] Bazin N, Bratu L. Depression in the elderly: prodroma or risk factor for dementia?",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e3182071b7e ] [PMID: 21336151 ] [56] Janssen  SF,  Gorgels  TG,  Ramdas  WD,  et  al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.preteyeres.2013.09.001 ] [PMID: 24055863 ] [57] Ghiso JA, Doudevski I, Ritch R, Rostagno AA.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e3182934af6 ] [PMID: 23733125 ] [58] Hirooka  K,  Manabe  S,  Tenkumo  K,  Nitta  E,  Sato  S,  Tsujikawa  A.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1186/1471-2415-14-118 ] [PMID: 25281998 ] [59] Hood DC, Kardon RH.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.preteyeres.2007.08.001 ] [PMID: 17889587 ] [60] Heijl A, Rossetti L, Goni F. Save Sight Years II Program, Module III Proceedings of Aurora Program, SSY II, Allergan Ophthalmology, Prague 2012.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2014.07.011 ] [PMID: 25444943 ] [62] Iester M, Mermoud A, Schnyder C. Frequency doubling technique in patients with ocular hypertension and glaucoma: correlation with octopus perimeter indices.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/S0161-6420(99)00058-5 ] [PMID: 10690827 ] [63] Iester M, Traverso CE, De Feo F, et al.",OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
[http://dx.doi.org/10.1097/01.ijg.0000176937.93143.bf ] [PMID: 16148585 ] © Actis et al.,OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/f0/TOOPHTJ-10-129.PMC4899511.pdf
"[http://dx.doi.org/10.1016/j.jaapos.2013.05.004 ] [PMID: 23911130 ] [2] Congdon NG, Ruiz S, Suzuki M, Herrera V. Determinants of pediatric cataract program outcomes and follow-up in a large series in Mexico.",Non-OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
[http://dx.doi.org/10.1016/j.jcrs.2007.06.025 ] [PMID: 17889776 ],OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.1016/j.jaapos.2010.02.007 ] [PMID: 20603061 ] [5] Chak M, Rahi JS.",OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.1136/bjo.2006.109603 ] [PMID: 17244652 ] [6] Gogate P, Khandekar R, Shrishrimal M, et al.",OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.3109/09286580903450338 ] [PMID: 20100097 ] [7] Vasavada AR, Nihalani BR.",Non-OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"ID 927840 [Internet] Available from: http://www.hindawi.com/12972584/ [9] Umar MM, Abubakar A, Achi I, Alhassan MB, Hassan A. Pediatric cataract surgery in National Eye Centre Kaduna, Nigeria: outcome and challenges.",Non-OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.4103/0974-9233.148356 ] [PMID: 25624681 ] [10] Bowman RJ, Kabiru J, Negretti G, Wood ML.",OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2007.01.030 ] [PMID: 17448539 ] [11] Khanna RC, Foster A, Krishnaiah S, Mehta MK, Gogate PM.",OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.4103/0301-4738.107194 ] [PMID: 23412523 ] [12] Gogate  PM,  Sahasrabudhe  M,  Shah  M,  et  al.",OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.4103/0301-4738.128630 ] [PMID: 24618489 ] [13] Matalia J, Anaspure H, Shetty BK, Matalia H. Intraoperative usefulness and postoperative results of the endoilluminator for performing primary posterior capsulectomy and anterior vitrectomy during pediatric cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.1038/eye.2014.136 ] [PMID: 24946844 ] [14] Gungor SG, Bulam B, Akman A, Colak M. Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery.",OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.4103/0301-4738.141045 ] [PMID: 25230962 ] [15] Krummenauer F, Landwehr I.",Non-OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.1016/j.sjopt.2012.05.005 ] [PMID: 23961005 ] [17] Hennig A, Schroeder B, Gilbert C. Bilateral pediatric cataract surgery: outcomes of 390 children from Nepal and Northern India.",Non-OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.3928/01913913-20130402-01 ] [PMID: 23565713 ] [18] Gogate P, Patil S, Kulkarni A, et al.",OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"[http://dx.doi.org/10.4103/0301-4738.116465 ] [PMID: 24008794 ] [19] Mwende J, Bronsard A, Mosha M, Bowman R, Geneau R, Courtright P. Delay in presentation to hospital for surgery for congenital and developmental cataract in Tanzania.",Non-OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
[http://dx.doi.org/10.1136/bjo.2005.074146 ] [PMID: 16234457 ] © Duke et al.,OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/81/TOOPHTJ-10-119.PMC4899512.pdf
http://dx.doi.org/10.1016/j.gore.2016.02.001 2352-5789/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/d2/fe/main.PMC4899515.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Multiple factors have an additive effect on decreasing lower extremity perfusion during surgery.,Non-OADS,/arxiv_data1/oa_pdf/d2/fe/main.PMC4899515.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/55/main.PMC4899516.pdf
http://dx.doi.org/10.1016/j.gore.2016.03.001 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/55/main.PMC4899516.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/55/main.PMC4899516.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Adult granulosa cell tumor CytoreductionHIPECIntraperitoneal chemotherapyOvarian neoplasma 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/74/main.PMC4899517.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.03.005 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/74/main.PMC4899517.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/74/main.PMC4899517.pdf
[http://dx.doi.org/10.7326/0003-4819-86-5-569] [PMID: 322563] [2] Goldstein EJ.,Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1093/clinids/23.Supplement_1.S97] [PMID: 8953114] [3] Sears CL, Islam S, Saha A, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1086/591130] [PMID: 18680416] [4] Boleij A, Hechenbleikner EM, Goodwin AC, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1093/cid/ciu787] [PMID: 25305284] [5] Sack RB, Myers LL, Almeido-Hill J, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
[http://dx.doi.org/10.1016/S0378-1097(03)00296-9] [PMID: 12757940] [7] Wexler HM.,OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
[http://dx.doi.org/10.1128/CMR.00008-07] [PMID: 17934076] [8] Salyers AA.,OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1146/annurev.mi.38.100184.001453] [PMID: 6388494] [9] Wick EC, Sears CL.",Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1097/QCO.0b013e32833da1eb] [PMID: 20697287] [10] Troy EB, Kasper DL.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.2741/3603] [PMID: 20036803] [11] Franco AA, Cheng RK, Chung GT, Wu S, Oh HB, Sears CL.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1016/S0041-0101(01)00160-X] [PMID: 11595636] [13] Wu S, Dreyfus LA, Tzianabos AO, Hayashi C, Sears CL.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"62   The Open Microbiology Journal, 2016, Volume 10 Fathi and Wu [http://dx.doi.org/10.1128/IAI.70.5.2463-2471.2002] [PMID: 11953383] [14] Sears CL.",Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1128/CMR.00053-08] [PMID: 19366918] [15] Wu S, Shin J, Zhang G, Cohen M, Franco A, Sears CL.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1128/IAI.00060-06] [PMID: 16926433] [16] Wu S, Lim KC, Huang J, Saidi RF, Sears CL.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1128/IAI.72.10.5832-5839.2004] [PMID: 15385484] [18] Myers LL, Firehammer BD, Shoop DS, Border MM.",Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1093/infdis/152.6.1344] [PMID: 3905990] [20] Rhee KJ, Wu S, Wu X, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1128/IAI.00814-08] [PMID: 19188353] [21] Wu S, Rhee KJ, Albesiano E, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1038/nm.2015] [PMID: 19701202] [22] Wick EC, Rabizadeh S, Albesiano E, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1097/MIB.0000000000000019] [PMID: 24704822] [23] Toprak NU, Yagci A, Gulluoglu BM, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1111/j.1469-0691.2006.01494.x] [PMID: 16842574] [24] Chen LA, Van Meerbeke S, Albesiano E, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1007/s10096-015-2425-7] [PMID: 26173688] [25] Ramamurthy D, Pazhani GP, Sarkar A, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1371/journal.pone.0060622] [PMID: 23577134] [26] Myers LL, Shoop DS, Stackhouse LL, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1053/gast.2003.50047] [PMID: 12557145] [30] Mundy LM, Sears CL.",Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1093/clinids/23.2.269] [PMID: 8842262] [31] Tong J, Liu C, Summanen P, Xu H, Finegold SM.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1016/j.anaerobe.2011.03.004] [PMID: 21439390] [32] Lee CS, Lee J.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
[http://dx.doi.org/10.1016/j.mimet.2010.07.012] [PMID: 20643165],OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.2166/wh.2011.120] [PMID: 21942191] [34] Miki T, Kuwahara T, Nakayama H, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.2152/jmi.52.101] [PMID: 15751280] [35] Avila-Campos MJ, Liu C, Song Y, Rowlinson MC, Finegold SM.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1128/JCM.02108-06] [PMID: 17301286] [36] Merino VR, Nakano V, Liu C, Song Y, Finegold SM, Avila-Campos MJ.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1128/JCM.01556-10] [PMID: 20980581] [37] Papaparaskevas J, Mela V, Houhoula DP, Pantazatou A, Petrikkos GL, Tsakris A.",Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1128/JCM.00449-13] [PMID: 23447634] [38] Ji D, Huang IH, Lai CC, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1007/s00253-007-1048-z] [PMID: 17598108] [40] Franco AA, Mundy LM, Trucksis M, Wu S, Kaper JB, Sears CL.",Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1007/s10096-014-2137-4] [PMID: 24820294] [42] Lagier JC, Armougom F, Million M, et al.",OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"[http://dx.doi.org/10.1111/1469-0691.12023] [PMID: 23033984] Received: July 13, 2015 Revised: October 20, 2015 Accepted: October 22, 2015 © Fathi and Wu; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"This is  an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/26/c7/TOMICROJ-10-57.PMC4899533.pdf
"Codon Optimization In order to identify a fragment common among all sequences, multiple sequence alignments were performed using ClustalW  software  ( http://www.ebi.ac.uk/Tools/clustalw2 ).",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.3923/jbs.2006.1146.1149 ] [2] Ghasemi A, Shirazi MH, Ranjbar R, Khorramizadeh MR, Daryani NE, Hosseini M. The prevalence of cagA and cagE genes in Helicobacter pylori  strains isolated from different patient groups by polymerase chain reaction.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
[http://dx.doi.org/10.3923/pjbs.2008.2579.2583 ] [PMID: 19260336 ] [3] Bateson MC.,Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1136/gut.35.5.716 ] [PMID: 8200579 ] [4] Khalifehgholi M, Shamsipour F, Ajhdarkosh H, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.5009/gnl.2009.3.2.81 ] [PMID: 20431728 ] [6] Anderl F, Gerhard M. Helicobacter pylori  vaccination: is there a path to protection?",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.3748/wjg.v20.i34.11939 ] [PMID: 25232229 ] [7] Wheeldon TU, Hoang TT, Phung DC, Björkman A, Granström M, Sörberg M. Long-term follow-up of Helicobacter pylori  eradication therapy in Vietnam: reinfection and clinical outcome.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1111/j.1365-2036.2005.02408.x ] [PMID: 15813841 ] [8] Corthésy-Theulaz  I,  Porta  N,  Glauser  M,  et  al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/0016-5085(95)90275-9 ] [PMID: 7797009 ] [9] Ermak TH, Giannasca PJ, Nichols R, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1084/jem.188.12.2277 ] [PMID: 9858514 ] [10] Ferrero RL, Thiberge JM, Huerre M, Labigne A. Recombinant antigens prepared from the urease subunits of Helicobacter spp.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/infdis/172.1.161 ] [PMID: 7797906 ] [12] Sun P, Wang JQ, Zhang YT, Zhao SG.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1186/2049-1891-5-14 ] [PMID: 24558967 ] [13] Yang XL, Liu WC, Yang WW, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2014.02.051 ] [PMID: 24625340 ] [15] Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2012.10.022 ] [PMID: 23084846 ] [18] Chen J, Li N, She F. Helicobacter pylori  outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2014.09.014 ] [PMID: 25236588 ] [19] Sutton P, Doidge C, Pinczower G, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1111/j.1574-695X.2006.00206.x ] [PMID: 17567282 ] [20] Satin B, Del Giudice G, Della Bianca V, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1084/jem.191.9.1467 ] [PMID: 10790422 ] [21] Stein M, Ruggiero P, Rappuoli R, Bagnoli F. Helicobacter pylori  CagA: from pathogenic mechanisms to its use as an anti-cancer vaccine.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.addr.2012.09.039 ] [PMID: 23026637 ] [24] Ghasemi A, Zarnani AH, Ghoodjani A, Rezania S, Salari MH, Jeddi-Tehrani M. Identification of a new immunogenic candidate conferring protection against Brucella melitensis  infection in mice.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.molimm.2014.06.017 ] [PMID: 24995396 ] [25] Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2014.09.013 ] [PMID: 25240754 ] [26] Corthésy B, Boris S, Isler P, Grangette C, Mercenier A.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1086/444425 ] [PMID: 16170763 ] [27] Wu  C,  Shi  Y,  Guo  H,  et  al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1111/j.1523-5378.2008.00609.x ] [PMID: 18466394 ] [28] Li HB, Zhang JY, He YF, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2012.10.091 ] [PMID: 23137845 ] [29] Liu KY, Shi Y, Luo P, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2011.06.099 ] [PMID: 21745524 ] [30] Eaton KA, Suerbaum S, Josenhans C, Krakowka S. Colonization of gnotobiotic piglets by Helicobacter pylori  deficient in two flagellin genes.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.ijmm.2013.08.005 ] [PMID: 24103649 ] [32] Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. The design of vaccines against Helicobacter pylori  and their development.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
[http://dx.doi.org/10.1146/annurev.immunol.19.1.523 ] [PMID: 11244046 ],Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1186/1472-6750-10-84 ] [PMID: 21118490 ] [34] Guo L, Liu K, Zhao W, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1007/s00253-012-4486-1 ] [PMID: 23064457 ] [35] Zhou WY, Shi Y, Wu C, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2009.05.009 ] [PMID: 19446591 ] [36] Cover TL, Krishna US, Israel DA, Peek RM Jr.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1136/gut.44.4.456 ] [PMID: 10075950 ] [38] Conradi J, Tegtmeyer N, Woźna M, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1128/IAI.70.4.2108-2120.2002 ] [PMID: 11895977 ] [40] Puigbo P, Guzman E, Romeu A, Garcia-Vallve S. OPTIMIZER: a web server for optimizing the codon usage of DNA sequences.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
35(Web Server issue) [http://dx.doi.org/10.1093/nar/gkm219 ] [41] Stothard P. The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences.,OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
[http://dx.doi.org/10.1186/1471-2105-8-4 ] [PMID: 17207271 ] [43] Zuker M. Mfold web server for nucleic acid folding and hybridization prediction.,OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/nar/gkg595 ] [PMID: 12824337 ] [44] Sato K, Hamada M, Asai K, Mituyama T. CENTROIDFOLD: a web server for RNA secondary structure prediction.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"Web Server issue [http://dx.doi.org/10.1093/nar/gkp367 ] [45] Sen TZ, Jernigan RL, Garnier J, Kloczkowski A. GOR V server for protein secondary structure prediction.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/bioinformatics/bti408 ] [PMID: 15797907 ] [46] Walsh I, Baù D, Martin AJ, Mooney C, Vullo A, Pollastri G. Ab initio and template-based prediction of multi-class distance maps by two- dimensional recursive neural networks.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1186/1472-6807-9-5 ] [PMID: 19183478 ] [47] Geourjon C, Deléage G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/nar/gkg508 ] [PMID: 12824312 ] [49] Edwards YJ, Cottage A. Bioinformatics methods to predict protein structure and function.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1385/MB:23:2:139 ] [PMID: 12632698 ] [50] Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1038/nprot.2010.5 ] [PMID: 20360767 ] [51] Vallat BK, Pillardy J, Elber R. A template-finding algorithm and a comprehensive benchmark for homology modeling of proteins.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1002/prot.21976 ] [PMID: 18300226 ] [52] Wiederstein M, Sippl MJ.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
35(Web Server issue): 21 [http://dx.doi.org/10.1093/nar/gkm290 ],Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1002/jcc.20303 ] [PMID: 16211540 ] [54] Willard L, Ranjan A, Zhang H, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/nar/gkg565 ] [PMID: 12824316 ] [55] Petersen B, Petersen TN, Andersen P, Nielsen M, Lundegaard C. A generic method for assignment of reliability scores applied to solvent accessibility predictions.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1186/1472-6807-9-51 ] [PMID: 19646261 ] [56] Saha S, Raghava GP.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"(Web Server issue) [http://dx.doi.org/10.1093/nar/gkl343 ] [57] Ivanciuc O, Schein CH, Braun W. SDAP: database and computational tools for allergenic proteins.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/nar/gkg010 ] [PMID: 12520022 ] [58] Larsen JE, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1186/1745-7580-2-2 ] [PMID: 16635264 ] [59] Saha S, Raghava G. BcePred: Prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties Artificial Immune Systems.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1002/prot.21078 ] [PMID: 16894596 ] [61] Haste AP, Nielsen M, Lund O.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1110/ps.062405906 ] [PMID: 17001032 ] [62] Ansari HR, Raghava GP.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1186/1745-7580-6-6 ] [PMID: 20961417 ] [63] Doytchinova  IA,  Flower  DR.  VaxiJen:  a  server  for  prediction  of  protective  antigens,  tumour  antigens  and  subunit  vaccines.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1186/1471-2105-8-4 ] [PMID: 17207271 ] [64] Ghasemi A, Ranjbar R, Amani J.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/nar/gkg510 ] [PMID: 12824380 ] [66] Rammensee  H,  Bachmann  J,  Emmerich  NP,  Bachor  OA,  Stevanović  S.  SYFPEITHI:  database  for  MHC  ligands  and  peptide  motifs.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1007/s002510050595 ] [PMID: 10602881 ] [67] Thompson  JD,  Higgins  DG,  Gibson  TJ.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/nar/22.22.4673 ] [PMID: 7984417 ] [68] Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T. Design of the linkers which effectively separate domains of a bifunctional fusion protein.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1093/protein/14.8.529 ] [PMID: 11579220 ] [69] Amet N, Lee HF, Shen WC.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1007/s11095-008-9767-0 ] [PMID: 19002568 ] [70] Bai Y, Shen WC.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1007/s11095-006-9059-5 ] [PMID: 16952003 ] [71] Sharp PM, Li WH.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
[http://dx.doi.org/10.1093/nar/15.3.1281 ] [PMID: 3547335 ] [72] Ikemura T. Correlation between the abundance of Escherichia coli  transfer RNAs and the occurrence of the respective codons in its protein genes: a proposal for a synonymous codon choice that is optimal for the E. coli  translational system.,Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
[http://dx.doi.org/10.1016/0022-2836(81)90003-6 ] [PMID: 6175758 ],OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1186/1742-4682-6-28 ] [PMID: 19995413 ] [74] Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2015.09.013 ] [PMID: 26384448 ] [75] De Groot AS, McMurry J, Marcon L, et al.",OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
[http://dx.doi.org/10.1016/j.vaccine.2005.01.059 ] [PMID: 15755582 ] © Mohammad et al.,Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/99/TOMICROJ-10-97.PMC4899534.pdf
"[http://dx.doi.org/10.1007/s12275-011-1064-7 ] [PMID: 21538235 ] [3] Garcia-Vidal C, Viasus D, Carratalà J. Pathogenesis of invasive fungal infections.",Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
[http://dx.doi.org/10.1097/QCO.0b013e32835fb920 ] [PMID: 23449139 ] [4] Ferrer J.,Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/S0020-7292(00)00350-7 ] [PMID: 11118561 ] [5] Pedersen LL, Owusu-Kwarteng J, Thorsen L, Jespersen L. Biodiversity and probiotic potential of yeasts isolated from Fura, a West African spontaneously fermented cereal.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/j.ijfoodmicro.2012.08.016 ] [PMID: 23072700 ] [6] Frank CF, Hostetter MK.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/j.trsl.2006.11.006 ] [PMID: 17383595 ] [7] Saegusa S, Totsuka M, Kaminogawa S, Hosoi T. Candida albicans  and Saccharomyces cerevisiae  induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/j.femsim.2004.03.006 ] [PMID: 15196572 ] [8] Ramos CL, Thorsen L, Schwan RF, Jespersen L. Strain-specific probiotics properties of Lactobacillus fermentum, Lactobacillus plantarum and Lactobacillus brevis  isolates from Brazilian food products.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/j.fm.2013.03.010 ] [PMID: 23764216 ] [9] Jensen H, Grimmer S, Naterstad K, Axelsson L. In vitro  testing of commercial and potential probiotic lactic acid bacteria.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/j.ijfoodmicro.2011.11.020 ] [PMID: 22177712 ] [10] Canil  C,  Rosenshine  I,  Ruschkowski  S,  Donnenberg  MS,  Kaper  JB,  Finlay  BB.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1128/AEM.71.11.7528-7530.2005 ] [PMID: 16269795 ] [12] Diebel LN, Liberati DM, Diglio CA, Dulchavsky SA, Brown WJ.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1097/00005373-199912000-00009 ] [PMID: 10608531 ] [13] Yeung CY, Chiau CJS, Chan WT, et al.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/j.micinf.2008.10.001 ] [PMID: 18983929 ] [15] Dessus-Babus S, Moore CG, Whittimore JD, Wyrick PB.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/j.micinf.2008.02.002 ] [PMID: 18396437 ] [16] Wyrick PB, Choong J, Davis CH, et al.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
[http://dx.doi.org/10.1128/IAI.01517-06 ] [PMID: 17088348 ],Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
[http://dx.doi.org/10.1046/j.1462-5822.2000.00058.x ] [PMID: 11207588 ] [19] Madara JL.,OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1172/JCI113987 ] [PMID: 2649511 ] [20] Okada  Y,  Irimajiri  A,  Inouye  A.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1007/BF01869406 ] [PMID: 845930 ] [21] Frizzell RA, Schultz SG.",Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
[http://dx.doi.org/10.1085/jgp.59.3.318 ] [PMID: 5058963 ] [22] Maccallum DM.,OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/j.micinf.2007.01.012 ] [PMID: 17383212 ] [24] Zhu W, Filler SG.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
[http://dx.doi.org/10.1111/j.1462-5822.2009.01412.x ] [PMID: 19919567 ] [25] Arendrup MC.,OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1371/journal.ppat.1003550 ] [PMID: 24086128 ] [27] Németh T, Tóth A, Szenzenstein J, et al.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1371/journal.pone.0068704 ] [PMID: 23874732 ] [28] Posteraro  B,  Sanguinetti  M,  D’Amore  G,  Masucci  L,  Morace  G,  Fadda  G.  Molecular  and  epidemiological  characterization  of  vaginal Saccharomyces cerevisiae  isolates.",Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1093/clinids/12.3.406 ] [PMID: 2193348 ] [30] Cimolai N, Gill MJ, Church D. Saccharomyces cerevisiae  fungemia: case report and review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1016/0732-8893(87)90158-1 ] [PMID: 3322656 ] [31] Eng RH, Drehmel R, Smith SM, Goldstein EJ.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1080/00362178485380651 ] [PMID: 6390738 ] [32] Nielsen H, Stenderup J, Bruun B. Fungemia with Saccharomycetaceae.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.3109/00365549009027100 ] [PMID: 2259868 ] [33] Oriol A, Ribera JM, Arnal J, Milla F, Batlle M, Feliu E. Saccharomyces cerevisiae  septicemia in a patient with myelodysplastic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1002/ajh.2830430424 ] [PMID: 8372820 ] [34] Velraeds MM, van der Mei HC, Reid G, Busscher HJ.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1046/j.1365-2672.2002.01759.x ] [PMID: 12392537 ] [36] Raths S, Rohrer J, Crausaz F, Riezman H. end3 and end4: two mutants defective in receptor-mediated and fluid-phase endocytosis in Saccharomyces cerevisiae.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1083/jcb.120.1.55 ] [PMID: 8380177 ] [37] Barrons R, Tassone D. Use of Lactobacillus  probiotics for bacterial genitourinary infections in women: a review.",Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
[http://dx.doi.org/10.1016/j.clinthera.2008.03.013 ] [PMID: 18405785 ] [38] Sweet RL.,OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
[http://dx.doi.org/10.1155/S1064744900000260 ] [PMID: 10968604 ],Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"[http://dx.doi.org/10.1111/j.1600-0463.2005.apm_113501.x ] [PMID: 16011656 ] [40] Aroutcheva A, Gariti D, Simon M, et al.",OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
[http://dx.doi.org/10.1067/mob.2001.115867 ] [PMID: 11518895 ] © Tsata et al.,OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/8e/TOMICROJ-10-90.PMC4899535.pdf
MATERIALS AND METHODS IDSwsp  Sequencing The  subcloned  gene  (pGEM-T  Easy -IDSwsp )  was  sequenced  at  the  Instituto  Nacional  de  Salud (http://www.ins.gov.co )  following  the  Sanger  method  [ 10].,OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"Primer Sequence 5´- 3´Number of nucleotides T7   TAATACGACTCACTATAGGG 20 SP6   TATTTAGGTGACACTATAG 19 IDS-F   G GAATTC TCCGAAACGCAGGCCAACTCG 28 IDS-R   G GCGGCCGC ACACTGAGGGATGTCTG 26 Bioinformatics Analysis of the IDS Enzyme Without Native Signal Peptide The access numbers used for IDS are AAA63197 ( http://www.ncbi.nlm.nih.gov ) in GenBank, 91046030 in Medline and  2122463  in  PubMed.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"ProtScale of ExPASy ( http://www.expasy.org ) was used to determine accessibility, hydrophobicity, polarity, and flexibility  profiles  [ 13].",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"Potential phosphorylation sites were determined with NetPhos 2.0 [ 17]; those of O- and N-glycosylation were determined with NetOGlyc 3.1 [ 18, 19] and NetNGlyc 1.0 software ( http://www.cbs.dtu.dk ), [20] respectively.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"The IDSnh  and IDSwsp  amino acid sequences were provided to the online Phyre 2.0 server through the Structural Bioinformatics Group, Imperial College London ( http://www.sbg.bio.ic.ac.uk ).",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
The template identified by Phyre for both proteins was a crystallographic structure with a resolution of 1.7 Å of a putative sulfatase from Bacteroides fragilis  registered in the Protein Data Bank (PDB) (http://www.rcsb.org ) with the access code 2QZU.,OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
To  estimate  the  correct  arrangement  of  the  dihedral  angles  (ψ/Ф)  a Ramachandran  plot  that  ignores  the  glycine  and  proline  residues  was  generated  by  the  RAMPAGE  server (http://mordred.bioc.cam.ac.uk).,OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"Bioinformatics Analysis of the Recombinant Enzyme IDSwsp Currently, over thirty million unique protein sequences have been deposited in public databases, a number that continues to grow rapidly ( http://www.ncbi.nlm.nih.gov ).",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"However, only about 100,000 protein structures have been determined experimentally ( http://www.rcsb.org ) despite the progress in research initiatives.",Non-OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1146/annurev-med-122313-085916 ] [PMID: 25587658 ] [2] Okuyama T, Tanaka A, Suzuki Y, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1016/j.ymgme.2009.08.006 ] [PMID: 19773189 ] [3] Coman DJ, Hayes IM, Collins V, Sahhar M, Wraith JE, Delatycki MB.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1016/j.jpeds.2007.10.015 ] [PMID: 18410781 ] [4] Espejo-Mojica AJ, Alméciga-Díaz CJ, Rodríguez A, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1016/j.ymgme.2015.06.001 ] [PMID: 26071627 ] [5] Poutou-Piñales RA, Vanegas Niño A, Landázuri P, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1007/s12275-013-2416-2 ] [PMID: 23625223 ] [7] Córdoba-Ruiz HA, Poutou-Piñales RA, Echeverri-Peña OY, et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1006/geno.1993.1406 ] [PMID: 8244397 ] [12] Wilson PJ, Morris CP, Anson DS, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1016/0022-2836(82)90515-0 ] [PMID: 7108955 ] [15] Bjellqvist B, Hughes GJ, Pasquali C, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1002/elps.11501401163 ] [PMID: 8125050 ] [16] Audain E, Ramos Y, Hermjakob H, Flower DR, Perez-Riverol Y.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
[http://dx.doi.org/10.1006/jmbi.1999.3310 ] [PMID: 10600390 ],OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1093/glycob/cwm050 ] [PMID: 17494086 ] [19] Julenius K, Mølgaard A, Gupta R, Brunak S. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O- glycosylation sites.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1093/glycob/cwh151 ] [PMID: 15385431 ] [20] Chuang G-Y, Boyington JC, Joyce MG, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1093/bioinformatics/bts426 ] [PMID: 22782545 ] [21] Kelley LA, Sternberg MJ.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1038/nprot.2009.2 ] [PMID: 19247286 ] [22] Pettersen EF, Goddard TD, Huang CC, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1002/jcc.20084 ] [PMID: 15264254 ] [23] Benkert P, Biasini M, Schwede T. Toward the estimation of the absolute quality of individual protein structure models.",Non-OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1093/bioinformatics/btq662 ] [PMID: 21134891 ] [24] Benkert P, Schwede T, Tosatto SC.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1186/1472-6807-9-35 ] [PMID: 19457232 ] [25] Maiti R, Domselaar G, Zhang H, Wishart D. SuperPose: a simple server for sophisticated structural superposition.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1093/nar/gkh477 ] [26] Willard L, Ranjan A, Zhang H, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.1093/nar/gkg565 ] [PMID: 12824316 ] [27] Neufeld EF, Muenzer J.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.3382/ps.2012-02993 ] [PMID: 24570443 ] [32] Sáenz-Suárez H, Poutou-Piñales RA, González-Santos J, et al.",OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"[http://dx.doi.org/10.3906/biy-1501-71 ] [33] Poutou-Piñales RA, Córdoba-Ruiz HA, Barrera-Avellaneda LA, Delgado-Boada JM.",Non-OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/5f/TOMICROJ-10-124.PMC4899537.pdf
"A web-based tool called MOLigoDesigner ( http://MOLigoDesigner.lanl.gov ) was provided to keep the making of all probes  minimal,  and  all  the  multiplex  assays  were  validated  individually.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1001/jama.285.21.2763 ] [PMID: 11386933 ] [2] Keim PS, Wagner DM.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
[http://dx.doi.org/10.1038/nrmicro2219 ] [PMID: 19820723 ] [3] Anonymous .,Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
Available online at http://wwwn.cdc.gov/nndss/script/casedef.aspx?condyrid=880&datepub=1/1/1999%2012:00:00%20am .,OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
Available  online  at  http://www.bt.cdc.gov/ lrn/biological.asp .,Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.4103/0255-0857.154901 ] [PMID: 25866005 ] [6] Becker S, Lochau P, Jacob D, Heuner K, Grunow R. Successful re-evaluation of broth medium T for growth of Francisella tularensis  ssp.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.mimet.2015.11.018 ] [PMID: 26658853 ] [7] Lamont EA, Wang P, Enomoto S, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1371/journal.pone.0114622 ] [PMID: 25536105 ] [8] Sissonen S, Rossow H, Karlsson E, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.3109/23744235.2015.1049657 ] [PMID: 26004621 ] [9] Kugeler KJ, Mead PS, Janusz AM, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1086/597261 ] [PMID: 19245342 ] [10] Vogler AJ, Birdsell D, Price LB, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/JB.01786-08 ] [PMID: 19251856 ] [11] Birdsell DN, Johansson A, Öhrman C, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.3201/eid2005.131559 ] [PMID: 24755401 ] [12] Farlow J, Smith KL, Wong J, Abrams M, Lytle M, Keim P. Francisella tularensis  strain typing using multiple-locus, variable-number tandem repeat analysis.",Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/JCM.39.9.3186-3192.2001 ] [PMID: 11526148 ] [13] Wang YH, Qiao FY, Cao J, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.ttbdis.2015.07.007 ] [PMID: 26210091 ] [14] Forsman M, Sandström G, Sjöstedt A.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
[http://dx.doi.org/10.1099/00207713-44-1-38 ] [PMID: 8123561 ],Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1111/j.1472-765X.2009.02788.x ] [PMID: 20070509 ] [17] Buzard GS, Baker D, Wolcott MJ, Norwood DA, Dauphin LA.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2011.02.010 ] [PMID: 21546201 ] [19] Trombley Hall A, McKay Zovanyi A, Christensen DR, Koehler JW, Devins Minogue T. Evaluation of inhibitor-resistant real-time PCR methods for diagnostics in clinical and environmental samples.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1371/journal.pone.0073845 ] [PMID: 24040090 ] [20] Whitehouse CA, Hottel HE.",Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.mcp.2006.08.003 ] [PMID: 17011748 ] [21] Matero P, Hemmilä H, Tomaso H, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1111/j.1469-0691.2010.03178.x ] [PMID: 20132255 ] [22] Mölsä M, Hemmilä H, Katz A, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.mimet.2015.05.026 ] [PMID: 26043838 ] [23] Turingan RS, Thomann HU, Zolotova A, Tan E, Selden RF.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1371/journal.pone.0056093 ] [PMID: 23418519 ] [24] Rydzewski  K,  Schulz  T,  Brzuszkiewicz  E,  et  al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1186/1471-2180-14-169 ] [PMID: 24961323 ] [25] Johansson A, Lärkeryd A, Widerström M, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1093/cid/ciu621 ] [PMID: 25097081 ] [26] Afset JE, Larssen KW, Bergh K, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.2807/1560-7917.ES2015.20.19.21125 ] [PMID: 25990357 ] [27] Larson MA, Nalbantoglu U, Sayood K, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1371/journal.pone.0124906 ] [PMID: 25918839 ] [28] Antwerpen  MH,  Prior  K,  Mellmann  A,  Höppner  S,  Splettstoesser  WD,  Harmsen  D.  Rapid  high  resolution  genotyping  of  Francisella tularensis  by whole genome sequence comparison of annotated genes (“MLST+”).",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
[http://dx.doi.org/10.1371/journal.pone.0123298 ] [PMID: 25856198 ] [29] http://www.globalmicrobialidentifier.org  Accessed on 2015 December 31.,Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.3390/s110303004 ] [PMID: 22163782 ] [31] Rastawicki  W,  Rokosz-Chudziak  N,  Chróst  A,  Gierczyński  R.  Development  and  evaluation  of  a  latex  agglutination  test  for  the  rapid serodiagnosis of tularemia.",Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.mimet.2015.02.012 ] [PMID: 25727796 ] [32] Sharma  N,  Hotta  A,  Yamamoto  Y,  et  al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/CVI.00516-12 ] [PMID: 23114700 ] [33] Sharma N, Hotta A, Yamamoto Y, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1089/vbz.2013.1349 ] [PMID: 24689989 ] [34] Chaignat V, Djordjevic-Spasic M, Ruettger A, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1186/1471-2334-14-234 ] [PMID: 24885274 ] [35] Rastawicki W, Wolaniuk N. [Comparison of usefulness of commercial ELISA Virion/Serion, homemade ELISA and tube agglutination test in serodiagnosis of tularemia].",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2012.05.030 ] [PMID: 22770772 ] [37] Dulay SB, Julich S, Tomaso H, O’Sullivan CK.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1007/s00216-014-7860-2 ] [PMID: 24817365 ] [38] Seo SH, Lee YR, Ho Jeon J, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.bios.2014.08.038 ] [PMID: 25194798 ] [39] Lundquist M, Caspersen MB, Wikström P, Forsman M. Discrimination of Francisella tularensis  subspecies using surface enhanced laser desorption ionization mass spectrometry and multivariate data analysis.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.femsle.2004.12.020 ] [PMID: 15668033 ] [40] Durighello E, Bellanger L, Ezan E, Armengaud J. Proteogenomic biomarkers for identification of Francisella  species and subspecies by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1021/ac501840g ] [PMID: 25215633 ] [41] Seibold E, Maier T, Kostrzewa M, Zeman E, Splettstoesser W. Identification of Francisella tularensis  by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry: fast, reliable, robust, and cost-effective differentiation on species and subspecies levels.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/JCM.01953-09 ] [PMID: 20181907 ] [42] Melničáková J, Derdáková M, Barák I.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1186/1756-3305-6-269 ] [PMID: 24330462 ] [43] Huelseweh B, Ehricht R, Marschall HJ.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1002/pmic.200500721 ] [PMID: 16622830 ] [44] Choi H, Jeon CS, Hwang I, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1039/c4lc00238e ] [PMID: 24828279 ] [45] Grunow R, Finke EJ.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1046/j.1469-0691.2002.00524.x ] [PMID: 12197873 ] [46] Janse I, Hamidjaja RA, Bok JM, van Rotterdam BJ.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1371/journal.pone.0035971 ] [PMID: 22540014 ] [48] Zasada AA, Formińska K, Zacharczuk K, Jacob D, Grunow R. Comparison of eleven commercially available rapid tests for detection of Bacillus anthracis, Francisella tularensis  and Yersinia pestis.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1111/lam.12392 ] [PMID: 25598285 ] [49] Seiner DR, Colburn HA, Baird C, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1111/jam.12107 ] [PMID: 23279070 ] [50] Cho  M,  Chung  S,  Jung  JH,  Rhie  GE,  Jeon  JH,  Seo  TS.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.bios.2014.05.018 ] [PMID: 24878840 ] [51] Schweighardt AJ, Battaglia A, Wallace MM.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1111/1556-4029.12283 ] [PMID: 24147813 ] [52] Yang Y, Wang J, Wen H, Liu H. Comparison of two suspension arrays for simultaneous detection of five biothreat bacterial in powder samples.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
[http://dx.doi.org/10.1155/2012/831052 ],Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1186/1297-9716-42-47 ] [PMID: 21385413 ] [54] Brinkman NE, Francisco R, Nichols TL, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1111/jam.12073 ] [PMID: 23167710 ] [55] Duodu  S,  Larsson  P,  Sjödin  A,  Soto  E,  Forsman  M,  Colquhoun  DJ.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.3354/dao02514 ] [PMID: 23324419 ] [56] Ostland VE, Stannard JA, Creek JJ, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.3354/dao072135 ] [PMID: 17140136 ] [57] Versage JL, Severin DD, Chu MC, Petersen JM.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/JCM.41.12.5492-5499.2003 ] [PMID: 14662930 ] [58] Loveless BM, Yermakova A, Christensen DR, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.mcp.2010.01.003 ] [PMID: 20100564 ] [59] Song J, Li PE, Gans J, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1007/978-1-4419-5913-3_51 ] [PMID: 20865530 ] [60] Aloni-Grinstein R, Shifman O, Lazar S, Steinberger-Levy I, Maoz S, Ber R. A rapid real-time quantitative PCR assay to determine the minimal  inhibitory  extracellular  concentration  of  antibiotics  against  an  intracellular  Francisella  tularensis  Live  Vaccine  Strain.",Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.3389/fmicb.2015.01213 ] [PMID: 26579112 ] [61] Lärkeryd A, Myrtennäs K, Karlsson E, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1093/bioinformatics/btu113 ] [PMID: 24574113 ] [62] Multari RA, Cremers DA, Bostian ML.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1364/AO.51.000B57 ] [PMID: 22410926 ] [63] Hua F, Zhang P, Zhang F, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1038/srep17178 ] [PMID: 26608358 ] [64] Seo Y, Kim JE, Jeong Y, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1309/JN3NTHK4VVWKJT4A ] [PMID: 18024317 ] [67] Kalasinsky KS, Hadfield T, Shea AA, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1021/ac0700575 ] [PMID: 17338507 ] [68] Grif K, Dierich MP, Much P, Hofer E, Allerberger F. Identifying and subtyping species of dangerous pathogens by automated ribotyping.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/S0732-8893(03)00095-6 ] [PMID: 12967744 ] [69] Forsman M, Sandström G, Jaurin B.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/JCM.40.8.2964-2972.2002 ] [PMID: 12149360 ] [71] Ibrahim A, Gerner-Smidt P, Sjöstedt A. Amplification and restriction endonuclease digestion of a large fragment of genes coding for rRNA as a rapid method for discrimination of closely related pathogenic bacteria.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/JB.186.17.5808-5818.2004 ] [PMID: 15317786 ] [73] Pandya GA, Holmes MH, Petersen JM, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1186/1471-2180-9-213 ] [PMID: 19811647 ] [74] Higgins  JA,  Hubalek  Z,  Halouzka  J,  et  al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/JCM.41.7.2924-2931.2003 ] [PMID: 12843022 ] [76] Caipang CM, Kulkarni A, Brinchmann MF, Korsnes K, Kiron V. Detection of Francisella  piscicida in Atlantic cod (Gadus morhua L) by the loop-mediated isothermal amplification (LAMP) reaction.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1016/j.tvjl.2009.03.027 ] [PMID: 19398357 ] [77] Johansson A, Forsman M, Sjöstedt A.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1111/j.1600-0463.2004.apm11211-1212.x ] [PMID: 15638842 ] [78] Splettstoesser WD, Tomaso H, Al Dahouk S, Neubauer H, Schuff-Werner P. Diagnostic procedures in tularaemia with special focus on molecular and immunological techniques.",Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
[http://dx.doi.org/10.1111/j.1439-0450.2005.00863.x ] [PMID: 16219088 ] [79] Wagar E. Bioterrorism and the role of the clinical microbiology laboratory.,Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/CMR.00033-15 ] [PMID: 26656673 ] [80] Sjödin A, Svensson K, Ohrman C, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1186/1471-2164-13-268 ] [PMID: 22727144 ] [81] Zeytun A, Malfatti SA, Vergez LM, Shin M, Garcia E, Chain PS.",Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/JB.00413-12 ] [PMID: 22628499 ] [82] Siddaramappa  S,  Challacombe  JF,  Petersen  JM,  Pillai  S,  Kuske  CR.",Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1186/1471-2164-13-422 ] [PMID: 22920915 ] [83] Sridhar S, Sharma A, Kongshaug H, Nilsen F, Jonassen I.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1186/1471-2164-13-598 ] [PMID: 23131096 ] [84] Davenport KW, Daligault HE, Minogue TD, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/genomeA.00941-14 ] [PMID: 25291764 ] [85] Johnson SL, Daligault HE, Davenport KW, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/genomeA.00147-15 ] [PMID: 25931589 ] [86] Atkins LM, Holder ME, Ajami NJ, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/genomeA.00898-15 ] [PMID: 26272574 ] [87] Johnson SL, Minogue TD, Daligault HE, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/genomeA.01046-15 ] [PMID: 26383665 ] [88] Song L, Yu Y, Feng L, et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"[http://dx.doi.org/10.1128/genomeA.01489-15 ] [PMID: 26679594 ] Received: July 13, 2015 Revised: October 20, 2015 Accepted: October 22, 2015 © Lai et al.",OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/86/24/TOMICROJ-10-64.PMC4899538.pdf
"The  pellet  was  lysed  in  the  lysis  buffer  and  used  for  real-time  PCR  as  described [http://www.geneohm.com , 32].",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1093/cid/cir308] [PMID: 21690621] [2] Gleghorn K, Grimshaw E, Kelly EK.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1001/archinte.168.17.1897] [PMID: 18809817] [4] Saruta K, Hoshina S, Machida K. Genetic identification of Staphylococcus aureus  by polymerase chain reaction using single-base-pair mismatch in 16S ribosomal RNA gene.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
[http://dx.doi.org/10.1111/j.1348-0421.1995.tb03280.x] [PMID: 8657010],OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1371/journal.pone.0031126] [PMID: 22363564] [8] Liu ZM, Shi XM, Pan F. Species-specific diagnostic marker for rapid identification of Staphylococcus aureus.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2007.06.011] [PMID: 17911002] [9] Oshima T, Miyachi H, Fusegawa H, Masukawa A, Ikeda M, Ando Y.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/S0732-8893(99)00060-7] [PMID: 10529876] [11] Eigner U, Veldenzer A, Fahr AM, Holfelder M. Retrospective evaluation of a PCR based assay for the direct detection of methicillin-resistant Staphylococcus aureus in clinical specimen.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1111/j.1469-0691.2005.01236.x] [PMID: 16153258] [13] Chadwick  SG,  Prasad  A,  Smith  WL,  Mordechai  E,  Adelson  ME,  Gygax  SE.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.00417-13] [PMID: 23698534] [14] Stegger M, Lindsay JA, Moodley A, Skov R, Broens EM, Guardabassi L. Rapid PCR detection of Staphylococcus aureus  clonal complex 398 by targeting the restriction-modification system carrying sau1-hsdS1.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.01970-10] [PMID: 21123532] [15] Al-Talib H, Yean CY, Al-Khateeb A, Hasan H, Ravichandran M. Rapid detection of methicillin-resistant Staphylococcus aureus  by a newly developed dry reagent-based polymerase chain reaction assay.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.jmii.2013.06.004] [PMID: 23927820] [16] Barski P, Piechowicz L, Galiński J, Kur J.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1006/mcpr.1996.0066] [PMID: 9025087] [17] Brakstad OG, Maeland JA, Tveten Y. Multiplex polymerase chain reaction for detection of genes for Staphylococcus aureus  thermonuclease and methicillin resistance and correlation with oxacillin resistance.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1111/j.1699-0463.1993.tb00165.x] [PMID: 8240787] [18] Vannuffel P, Laterre PF, Bouyer M, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1055/s-2007-1024385] [PMID: 11256043] [20] Francois P, Pittet D, Bento M, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.41.1.254-260.2003] [PMID: 12517857] [21] Montazeri EA, Khosravi AD, Jolodar A, Ghaderpanah M, Azarpira S. Identification of methicillin-resistant Staphylococcus aureus  (MRSA) strains isolated from burn patients by multiplex PCR.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.burns.2014.08.018] [PMID: 25441547] [22] García-Álvarez L, Holden MT, Lindsay H, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/S1473-3099(11)70126-8] [PMID: 21641281] [23] Becker K, Larsen AR, Skov RL, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
[http://dx.doi.org/10.1128/JCM.00075-13] [PMID: 23515551],Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.39.11.4037-4041.2001] [PMID: 11682527] [25] Zhang K, Sparling J, Chow BL, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.42.11.4947-4955.2004] [PMID: 15528678] [26] Zhang K, McClure JA, Elsayed S, Louie T, Conly JM.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.01309-07] [PMID: 18160447] [27] Bonnstetter KK, Wolter DJ, Tenover FC, McDougal LK, Goering RV.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.01228-06] [PMID: 17093011] [28] Al-Talib H, Yean CY, Al-Khateeb A, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1186/1471-2180-9-113] [PMID: 19476638] [29] Panda S, Kar S, Choudhury R, Sharma S, Singh DV.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1111/1574-6968.12383] [PMID: 24417390] [30] Ghodousi A, Nomanpour B, Davoudi S, et al.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.4103/0377-4929.107787] [PMID: 23455786] [31] O’Neill E, Humphreys H, O’Gara JP.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1099/jmm.0.005504-0] [PMID: 19273632] [32] Oberdorfer K, Pohl S, Frey M, Heeg K, Wendt C. Evaluation of a single-locus real-time polymerase chain reaction as a screening test for specific detection of methicillin-resistant Staphylococcus aureus in ICU patients.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s10096-006-0203-2] [PMID: 17024506] [33] Mehta MS, Paule SM, Hacek DM, Thomson RB, Kaul KL, Peterson LR.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.00230-08] [PMID: 18448688] [34] Huletsky A, Lebel P, Picard FJ, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1086/428579] [PMID: 15824989] [35] Hagen RM, Seegmüller I, Navai J, Kappstein I, Lehn N, Miethke T. Development of a real-time PCR assay for rapid identification of methicillin-resistant Staphylococcus aureus from clinical samples.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.ijmm.2004.12.008] [PMID: 15969468] [36] Danial J, Noel M, Templeton KE, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1099/jmm.0.025288-0] [PMID: 21109629] [37] Stratidis J, Bia FJ, Edberg SC.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2006.12.017] [PMID: 17368796] [38] Wellinghausen N, Siegel D, Gebert S, Winter J.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s10096-009-0723-7] [PMID: 19277734] [39] Tan TY, Corden S, Barnes R, Cookson B.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.39.12.4529-4531.2001] [PMID: 11724876] [40] Warren DK, Liao RS, Merz LR, Eveland M, Dunne WM Jr.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.42.12.5578-5581.2004] [PMID: 15583284] [41] Desjardins  M,  Guibord  C,  Lalonde  B,  Toye  B,  Ramotar  K.  Evaluation  of  the  IDI-MRSA  assay  for  detection  of  methicillin-resistant Staphylococcus aureus from nasal and rectal specimens pooled in a selective broth.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
[http://dx.doi.org/10.1128/JCM.44.4.1219-1223.2006] [PMID: 16597841],Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2008.03.012] [PMID: 18501547] [43] Sabet  NS,  Subramaniam  G,  Navaratnam  P,  Sekaran  SD.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.ijantimicag.2006.12.017] [PMID: 17314034] [44] Huletsky A, Giroux R, Rossbach V, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.42.5.1875-1884.2004] [PMID: 15131143] [45] Söderquist B, Neander M, Dienus O, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1111/j.1600-0463.2011.02849.x] [PMID: 22515298] [46] Kim JU, Cha CH, An HK, Lee HJ, Kim MN.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.02495-12] [PMID: 23269729] [47] Sabet  NS,  Subramaniam  G,  Navaratnam  P,  Sekaran  SD.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2006.02.013] [PMID: 16650954] [48] Renwick L, Hardie A, Girvan EK, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s10096-008-0503-9] [PMID: 18357477] [49] Fosheim GE, Nicholson AC, Albrecht VS, Limbago BM.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.00795-11] [PMID: 21697325] [50] Yadav MK, Kwon SK, Huh HJ, Chae SW, Song JJ.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s12223-011-0085-2] [PMID: 22187362] [51] Kilic  A,  Muldrew  KL,  Tang  YW,  Basustaoglu  AC.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2009.11.010] [PMID: 20226325] [52] Kilic  A,  Basustaoglu  AC.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.resmic.2011.07.009] [PMID: 21925597] [53] Oh AC, Lee JK, Lee HN, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2011.02.006] [PMID: 21497042] [55] Laurent C, Bogaerts P, Schoevaerdts D, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s10096-010-0958-3] [PMID: 20512518] [56] Patel PA, Schora DM, Peterson KE, Grayes A, Boehm S, Peterson LR.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2014.05.019] [PMID: 24952987] [57] Valour F, Blanc-Pattin V, Freydière AM, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2013.11.026] [PMID: 24374309] [58] Cercenado E, Marín M, Burillo A, Martín-Rabadán P, Rivera M, Bouza E. Rapid detection of Staphylococcus aureus in lower respiratory tract secretions from patients with suspected ventilator-associated pneumonia: evaluation of the Cepheid Xpert MRSA/SA SSTI assay.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
[http://dx.doi.org/10.1128/JCM.02409-12] [PMID: 22993185],Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.02487-07] [PMID: 18685003] [60] Wolk DM, Picton E, Johnson D, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.01714-08] [PMID: 19129414] [61] Ghebremedhin B, König B, König W. BD GeneOhm-MRSA assay for detection of methicillin-resistant Staphylococcus aureus  directly in nasal and non-nasal swab specimens from haematologic patients.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1556/EuJMI.1.2011.4.5] [PMID: 24516736] [62] Lucke K, Hombach M, Hug M, Pfyffer GE.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.01990-09] [PMID: 20071545] [63] Hirvonen JJ, von Lode P, Nevalainen M, Rantakokko-Jalava K, Kaukoranta SS.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s10096-012-1637-3] [PMID: 22639174] [64] Yam WC, Siu GK, Ho PL, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.00488-13] [PMID: 23784133] [65] Arcenas RC, Spadoni S, Mohammad A, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.jmoldx.2012.01.015] [PMID: 22584139] [66] Gill P, Ghaemi A. Nucleic acid isothermal amplification technologies: a review.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1080/15257770701845204] [PMID: 18260008] [67] Goldmeyer J, Li H, McCormac M, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.02234-07] [PMID: 18234878] [68] Frech GC, Munns D, Jenison RD, Hicke BJ.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1186/1756-0500-5-430] [PMID: 22882800] [69] Notomi T, Okayama H, Masubuchi H, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1093/nar/28.12.e63] [PMID: 10871386] [70] Misawa Y, Yoshida A, Saito R, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s10156-007-0508-9] [PMID: 17593498] [71] Wang  XR,  Wu  LF,  Wang  Y,  Ma  YY,  Chen  FH,  Ou  HL.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s12010-014-1328-x] [PMID: 25349088] [72] Su J, Liu X, Cui H, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1186/1472-6750-14-8] [PMID: 24456841] [73] Zhao X, Li Y, Park M, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.4014/jmb.1207.07022] [PMID: 23412068] [74] Hanaki K, Sekiguchi J, Shimada K, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.mimet.2010.12.004] [PMID: 21167878] [75] Chan WS, Tang BS, Boost MV, Chow C, Leung PH.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.bios.2013.09.027] [PMID: 24125759] [76] Towner KJ, Talbot DC, Curran R, Webster CA, Humphreys H. Development and evaluation of a PCR-based immunoassay for the rapid detection of methicillin-resistant Staphylococcus aureus.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1099/00222615-47-7-607] [PMID: 9839565] [77] Vannuffel P, Gigi J, Ezzedine H, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.resmic.2006.08.004] [PMID: 17005377] [79] Francis  ST,  Rawal  S,  Roberts  H,  Riley  P,  Planche  T,  Kennea  NL.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1111/j.1651-2227.2010.01899.x] [PMID: 20528798] [80] Fang H, Hedin G. Rapid screening and identification of methicillin-resistant Staphylococcus aureus  from clinical samples by selective-broth and real-time PCR assay.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.41.7.2894-2899.2003] [PMID: 12843018] [81] Johnson JA, Wright ME, Sheperd LA, Musher DM, Dang BN.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.7812/TPP/14-101] [PMID: 25432002] [82] Kerremans JJ, Maaskant J, Verbrugh HA, van Leeuwen WB, Vos MC.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.diagmicrobio.2008.04.004] [PMID: 18501551] [83] Grisold AJ, Leitner E, Mühlbauer G, Marth E, Kessler HH.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.40.7.2392-2397.2002] [PMID: 12089253] [84] Kim MH, Lee WI, Kang SY.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.3349/ymj.2013.54.5.1282] [PMID: 23918582] [85] Fodrie TY, Allen SD, Blue DE, Gary P, Cheng L. Evaluation of a real-time polymerase chain reaction assay using analyte-specific reagents for detection of methicillin-resistant Staphylococcus aureus nasal carriage.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1086/651093] [PMID: 20184438] [87] Oberdorfer K, Pohl S, Frey M, Heeg K, Wendt C. Evaluation of a single-locus real-time polymerase chain reaction as a screening test for specific detection of methicillin-resistant Staphylococcus aureus in ICU patients.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s10096-006-0203-2] [PMID: 17024506] [88] Shrestha  NK,  Tuohy  MJ,  Hall  GS,  Isada  CM,  Procop  GW.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.40.7.2659-2661.2002] [PMID: 12089301] [89] Levi K, Towner KJ.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1007/s10096-005-1336-4] [PMID: 15926061] [90] Peterson LR, Liesenfeld O, Woods CW, et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.00003-10] [PMID: 20335423] [91] Reischl U, Linde HJ, Metz M, Leppmeier B, Lehn N. Rapid identification of methicillin-resistant Staphylococcus aureus  and simultaneous species confirmation using real-time fluorescence PCR.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1128/JCM.41.7.3187-3191.2003] [PMID: 12843062] Received: July 13, 2015 Revised: January  3, 2016 Accepted: January 9, 2016 © Liu et al.",OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"This is  an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/42/97/TOMICROJ-10-45.PMC4899539.pdf
"[http://dx.doi.org/10.1016/j.ccm.2014.10.003 ] [PMID: 25676517 ] [2] Hruska K, Kaevska M. Mycobacteria in water, soil, plants and air.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1164/rccm.200604-571ST ] [PMID: 17277290 ] [4] Primm TP, Lucero CA, Falkinham JO III.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
[http://dx.doi.org/10.1128/CMR.17.1.98-106.2004 ] [PMID: 14726457 ] [5] Katoch VM.,OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1016/j.ccm.2014.11.002 ] [PMID: 25676522 ] [7] Kim BJ, Lee SH, Lyu MA, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1016/S1369-5274(99)80052-6 ] [PMID: 10383862 ] [9] Padya L, Chin’ombe N, Magwenzi M, Mbanga J, Ruhanya V, Nziramasanga P. Molecular identification of mycobacterium  species of public health importance in cattle in Zimbabwe by 16S rRNA gene sequencing.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.5858/arpa.2012-0203-RS ] [PMID: 25076301 ] [12] Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
[http://dx.doi.org/10.1111/j.1469-0691.2008.02070.x ] [PMID: 18828852 ] [13] Böttger EC.,OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1111/j.1574-6968.1989.tb03617.x ] [PMID: 2482222 ] [14] Böddinghaus B, Rogall T, Flohr T, Blöcker H, Böttger EC.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
[http://dx.doi.org/10.1099/ijs.0.63222-0 ] [PMID: 15653890 ] [17] Falkinham JO III.,Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1111/hiv.12251 ] [PMID: 25854195 ] [19] Landriscina A, Musaev T, Amin B, Friedman AJ.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1093/infdis/165.6.1082 ] [PMID: 1349906 ] [21] Sharma K, Mewara A, Gupta N, Sharma A, Varma S. Multiplex PCR in diagnosis of M. tuberculosis  and M. avium  co-infection from lymph node in an AIDS patient.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
[http://dx.doi.org/10.4103/0255-0857.150940 ] [PMID: 25657138 ],Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1586/14787210.6.3.351 ] [PMID: 18588499 ] [23] Cabria F, Torres MV, García-Cía JI, Dominguez-Garrido MN, Esteban J, Jimenez MS. Cervical lymphadenitis caused by Mycobacterium lentiflavum.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1097/00006454-200206000-00022 ] [PMID: 12182389 ] [24] Niobe  SN,  Bebear  CM,  Clerc  M,  Pellegrin  JL,  Bebear  C,  Maugein  J.  Disseminated  Mycobacterium  lentiflavum  infection  in  a  human immunodeficiency virus-infected patient.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.39.5.2030-2032.2001 ] [PMID: 11326043 ] [25] Molteni C, Gazzola L, Cesari M, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.3201/eid1101.040523 ] [PMID: 15705334 ] [26] Milne BW, Arnold MH, Hudson B, Coolican MR. Infectious arthritis of the knee caused by Mycobacterium terrae : a case report.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1086/524897 ] [PMID: 18171275 ] [28] Fusco da Costa AR, Fedrizzi T, Lopes ML, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1099/ijs.0.068395-0 ] [PMID: 25487637 ] [29] Johnson MM, Waller EA, Leventhal JP.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1097/MCP.0b013e3282f9e650 ] [PMID: 18427243 ] [30] Shojaei H, Goodfellow M, Magee JG, Freeman R, Gould FK, Brignall CG.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1099/00207713-47-4-1205 ] [PMID: 9336929 ] [31] Shojaei H, Hashemi A, Heidarieh P, Naser AD.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.3201/eid1703.101400 ] [PMID: 21392457 ] [32] Dibaj R, Azadi D, Karami M, Naser AD, Shojaei H. First report of isolation of Mycobacterium novocastrense  from water supplies.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1111/apm.12165 ] [PMID: 24033409 ] [33] Grech M, Carter R, Thomson R. Clinical significance of Mycobacterium asiaticum  isolates in Queensland, Australia.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.01602-09 ] [PMID: 19864478 ] [34] Adékambi T, Raoult D, Drancourt M. Mycobacterium barrassiae  sp.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.00724-06 ] [PMID: 17021072 ] [35] Turenne  C,  Chedore  P,  Wolfe  J,  Jamieson  F,  May  K,  Kabani  A.  Phenotypic  and  molecular  characterization  of  clinical  isolates  of Mycobacterium elephantis  from human specimens.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.40.4.1230-1236.2002 ] [PMID: 11923337 ] [36] Chan AW, Kabbani S, Staton G, Kraft CS.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.03107-13 ] [PMID: 24452164 ] [37] Huber J, Richter E, Binder L, Maass M, Eberl R, Zenz W. Mycobacterium bohemicum  and cervical lymphadenitis in children.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.3201/eid1407.080142 ] [PMID: 18598648 ] [38] Parashar D, Das R, Sharma VD, Chauhan DS, Katoch VM.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.43.3.1473-1474.2005 ] [PMID: 15750138 ] [41] Kremer K, van Soolingen D, Frothingham R, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1099/ijs.0.045070-0 ] [PMID: 23159753 ] [43] Tortoli E, Rindi L, Goh KS, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1099/ijs.0.63485-0 ] [PMID: 15879240 ] [44] Syed SS, Aderinboye O, Hanson KE, Spitzer ED.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.3201/eid1609.100433 ] [PMID: 20735941 ] [45] Zhang Y, Zhang J, Fang C, Pang H, Fan J. Mycobacterium litorale  sp.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1099/ijs.0.033449-0 ] [PMID: 21742818 ] [46] Hormisch D, Brost I, Kohring GW, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1078/0723202042369866 ] [PMID: 15612622 ] [47] Brown-Elliott  BA,  Wallace  RJ  Jr,  Petti  CA,  et  al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.00853-10 ] [PMID: 20881180 ] [48] Morimoto Y, Chan ED, Heifets L, Routes JM.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1016/j.jinf.2006.12.010 ] [PMID: 17306883 ] [49] Beer K, Waibel J. Disfiguring scarring following mesotherapy-associated Mycobacterium cosmeticum  infection.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1002/ibd.21804 ] [PMID: 21739530 ] [51] Gämperli A, Bosshard PP, Sigrist T, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.43.8.4283-4285.2005 ] [PMID: 16082002 ] [52] Tortoli E, Galli L, Andebirhan T, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e328235a53c ] [PMID: 17589204 ] [53] Raad II, Vartivarian S, Khan A, Bodey GP.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1093/clinids/13.6.1120 ] [PMID: 1775845 ] [54] Hogg GG, Schinsky MF, McNeil MM, Lasker BA, Silcox VA, Brown JM.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1099/00207713-50-2-575 ] [PMID: 10758863 ] [56] Levi MH, Bartell J, Gandolfo L, et al.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1128/JCM.41.5.2147-2152.2003 ] [PMID: 12734264 ] [57] Spiegl PV, Feiner CM.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1177/107110079401501211 ] [PMID: 7894643 ] [58] Makovcova J, Slany M, Babak V, Slana I, Kralik P. The water environment as a source of potentially pathogenic mycobacteria.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.2166/wh.2013.102 ] [PMID: 24937219 ] [59] von Reyn CF, Maslow JN, Barber TW, Falkinham JO III, Arbeit RD.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1016/S0140-6736(94)90239-9 ] [PMID: 7910236 ] [60] Falkinham JO III, Norton CD, LeChevallier MW.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
[http://dx.doi.org/10.1128/AEM.67.3.1225-1231.2001 ] [PMID: 11229914 ],OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.20506/rst.20.1.1270 ] [PMID: 11288515 ] [62] Cirillo JD, Falkow S, Tompkins LS, Bermudez LE.",OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/TOMICROJ-10-113.PMC4899540.pdf
"[http://dx.doi.org/10.1056/NEJMra0804575 ] [PMID: 19864676 ] [3] Noel JS, Fankhauser RL, Ando T, Monroe SS, Glass RI.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1086/314783 ] [PMID: 10228052 ] [4] Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinjé J, Parashar UD.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.3201/eid1408.071114 ] [PMID: 18680645 ] [5] Tate JE, Panozzo CA, Payne DC, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1542/peds.2008-3528 ] [PMID: 19581260 ] [6] Payne DC, Vinjé J, Szilagyi PG, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1056/NEJMsa1206589 ] [PMID: 23514289 ] [7] Bean NH, Griffin PM.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.7326/0003-4819-126-7-199704010-00002 ] [PMID: 9092315 ] [9] Thorne LG, Goodfellow IG.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1099/vir.0.059634-0 ] [PMID: 24243731 ] [10] Clarke IN, Estes MK, Green KY, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1093/infdis/129.6.709 ] [PMID: 4209723 ] [12] Okada S, Sekine S, Ando T, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1086/315589 ] [PMID: 10804147 ] [15] Madore HP, Treanor JJ, Buja R, Dolin R. Antigenic relatedness among the Norwalk-like agents by serum antibody rises.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1002/jmv.1890320206 ] [PMID: 1704048 ] [16] Treanor JJ, Jiang X, Madore HP, Estes MK.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1099/vir.0.19478-0 ] [PMID: 14718622 ] [18] Xi JN, Graham DY, Wang KN, Estes MK.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1126/science.2177224 ] [PMID: 2177224 ] [19] Green SM, Dingle KE, Lambden PR, Caul EO, Ashley CR, Clarke IN.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1099/0022-1317-75-8-1883 ] [PMID: 8046390 ] [20] Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.virol.2005.11.015 ] [PMID: 16343580 ] [21] Martella V, Lorusso E, Decaro N, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.3201/eid1408.080062 ] [PMID: 18680664 ] [22] Tse H, Lau SK, Chan W-M, Choi GK, Woo PC, Yuen K-Y.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JVI.01312-12 ] [PMID: 22879606 ] [23] Kroneman A, Vega E, Vennema H, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1007/s00705-013-1708-5 ] [PMID: 23615870 ] [24] Bull RA, Tanaka MM, White PA. Norovirus recombination.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1099/vir.0.83321-0 ] [PMID: 18024905 ] [25] Nayak MK, Balasubramanian G, Sahoo GC, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.virol.2008.04.027 ] [PMID: 18555887 ] [26] Siebenga  JJ,  Vennema  H,  Zheng  DP,  et  al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1086/605127 ] [PMID: 19627248 ] [27] Vega E, Barclay L, Gregoricus N, Shirley SH, Lee D, Vinjé J. Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.02680-13 ] [PMID: 24172151 ] [28] Verhoef L, Hewitt J, Barclay L, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.3201/eid2104.141073 ] [PMID: 25811368 ] [29] Kapikian AZ, Chanock RM.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.00654-10 ] [PMID: 20554813 ] [31] Glass RI, Noel J, Ando T, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1086/315588 ] [PMID: 10804134 ] [32] Lambden PR, Caul EO, Ashley CR, Clarke IN.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1126/science.8380940 ] [PMID: 8380940 ] [33] Jiang X, Wang J, Graham DY, Estes MK.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1002/jmv.1890470416 ] [PMID: 8636708 ] [40] Le Guyader F, Neill FH, Estes MK, Monroe SS, Ando T, Atmar RL.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1007/BF01718228 ] [PMID: 8973536 ] [41] Vinje  J,  Koopmans  PG.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1007/BF01309781 ] [PMID: 7515226 ] [43] Wang J, Jiang X, Madore HP, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9071(199705)52:1<14::AID-JMV3>3.0.CO;2-U ] [PMID: 9131452 ] [45] Häfliger D, Gilgen M, Lüthy J, Hübner P. Seminested RT-PCR systems for small round structured viruses and detection of enteric viruses in seafood.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/S0168-1605(97)00041-X ] [PMID: 9237119 ] [46] Noel JS, Ando T, Leite JP, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9071(199712)53:4<372::AID-JMV10>3.0.CO;2-H ] [PMID: 9407386 ] [47] Katayama K, Shirato-Horikoshi H, Kojima S, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1006/viro.2002.1568 ] [PMID: 12202225 ] [48] Kojima S, Kageyama T, Fukushi S, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/S0166-0934(01)00404-9 ] [PMID: 11742657 ] [49] Vinjé J, Hamidjaja RA, Sobsey MD.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2003.11.001 ] [PMID: 14738976 ] [50] Stene-Johansen K, Grinde B.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9071(199611)50:3<207::AID-JMV1>3.0.CO;2-D ] [PMID: 8923284 ] [51] Green J, Henshilwood K, Gallimore CI, Brown DW, Lees DN.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1186/1471-2180-1-14 ] [PMID: 11511325 ] [53] Ratcliff RM, Doherty JC, Higgins GD.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.40.11.4091-4099.2002 ] [PMID: 12409380 ] [54] Medici MC, Martinelli M, Ruggeri FM, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.43.8.3772-3778.2005 ] [PMID: 16081909 ] [55] Shieh Y, Monroe SS, Fankhauser RL, Langlois GW, Burkhardt W III, Baric RS.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1086/315578 ] [PMID: 10804149 ] [56] Greene SR, Moe CL, Jaykus LA, Cronin M, Grosso L, Aarle Pv.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"Molecular Diagnostic Methods for Detection of Human Noroviruses The Open Microbiology Journal, 2016, Volume 10    87 [http://dx.doi.org/10.1016/S0166-0934(02)00286-0 ] [PMID: 12565163 ] [57] Moore C, Clark EM, Gallimore CI, Corden SA, Gray JJ, Westmoreland D. Evaluation of a broadly reactive nucleic acid sequence based amplification assay for the detection of noroviruses in faecal material.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/S1386-6532(03)00170-7 ] [PMID: 15018858 ] [58] Patterson SS, Smith MW, Casper ET, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1111/j.1365-2672.2006.02934.x ] [PMID: 16968307 ] [59] Houde A, Leblanc D, Poitras E, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2006.03.001 ] [PMID: 16616378 ] [60] Kou X, Wu Q, Zhang J, Fan H. Rapid detection of noroviruses in fecal samples and shellfish by nucleic acid sequence-based amplification.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.44.4.1376-1381.2006 ] [PMID: 16597865 ] [62] Yoda  T,  Suzuki  Y,  Yamazaki  K,  et  al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1002/jmv.20802 ] [PMID: 17245722 ] [63] Iturriza-Gómara M, Xerry J, Gallimore CI, Dockery C, Gray J.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jcv.2008.02.012 ] [PMID: 18394955 ] [64] Miller I, Gunson R, Carman WF.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/S1386-6532(02)00110-5 ] [PMID: 12367659 ] [65] Richards GP, Watson MA, Kingsley DH.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2003.10.011 ] [PMID: 14715308 ] [66] Pang X, Lee B, Chui L, Preiksaitis JK, Monroe SS.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.42.10.4679-4685.2004 ] [PMID: 15472327 ] [67] Schmid M, Oehme R, Schalasta G, Brockmann S, Kimmig P, Enders G. Fast detection of Noroviruses using a real-time PCR assay and automated sample preparation.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1186/1471-2334-4-15 ] [PMID: 15186502 ] [68] Kageyama  T,  Kojima  S,  Shinohara  M,  et  al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.41.4.1548-1557.2003 ] [PMID: 12682144 ] [69] Höhne  M,  Schreier  E.  Detection  and  characterization  of  norovirus  outbreaks  in  Germany:  application  of  a  one-tube  RT-PCR  using  a fluorogenic real-time detection system.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1002/jmv.10573 ] [PMID: 14695676 ] [70] Jothikumar N, Lowther JA, Henshilwood K, Lees DN, Hill VR, Vinjé J.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/AEM.71.4.1870-1875.2005 ] [PMID: 15812014 ] [71] Dreier J, Störmer M, Mäde D, Burkhardt S, Kleesiek K. Enhanced reverse transcription-PCR assay for detection of norovirus genogroup I. J Clin Microbiol 2006; 44(8): 2714-20.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.00443-06 ] [PMID: 16891482 ] [72] Trujillo AA, McCaustland KA, Zheng DP, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.44.4.1405-1412.2006 ] [PMID: 16597869 ] [73] Ishida S, Yoshizumi S, Ikeda T, Miyoshi M, Okano M, Okui T. Sensitive and rapid detection of norovirus using duplex TaqMan reverse transcription-polymerase chain reaction.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1002/jmv.21142 ] [PMID: 18360905 ] [74] Logan C, O’Leary JJ, O’Sullivan N. Real-time reverse transcription PCR detection of norovirus, sapovirus and astrovirus as causative agents of acute viral gastroenteritis.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2007.05.031 ] [PMID: 17644197 ] [75] Rolfe KJ, Parmar S, Mururi D, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
[http://dx.doi.org/10.1016/j.jcv.2007.05.005 ] [PMID: 17604686 ],OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.mcp.2008.02.003 ] [PMID: 18424068 ] [77] Hymas W, Atkinson A, Stevenson J, Hillyard D. Use of modified oligonucleotides to compensate for sequence polymorphisms in the real- time detection of norovirus.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2006.12.009 ] [PMID: 17222467 ] [78] Mohamed N, Belák S, Hedlund KO, Blomberg J.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2005.09.006 ] [PMID: 16289337 ] [79] Wolf S, Williamson WM, Hewitt J, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/AEM.00572-07 ] [PMID: 17616614 ] [80] Maeda  H,  Fujimoto  C,  Haruki  Y,  et  al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/S0928-8244(03)00224-4 ] [PMID: 14557000 ] [81] Buss SN, Leber A, Chapin K, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.02674-14 ] [PMID: 25588652 ] [82] Khare  R,  Espy  MJ,  Cebelinski  E,  et  al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.01637-14 ] [PMID: 25100818 ] [83] Mengelle C, Mansuy JM, Prere MF, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1111/1469-0691.12255 ] [PMID: 23714194 ] [84] Navidad JF, Griswold DJ, Gradus MS, Bhattacharyya S. Evaluation of Luminex xTAG gastrointestinal pathogen analyte-specific reagents for high-throughput, simultaneous detection of bacteria, viruses, and parasites of clinical and public health importance.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.00896-13 ] [PMID: 23850948 ] [85] Wessels E, Rusman LG, van Bussel MJ, Claas EC.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1111/1469-0691.12364 ] [PMID: 24131399 ] [86] Kahlau P, Malecki M, Schildgen V, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1186/2193-1801-2-106 ] [PMID: 23544178 ] [87] Vocale C, Rimoldi SG, Pagani C, et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.ijid.2015.02.011 ] [PMID: 25749649 ] [88] Higgins RR, Beniprashad M, Cardona M, Masney S, Low DE, Gubbay JB.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.00599-11 ] [PMID: 21775550 ] [89] Liu J, Gratz J, Amour C, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.02658-12 ] [PMID: 23175269 ] [90] Liu Y, Xu ZQ, Zhang Q, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.06790-11 ] [PMID: 22518865 ] [91] Hamza IA, Jurzik L, Wilhelm M. Development of a Luminex assay for the simultaneous detection of human enteric viruses in sewage and river water.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2014.04.002 ] [PMID: 24747587 ] [92] Jäskeläinen AJ, Maunula L. Applicability of microarray technique for the detection of noroviruses and astroviruses.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2006.05.015 ] [PMID: 16781784 ] [93] Pagotto  F,  Corneau  N,  Mattison  K,  Bidawid  S.  Development  of  a  DNA  microarray  for  the  simultaneous  detection  and  genotyping  of noroviruses.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1016/j.jviromet.2008.03.010 ] [PMID: 18471900 ] [95] Chen H, Mammel M, Kulka M, Patel I, Jackson S, Goswami BB.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.2174/1874357901105010052 ] [PMID: 21660190 ] [96] Kim JM, Kim SY, Park YB, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1007/s12275-012-2228-9 ] [PMID: 23104327 ] [97] Chen H, Chen X, Hu Y, Yan H. Reproducibility, fidelity, and discriminant validity of linear RNA amplification for microarray-based identification of major human enteric viruses.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1007/s00253-013-4769-1 ] [PMID: 23455564 ] [98] Hu Y, Yan H, Mammel M, Chen H. Sequence-independent amplification coupled with DNA microarray analysis for detection and genotyping of noroviruses.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1186/s13568-015-0156-x ] [PMID: 26556029 ] [99] Martínez MA, Soto-Del Río MdeL, Gutiérrez RM, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JCM.01317-14 ] [PMID: 25355758 ] [100] Nakamura S, Yang CS, Sakon N, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1371/journal.pone.0004219 ] [PMID: 19156205 ] [101] Wong TH, Dearlove BL, Hedge J, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1186/1743-422X-10-335 ] [PMID: 24220146 ] [102] Batty EM, Wong TH, Trebes A, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1371/journal.pone.0066129 ] [PMID: 23762474 ] [103] Kundu S, Lockwood J, Depledge DP, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1093/cid/cit287 ] [PMID: 23645848 ] [104] Bull RA, Eden JS, Luciani F, McElroy K, Rawlinson WD, White PA.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JVI.06712-11 ] [PMID: 22205753 ] [105] Cotten M, Petrova V, Phan MV, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JVI.01333-14 ] [PMID: 25056894 ] [106] Boon D, Mahar JE, Abente EJ, et al.",OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"[http://dx.doi.org/10.1128/JVI.00472-11 ] [PMID: 21715504 ] Received: July 13, 2015 Revised: January 11, 2016 Accepted: January 12, 2016 © Chen and Hu; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/TOMICROJ-10-78.PMC4899541.pdf
Available from: http://emedicine.medscape.com/article/905119-over view  6.,Non-OADS,/arxiv_data1/oa_pdf/1d/55/main.PMC4899542.pdf
Available from:  http://www.heartviews.org/article.asp?issn=1995705 X;year=2007;volume=8;issue=2;spage=52;epage=61; aulast=Balaguru   9.,Non-OADS,/arxiv_data1/oa_pdf/1d/55/main.PMC4899542.pdf
Available from : http://www.appliedradiology .com/Issues/2003/12/S upplements/CT-angiography--Optimizing-contrast-us e-in-pediatric-patients.aspx   14.,Non-OADS,/arxiv_data1/oa_pdf/1d/55/main.PMC4899542.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/a9/main.PMC4899544.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.01.004 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/a9/main.PMC4899544.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/a9/main.PMC4899544.pdf
"1, 1~10, March , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.1.001  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received December  22, 2015, Received in revised form December  29, 2015, Accepted January  8, 2016   † Corresponding Author : Youngki Lee, Dept.",Non-OADS,/arxiv_data1/oa_pdf/42/3b/DR-20-1.PMC4899554.pdf
"1, 11~22, March , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.1.011  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received December 30, 2015, Received in revised form January  8, 2016, Accepted January 15, 2016    † Corresponding Author : Hee-Woong Kang, East Sea Fisheries Research Institute, NIFS,  Gangneung  25435, Korea.",Non-OADS,/arxiv_data1/oa_pdf/40/1b/DR-20-11.PMC4899555.pdf
"1, 23~29, March , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.1.023  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received January 15, 2016, Received in revised form January 22, 2016, Accepted February  1, 2016    † Corresponding Author : Young -Don Lee , Marine Science Institute, Jeju National University , 19-5, Hamdeok 5(o) -gill, Jocheon, Jeju 63333, Korea .",Non-OADS,/arxiv_data1/oa_pdf/4c/b5/DR-20-23.PMC4899556.pdf
"1, 31~40, March , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.1.031  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received February  8, 2016, Received in revised form February  16, 2016, Accepted February 25, 2016    † Corresponding Author : Jae Min Park , Gyeongsangbuk -do Native Fish Business Center, Uiseong 37366, Korea .",Non-OADS,/arxiv_data1/oa_pdf/3f/f3/DR-20-31.PMC4899557.pdf
"1, 51~61, March , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.1.051  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received March  2, 2016, Received in revised form March 8, 2016, Accepted March 14, 2016    † Corresponding Author : Joon Yeong Kwon , Dept.",Non-OADS,/arxiv_data1/oa_pdf/74/59/DR-20-51.PMC4899558.pdf
The amino acid (aa) sequence obtained by  ExPASy Translate Tool ( http://www.expasy.ch/tools/dan.,OADS,/arxiv_data1/oa_pdf/74/59/DR-20-51.PMC4899558.pdf
"1, 63~71, March , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.1.063  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received March 8, 2016, Received in revised form March 14, 2016, Accepted March 1 9, 2016    † Corresponding Author : Young Min Choi , Dept .",Non-OADS,/arxiv_data1/oa_pdf/3f/a8/DR-20-63.PMC4899559.pdf
"[http://dx.doi.org/10.1093/cid/cir181 ] [PMID: 21498385 ] [2] Boleij A, Hechenbleikner EM, Goodwin AC, et al.",OADS,/arxiv_data1/oa_pdf/32/f5/TOMICROJ-10-43.PMC4899560.pdf
"[http://dx.doi.org/10.1093/cid/ciu787 ] [PMID: 25305284 ] [3] Keim PS, Wagner DM.",OADS,/arxiv_data1/oa_pdf/32/f5/TOMICROJ-10-43.PMC4899560.pdf
"[http://dx.doi.org/10.1038/nrmicro2219 ] [PMID: 19820723 ] [4] Ellis J, Oyston PC, Green M, Titball RW.",OADS,/arxiv_data1/oa_pdf/32/f5/TOMICROJ-10-43.PMC4899560.pdf
"[http://dx.doi.org/10.1128/CMR.15.4.631-646.2002 ] [PMID: 12364373 ] [5] Glass RI, Parashar UD, Estes MK.",OADS,/arxiv_data1/oa_pdf/32/f5/TOMICROJ-10-43.PMC4899560.pdf
[http://dx.doi.org/10.1056/NEJMra0804575 ] [PMID: 19864676 ] Lan Hu Center for Food Safety and Applied Nutrition U.S Food and Drug Administration U.S.A Email: lan16686@yahoo.com © Lan Hu; Licensee Bentham Open.,Non-OADS,/arxiv_data1/oa_pdf/32/f5/TOMICROJ-10-43.PMC4899560.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/32/f5/TOMICROJ-10-43.PMC4899560.pdf
"Ahead of   print, available at: http://msj.sagepub.com/content/early/2012/03/02/1352458512438237.abstract [PubMed] 5.",Non-OADS,/arxiv_data1/oa_pdf/64/82/main.PMC4899566.pdf
Available at: http://www.hindawi.com/crim/radiology/2012/363705/ [PubMed]9.,Non-OADS,/arxiv_data1/oa_pdf/64/82/main.PMC4899566.pdf
Available from: http://www.academicjournals.org/ijmms/PDF/pdf2009/Feb/Bhatia%20et%20al.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/d3/main.PMC4899574.pdf
"Bioinformatics analysis, Sanger validation and co-segregation analysis After Illumina HiSeq 2000 sequencing, the low-quality reads and adaptor sequences were ﬁltered out using the Solexa QA package (Massey University, Palmerston North, New Zealand)5and the cutadapt program (http://code.google.com/p/cutadapt/), respectively.",OADS,/arxiv_data1/oa_pdf/60/bc/hgv20169.PMC4899602.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)A novel mutation in COMP causing pseudoachondroplasia H Luo et al 5 © 2016 The Japan Society of Human Genetics Human Genome Variation (2016) 16009",Non-OADS,/arxiv_data1/oa_pdf/60/bc/hgv20169.PMC4899602.pdf
"Retrospective CMA approach A total of 334 genes obtained from published clinical reports, reviews, CMAstudies and the OMIM (Online Mendelian Inheritance in Man) database (http://www.omim.org/) were included in constructing a customized CMA ‘DSD Track ’(Supplementary Table S1; listed by size).",OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
Probe coverage was also veri ﬁed from the Affymetrix website (https://www.affymetrix.com/analysis/netaffx/showresults.affx).,OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
We aligned the CNVs detected from our study with the following tracks from the UCSC Genome Browser21 (http://genome.ucsc.edu/cgi-bin/hgGateway): RefSeq genes; commonCNV data (inclusive and stringent data) by Zarrei et al.,OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
",13obtained from DGV (database of genomic variants; http://dgv.tcag.ca/gb2/gbrowse/dgv2_ hg19/); the ClinGen database, which curates benign, uncertain clinical signiﬁcance likely benign (UCS LB), UCS likely pathogenic (LP), UCS and curated pathogenic genes; DECIPHER22(https://decipher.sanger.ac.uk/); Segmental Duplications; CGIs, UniProt/SwissProt Protein and Secondary Annotations for regions and domains; and Transcription Factor ChIP forpredicted transcription factor binding sites.",OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
"We also aligned our small CNV data set with the WashU Epigenome Browser23(http://epigenomegateway.wustl.edu/browser/) to investigate the following features: RefSeq genes; CGIs; repeat elements; chromHMM ofthe ovary for predicted regulatory regions; H3K27Ac and H3K4me1 of the ovary (histone regions predicted to be regulatory); methylC-seq of the fetaltestis and ovary for DNA methylation (CGI or regulatory); RNA-seq of fetaland adult ovaries for predicted RNA expression; and cis (local) and trans(interchromosomal) interactions (human foreskin ﬁbroblast, high-content genome conformation capture; density map or circle plot representation).",OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
"We also used the following databases for correlating molecular function with the biological processes involved in DSD genes: UniProt (http://www.uniprot.org/), BGee (http://bgee.unil.ch/); GeneMania (http://www.genemania.org/) and STRING (http://string-db.org/) for the genetic and physicalinteractions of these genes.",OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
We investigated 34 genes known to be imprinted (list obtained from the GeneImprint database: http://www.geneimprint.com/) for ROHs and CNVs (Supple- mentary Table S12).,OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
"Genetic ( a) and physical ( b) interactions, pathway associations ( c) and co-expression ( d)o f CTNNB1 with other 125 genes (DSD, imprinted, position effect) with CNVs and ROH (GeneMANIA; http://www.genemania.org/).",OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv).Integrated small CNVs and epigenome maps of DSD IE Amarillo et al 14 Human Genome Variation (2016) 16012 © 2016 The Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/08/51/hgv201612.PMC4899613.pdf
" Case Rep Oncol 2016;9:126 –133  DOI: 10.1159/000443476   Published online: February 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0126$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/f6/49/cro-0009-0126.PMC4899633.pdf
" Case Rep Ophthalmol  2016;7:108 –111  DOI: 10.1159/000444164   Published online: February 20, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0108$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/9c/ea/cop-0007-0108.PMC4899634.pdf
" Case Rep Ophthalmol 2016;7:125 –129  DOI: 10.1159/000444438   Published online: February 26, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/16/0071‒0125$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/54/4a/cop-0007-0125.PMC4899636.pdf
" Case Rep Dermatol 2016;8:26 –30  DOI: 10.1159/000444045   Published online: February 5, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6567/16/0081‒0026$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/c1/ae/cde-0008-0026.PMC4899637.pdf
" Case Rep Oncol 2016;9:106 –111  DOI: 10.1159/000443876   Published online: February 6, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0106$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/58/e9/cro-0009-0106.PMC4899638.pdf
" Case Rep Ophthalmol  2016;7:115 –118  DOI: 10.1159/000444215   Published online: February 24, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0115$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/29/8d/cop-0007-0115.PMC4899639.pdf
" Case Rep Ophthalmol 2016;7:130 –134  DOI: 10.1159/000444077   Published online: February 26, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/16/0071‒0130$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/93/dc/cop-0007-0130.PMC4899640.pdf
" Case Rep Oncol  2016;9:100 –105  DOI: 10.1159/000443633   Published online: February 6, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/16/0091‒0100$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/68/8a/cro-0009-0100.PMC4899643.pdf
http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/estomago/defini cao.,Non-OADS,/arxiv_data1/oa_pdf/68/8a/cro-0009-0100.PMC4899643.pdf
" Case Rep Oncol  2016;9:143 –147  DOI: 10.1159/000443162   Published online: February 20, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/16/0091‒0143$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/bb/f7/cro-0009-0143.PMC4899644.pdf
" Case Rep Dermatol 2016;8:22 –25  DOI: 10.1159/000443950   Published online: February 3, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6567/16/0081‒0022$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/cd/ae/cde-0008-0022.PMC4899645.pdf
" Case Rep Oncol 2016;9:138 –142  DOI: 10.1159/000443726   Published online: February 19, 2016  © 2016 The Author(s)   Published by S. Karger AG,  Basel   1662‒6575/16/0091‒0138$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ef/54/cro-0009-0138.PMC4899646.pdf
" Case Rep Dermatol  2016;8:36 –41  DOI: 10.1159/000444212   Published online: February 13, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/16/0081‒0036$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/e9/fb/cde-0008-0036.PMC4899647.pdf
" Case Rep Ophthalmol  2016;7:112 –114  DOI: 10.1159/000444180   Published online: February 20, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0112$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/62/16/cop-0007-0112.PMC4899648.pdf
" Case Rep Oncol 2016;9:119 –125  DOI: 10.1159/000443724   Published online: February 20, 2016  © 2016 The Au thor(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0119$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicens e).",Non-OADS,/arxiv_data1/oa_pdf/31/cf/cro-0009-0119.PMC4899649.pdf
" Case Rep Ophthalmol  2016;7:103 –107  DOI: 10.1159/000444046   Published online: February 20, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0103$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/a0/eb/cop-0007-0103.PMC4899650.pdf
" Case Rep Neurol  2016;8:53 –58  DOI: 10.1159/000444278   Published online: February 26, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒680X/16/0081‒0053$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/78/eb/crn-0008-0053.PMC4899651.pdf
" Case Rep Dermatol  2016;8:52 –58  DOI: 10.1159/000444317   Published online: February 24, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/16/0081‒0052$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/fb/40/cde-0008-0052.PMC4899652.pdf
" Case Rep Ophthalmol  2016;7:85 –89  DOI: 10.1159/000444163   Published online: February 12, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0085$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/14/bf/cop-0007-0085.PMC4899653.pdf
" Case Rep Ophthalmol 2016;7:90 –95  DOI: 10.1159/000444291   Published online: February 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, B asel  1663‒2699/16/0071‒0090$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/d7/8f/cop-0007-0090.PMC4899654.pdf
" Case Rep Ophthalmol 2016;7:119 –124  DOI: 10.1159/000444437   Published online: February 26, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/16/0071‒0119$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/35/bb/cop-0007-0119.PMC4899655.pdf
" Case Rep Dermatol  2016;8:31 –35  DOI: 10.1159/000444162   Published online: February 6, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/16/0081‒0031$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/8c/a6/cde-0008-0031.PMC4899656.pdf
" Case Rep Oncol 2016;9:134 –137  DOI: 10.1159/000443986   Published online: February 19, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0134$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  Intern ational License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/4b/35/cro-0009-0134.PMC4899657.pdf
" Case Rep Neurol 2016;8:39 –46  DOI: 10.1159/000444167   Published online: February 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒680X/16/0081‒0039$39.50/0   www.karger.com/crn   This article is licensed under th e Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/07/25/crn-0008-0039.PMC4899658.pdf
" Case Rep Ophthalmol  2016;7:96 –102  DOI: 10.1159/000444213   Published online: February 23, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0096$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/12/da/cop-0007-0096.PMC4899659.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: February 17, 2016 EXTRA  Takahiko Kawamura, MD, PhD   Center for Preventive Medicine, Chubu Rosai Hospital   1-10-6 Komei, Minato-ku   Nagoya 455-8530 (Japan)   E-Mail kawamura.hsc   @   chubuh.rofuku.go.jp www.karger.com/dee DOI: 10.1159/000443497  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/32/42/dee-0006-0055.PMC4899660.pdf
" Case Rep Dermatol 2016;8:42 –51  DOI: 10.1159/000443696   Published online: February 13, 2016  © 2016 Th e Author(s)   Published by S. Karger AG, Basel   1662‒6567/16/0081‒0042$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/c3/73/cde-0008-0042.PMC4899661.pdf
" Case Rep Neurol 2016;8:47 –52  DOI: 10.1159/000443787   Published online: February 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒680X/16/0081‒0047$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ff/bc/crn-0008-0047.PMC4899662.pdf
"Online:  http://www.myelitis.org/newsletters/j1/journal-1-11.htm, last accessed August 18, 2012.",Non-OADS,/arxiv_data1/oa_pdf/57/56/main.PMC4899667.pdf
2006; 39  (5): 396-399. http://jkns.or.kr/htm/abstract.asp?no=0042006077&m=0 06/06/2012Brachial plexus tumor simulating an axillary metastasis from breast carcinoma RCR  Radiology Case Reports | radiology.casereports.net 4 2012 | Volume 7 | Issue 3,Non-OADS,/arxiv_data1/oa_pdf/96/ea/main.PMC4899669.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: February 17, 2016 EXTRA  Dr. Dennis Chuen Chai Seow    Department of Geriatric Medicine   Singapore General Hospital   Singapore 169608   E-Mail dennis.seow.c.c   @   sgh.com.sg www.karger.com/dee DOI: 10.1159/000442382  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/42/34/dee-0006-0043.PMC4899677.pdf
1999 April; 92(4): 159-163.  http://www.ncbi.nlm.nih.gov/pubmed?term=PMC12 97135   14.,OADS,/arxiv_data1/oa_pdf/d0/00/main.PMC4899682.pdf
2000 August 22;  163(4): 429-31. http://www.ncbi.nlm.nih.gov/pubmed?term=PMC80 379 17.,Non-OADS,/arxiv_data1/oa_pdf/d0/00/main.PMC4899682.pdf
"January 3, 2008.  http://faoj.org/2008/01/03/editorial-elements-of-a-case-report/.",Non-OADS,/arxiv_data1/oa_pdf/d0/00/main.PMC4899682.pdf
Available at: http://www.samhsa.gov/  2.,Non-OADS,/arxiv_data1/oa_pdf/6b/eb/main.PMC4899805.pdf
(http://www.pearsonclinical.com/childhood/products/100000123/bay-ley-scales-of-infant-and-toddler-development-third-edition-bayley-iii.html.),Non-OADS,/arxiv_data1/oa_pdf/be/23/pr201632a.PMC4899820.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Volume 79  |  N umber 6  |  June 2016       Pediatric ReSeARCh  869",Non-OADS,/arxiv_data1/oa_pdf/be/23/pr201632a.PMC4899820.pdf
"Last date of  access: Nov 19, 2011. http://www.uptodate.com/contents/radiologic-evaluation-of-the-painful-hip-in-adults   2.",Non-OADS,/arxiv_data1/oa_pdf/08/61/main.PMC4899855.pdf
"Last date of  access: November 19, 2011. http://www.uptodate.com/contents/musculoskeletal-changes-and-pain-during-pregnancy  12.",Non-OADS,/arxiv_data1/oa_pdf/08/61/main.PMC4899855.pdf
"Last date of  access: November 19, 2011. http://www.uptodate.com/contents/epidemiology-and-etiology-of-premenopausal-osteoporosis  17.",Non-OADS,/arxiv_data1/oa_pdf/08/61/main.PMC4899855.pdf
Indian J Radiol Imaging  2002; 12:399-401.  http://www.ijri.org/text.asp?2002/12/3/399/28493 .,Non-OADS,/arxiv_data1/oa_pdf/fc/64/main.PMC4899877.pdf
[http://www.ispub.com/journal/the_internet_journal_of_pathology/volume_7_number_1_10/article/ischemic_fasciitis_unusual_location_and_presentation.html] 5.,Non-OADS,/arxiv_data1/oa_pdf/85/ea/main.PMC4899984.pdf
26]; Available from: http://en.wikipedia.org/wiki/Batting_(cricket)  13.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/main.PMC4900047.pdf
"(Image courtesy of the University of Washington Musculo-skeletal Atlas [http://www.rad.washington.edu/academics/academic-sectio ns/msk/muscle-atlas] , and is used with permission).",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/main.PMC4900047.pdf
http://ghr.nlm.nih.gov/condition/cystic-ﬁbrosis Up-dated October 2010.,Non-OADS,/arxiv_data1/oa_pdf/e2/83/main.PMC4900058.pdf
1992  June;4(3):389-519. http://journals.lww.com/co-pediatrics/Abstract/1992/06000/Recent_advances_in_cystic_ﬁbrosis.2.aspx Last accessed Dec 2010.,Non-OADS,/arxiv_data1/oa_pdf/e2/83/main.PMC4900058.pdf
http://www.genet.sickkids.on.ca/Home.html  Last ac- cessed Dec 2010  7.,Non-OADS,/arxiv_data1/oa_pdf/e2/83/main.PMC4900058.pdf
http://www.indianjmedsci.org/text.asp?2004/58/5/2 06/8296.,Non-OADS,/arxiv_data1/oa_pdf/2c/27/main.PMC4900059.pdf
"In: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2010. http://www.uptodate.com/online/content/topic.do?topicKey=thyroid/13843&view=print .",Non-OADS,/arxiv_data1/oa_pdf/2c/27/main.PMC4900059.pdf
Available at: http://www.kbdfoundation.org/aboutus_kashin_beckdisease.htm.,Non-OADS,/arxiv_data1/oa_pdf/15/0c/main.PMC4900063.pdf
Available from http://www.ankletightrope.com/easyedit/ﬁles/ac%20j oint%20tightrope%20brochure.pdfTightRope ﬁxation of complex acromioclavicular separation: A high-wire act RCR  Radiology Case Reports | radiology.casereports.net 3 2011 | Volume 6 | Issue 3Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/90/a6/main.PMC4900064.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribut ion-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.UPSALA JOURNAL OF MEDICAL SCIENCES, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/b9/7e/iups-121-71.PMC4900074.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any me dium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.UPSALA JOURNAL OF MEDICAL SCIENCES, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/15/10/iups-121-151.PMC4900077.pdf
"2, 151–154http://dx.doi.org/10.3109/03009734.2016.1165776",Non-OADS,/arxiv_data1/oa_pdf/15/10/iups-121-151.PMC4900077.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1162037Sir—We read with a great interest the recent paper by Jacobs  et al.,Non-OADS,/arxiv_data1/oa_pdf/f6/88/iort-87-318.PMC4900078.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1152450Background and purpose —  Coronal and sagittal plane long bone  deformities can be corrected with guided growth, whereas trans- verse plane rotational deformities require osteotomy and internal  or external ﬁ  xation.",Non-OADS,/arxiv_data1/oa_pdf/f4/7b/iort-87-301.PMC4900079.pdf
This is an Open Access article distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1141631Background and purpose —  The safety aspects of bilateral simul - taneous total knee arthroplasty (BSTKA) are still debated.,Non-OADS,/arxiv_data1/oa_pdf/95/47/iort-87-286.PMC4900080.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1170548Background and purpose —  Knee pain after total knee arthro- plasty (TKA) is not uncommon.,Non-OADS,/arxiv_data1/oa_pdf/9f/a5/iort-87-274.PMC4900081.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1161451Background and purpose —  Assessment of potential disparities  in access to care is a vital part of achieving equity in health and  healthcare.,Non-OADS,/arxiv_data1/oa_pdf/1c/c8/iort-87-245.PMC4900082.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1151122Background and purpose —  There are limited data on risk factors  for avascular necrosis of the hip, but cirrhosis has been proposed  as a risk factor.",Non-OADS,/arxiv_data1/oa_pdf/d7/00/iort-87-231.PMC4900083.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/d7/00/iort-87-231.PMC4900083.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1166876Background and purpose —  There is a general call for phased  introduction of new implants, and one step in the introduction is  an early evaluation of micromotion.",Non-OADS,/arxiv_data1/oa_pdf/7a/22/iort-87-262.PMC4900084.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1155130Background and purpose —  Acute kidney injury (AKI) is associ- ated with increased short-term and long-term mortality in inten- sive care populations and in several surgical specialties, but there  are very few data concerning orthopedic populations.",Non-OADS,/arxiv_data1/oa_pdf/6b/87/iort-87-235.PMC4900085.pdf
2014. http://www.usrds.org/2014/ download/V1_Ch_i_Intro_14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/87/iort-87-235.PMC4900085.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2015.1137182Background and purpose —  In hip arthroplasty, acetabular  inclination and anteversion—and also femoral stem torsion—are  generally assessed by eye intraoperatively.",Non-OADS,/arxiv_data1/oa_pdf/09/7d/iort-87-225.PMC4900086.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1152853Background and purpose —  Biodegradable cement restrictors  are widely used in hip arthroplasty.,Non-OADS,/arxiv_data1/oa_pdf/2c/91/iort-87-239.PMC4900087.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1153359Background and purpose —  Results from case-control studies of  maternal age at conception and risk of idiopathic clubfoot have  been inconsistent.,Non-OADS,/arxiv_data1/oa_pdf/de/d9/iort-87-291.PMC4900088.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1156932Sir—I read with interest the paper by Davda et al.,Non-OADS,/arxiv_data1/oa_pdf/2b/89/iort-87-314.PMC4900089.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1173982Background and purpose —  Total knee arthroplasty (TKA) may  cause postoperative periprosthetic bone loss due to stress shield- ing.,Non-OADS,/arxiv_data1/oa_pdf/76/43/iort-87-268.PMC4900090.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1167524Background and purpose —  Historically, high 30-day and 1-year  mortality post-amputation rates (> 30% and 50%, respectively)  have been reported in patients with a transtibial or higher  non-traumatic lower extremity amputation (LEA).",Non-OADS,/arxiv_data1/oa_pdf/3a/a3/iort-87-306.PMC4900091.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1155253Background and purpose —  It has been suggested that preopera- tive posterior tilt of the femoral head may increase the risk of ﬁ  xa- tion failure in Garden-I and -II femoral neck fractures.,Non-OADS,/arxiv_data1/oa_pdf/a0/31/iort-87-252.PMC4900092.pdf
The DAG diagram  was drawn with DAGitty version 2.3 (http://www.dagitty.net;   Textor et al.,OADS,/arxiv_data1/oa_pdf/a0/31/iort-87-252.PMC4900092.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2015.1135662Background and purpose —  Although the results of primary total  hip replacements (THRs) are generally excellent, sometimes seri- ous complications arise.",Non-OADS,/arxiv_data1/oa_pdf/60/b9/iort-87-209.PMC4900093.pdf
Available  from: http://www.pvk.ﬁ  /en/Statistics/.,OADS,/arxiv_data1/oa_pdf/60/b9/iort-87-209.PMC4900093.pdf
Available from: http://www.julkari.ﬁ  /handle/10024/120409.,Non-OADS,/arxiv_data1/oa_pdf/60/b9/iort-87-209.PMC4900093.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1152855Background and purpose —  Childhood fractures are associated  with lower peak bone mass (a determinant of osteoporosis in old  age) and higher adult fracture risk.,Non-OADS,/arxiv_data1/oa_pdf/87/76/iort-87-296.PMC4900094.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1162898Background and purpose —  Recent studies have demonstrated  a high incidence of postoperative periprosthetic femoral fracture  (PPF) in elderly patients treated with 2 commonly used cemented,  polished tapered stems.",Non-OADS,/arxiv_data1/oa_pdf/33/ba/iort-87-257.PMC4900095.pdf
2014; 196.  http://www.shpr.se/sv/Publications/DocumentsReports.aspx.,Non-OADS,/arxiv_data1/oa_pdf/33/ba/iort-87-257.PMC4900095.pdf
2015. http://www.shpr.,Non-OADS,/arxiv_data1/oa_pdf/33/ba/iort-87-257.PMC4900095.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1161453Sir—We read the study of Tilbury et al.,Non-OADS,/arxiv_data1/oa_pdf/62/77/iort-87-312.PMC4900096.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2016.1156934Background and purpose —  When evaluating the outcome after  total knee arthroplasty (TKA), increasing emphasis has been put  on patient satisfaction and ability to perform activities of daily  living.",Non-OADS,/arxiv_data1/oa_pdf/0e/1f/iort-87-280.PMC4900097.pdf
"This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.3109/17453674.2015.1135664Background and purpose —  In preparing patients for total hip  replacement surgery, providing thorough information helps to  reduce anxiety, manage postoperative pain, prevent complica- tions, and better engage patients in their rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/2a/44/iort-87-218.PMC4900098.pdf
"Garellick G, Rogmark C, Kärrrholm J, Rolfson O. Swedish Hip Arthroplasty  Register, Annual Report 2012.  http://www.shpr.se.",OADS,/arxiv_data1/oa_pdf/2a/44/iort-87-218.PMC4900098.pdf
http://www.skl.,Non-OADS,/arxiv_data1/oa_pdf/2a/44/iort-87-218.PMC4900098.pdf
Available at: http://seer.cancer.gov/csr/1975_2001/.,Non-OADS,/arxiv_data1/oa_pdf/da/97/main.PMC4900114.pdf
"Frontiers in Psychology, 6, 1070, http://doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/i1534-7362-16-6-15.PMC4900139.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–4 DOI: 10.1177/2054270415623145",Non-OADS,/arxiv_data1/oa_pdf/1e/fd/10.1177_2054270415623145.PMC4900196.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–6 DOI: 10.1177/2054270416632702",Non-OADS,/arxiv_data1/oa_pdf/31/5b/10.1177_2054270416632702.PMC4900198.pdf
2009 https://www.dh.gov.uk/en/Publicationandsatattistics/Publiactions/ DH101398.,Non-OADS,/arxiv_data1/oa_pdf/31/5b/10.1177_2054270416632702.PMC4900198.pdf
http://www.surgeongeneral.gov/topics/deepvein.,Non-OADS,/arxiv_data1/oa_pdf/31/5b/10.1177_2054270416632702.PMC4900198.pdf
2005 http://www.publications.,Non-OADS,/arxiv_data1/oa_pdf/31/5b/10.1177_2054270416632702.PMC4900198.pdf
https://dh.gov.uk/en/Publicationsandstattistics/Publications PolicyAndGuidance/DH_088215.,Non-OADS,/arxiv_data1/oa_pdf/31/5b/10.1177_2054270416632702.PMC4900198.pdf
"DH, 2008. https://dh.gov.uk/en/Publicationsandstattistics/PublicationsPolicyAndGuidance/DH_091443.22.",Non-OADS,/arxiv_data1/oa_pdf/31/5b/10.1177_2054270416632702.PMC4900198.pdf
[http://news.bbc.co.uk /1/hi/health/8382584.stm].,Non-OADS,/arxiv_data1/oa_pdf/31/5b/10.1177_2054270416632702.PMC4900198.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/91/2c/10.1177_2054270416635036.PMC4900203.pdf
"With a 1http://kepler.nasa.gov as of May 10, 2016 1NSF Astronomy and Astrophysics Postdoctoral Fellow, UC President’s Postdoctoral Program Fellow, Department of Physics and Astronomy, University of California, Los Angeles, and Harvard-Smithsonian Center for Astrophysics, Cambridge, Massachusetts.",Non-OADS,/arxiv_data1/oa_pdf/79/57/ast.2015.1353.PMC4900229.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ASTROBIOLOGY Volume 16, Number 6, 2016Mary Ann Liebert, Inc.DOI: 10.1089/ast.2015.1353 443",Non-OADS,/arxiv_data1/oa_pdf/79/57/ast.2015.1353.PMC4900229.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF WOMEN’S HEALTH Volume 25, Number 6, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jwh.2015.5708 606",Non-OADS,/arxiv_data1/oa_pdf/81/e1/jwh.2015.5708.PMC4900245.pdf
"Available at http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf Ac- cessed March 21, 2016.",OADS,/arxiv_data1/oa_pdf/81/e1/jwh.2015.5708.PMC4900245.pdf
Available at: http://seer.cancer.gov/csr/1975_ 2012/.,Non-OADS,/arxiv_data1/oa_pdf/81/e1/jwh.2015.5708.PMC4900245.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Inheritancem.3243A NG mutation Mitochondrial myopathy, encephalopathy, lac- tate acidosis and stroke-like episodes (MELAS) Maternally inherited diabetes and deafness(MIDD)Genetic counselling 1.",Non-OADS,/arxiv_data1/oa_pdf/69/25/main.PMC4900294.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.04.007 2214-6474/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/69/25/main.PMC4900294.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/25/main.PMC4900294.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: GlycosaminoglycanJoint-space-narrowingKellgren –Lawrence score Knee-osteoarthritis Radiography Synovial- ﬂuid 1.,Non-OADS,/arxiv_data1/oa_pdf/f8/a3/main.PMC4900295.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.05.002 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/a3/main.PMC4900295.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/a3/main.PMC4900295.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/5c/main.PMC4900296.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.05.014 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/5c/main.PMC4900296.pdf
"[4] M. Saf ﬁ, N. Howard, Exploring the effectiveness of mandatory premarital screening and genetic counselling programmes for b-thalassaemia in the Middle East: a scoping review, Public Health Genomics 18 (4) (2015) 193e203, http://dx.doi.org/10.1159/000430837 .",Non-OADS,/arxiv_data1/oa_pdf/3a/5c/main.PMC4900296.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Wheelchair usersSpinal cord injuryBiomarkersPhysical activityReactive oxygen species (ROS) 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.05.001 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"22 (2012) 161 –200, http://dx.doi.org/10.4081/ejtm.2012.1799 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Yakura, De ﬁnition of complete spinal cord injury, Paraplegia 29 (1991) 573 –581, http://dx.doi.org/10.1038/sc.1991.85 .",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"54 (1977) 251 –265, http://dx.doi.org/ 10.1016/0014-4886(77)90268-0 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Van Asten, B. Oeseburg, R.A. Binkhorst, Properties of the venous vascular system in the lower extremities of individuals with paraplegia, Paraplegia 32 (1994) 810 –816, http://dx.doi.org/10.1038/sc.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"388 (1996) 379 –383, http://dx.doi.org/ 10.1007/978-1-4613-0333-6_50 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"72 (1992) 1393 –1400, http://dx.doi.org/10.1002/mus.21746 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"77 (1996) 1260 –1265, http://dx.doi.org/10.1016/S0003- 9993(96)90190-2 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"80 (1999) 373 –378, http://dx.doi.org/10.1016/j.jelekin.2013.04.007 .9 E.J.R.",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Duddley, Surface electrical stimulation of skeletal muscle after spinal cord injury, Spinal Cord 37 (1999) 251 –257, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Fox, D. Grundy, I. Swain, Limb blood ﬂow, cardiac output and quadriceps muscle bulk following spinal cord injury and the effect of training for the Odstock functional electrical stimulation standing system, Paraplegia 31 (1993) 303 –310, http://dx.doi.org/10.1038/sc.1993.54 .",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"92 (2002) 2335 –2340, http://dx.doi.org/10.1152/japplphysiol.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"35 (2003) 901 –907, http://dx.doi.org/10.1249/01.MSS.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"23 (1997) 48–60,http://dx.doi.org/10.2165/00007256-199723010-00005 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Krassioukov, Orthostatic hypertension following spi- nal cord injury: understanding clinical pathophysiology, Spinal Cord 44 (2006)341 –351, http://dx.doi.org/10.1038/sj.sc.3101855 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Tun, D. Gagnon, R. Brown, A pro- spective assessment of mortality in chronic spinal cord injury, Spinal Cord 43 (2005) 408 –416, http://dx.doi.org/10.1038/sj.sc.3101729 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"80 (1999) 1411 –1419, http://dx.doi.org/10.1016/S0003-9993(99)90252-6 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"35 (2003) 1977 –1985, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"41 (3) (2007) 194 –197, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"2 (1964) 287 –298, http://dx.doi.org/ 10.1038/sj.sc.3101855 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"592 (2014) 1727 –1728, http://dx.doi.org/10.1113/jphysiol.2014.272666 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"81 (2006) 264 – 270, http://dx.doi.org/10.1590/S0066- 782X2006001900029 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"30 (2007) 5 –9,http://dx.doi.org/10.1016/j.apmr.",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
15 (1996) 1753 –1765 ( http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"32 (2004) 14 –18, http://dx.doi.org/10.1051/sm/2010013 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"351 (2011) 251 –259, http://dx.doi.org/10.1007/s11010-011- 0732-6 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Dudley, Blood ﬂow response in individuals with incom- plete spinal cord injuries, Spinal Cord 40 (2002) 639 –645, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"302 (1980) 987 –991, http://dx.doi.org/10.1056/ NEJM198005013021802 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"108 (1998) 101 –106, http://dx.doi.org/10.1385/0-89603-472-0:107 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"154 (4) (2001) 348 –356, http://dx.doi.org/10.1093/aje/154.4.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"41 (2006) 1044 –1049, http://dx.doi.org/10.1007/ s00228-008-0602-7 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"53 (2012) 701 –709, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"43 (2007) 645 –657, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"1 (2005) 290 –297, http://dx.doi.org/10.1038/nchembio734 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"40 (2006) 295 –302, http://dx.doi.org/10.1016/j.freeradbiomed.2005.08.025 .",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"188(2006) 123 –127, http://dx.doi.org/10.1111/j.1748-1716.2006.01612.x .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Mysiw, Muscle atrophy is prevented in patients with acute spinal cord injury using functional electrical stimulation, Spinal Cord 36 (1998) 463 –469, http://dx.doi.org/10.1038/sj.sc.3100679 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"[50] E. Wilmet, A.A. Ismail, A. Heilporn, D. Welraeds, P. Bergmann, Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section,Paraplegia 33 (1995) 674 –677, http://dx.doi.org/10.1038/sc.1995.141 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"19 (1987) (1987) 195 –201, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"[52] M. Ide, H. Ogata, M. Kobayashi, F. Tajima, K. Hatada, Anthropometric features of wheelchair marathon race competitors with spinal cord injuries, Paraplegia 32(1994) 174 –179, http://dx.doi.org/10.1038/sc.1994.31 .",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Pierson Jr., Measurement of body fat in individuals with tetraplegia: a comparison of eight clinical methods, Paraplegia 33 (1995) 402 –408, http://dx.doi.org/10.1038/sc.1995.90 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"95 (2003) 2398 –2407, http://dx.doi.org/ 10.1152/japplphysiol.00729.2002 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"31 (2006) 283 –291, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"The Caerphilly and Speedwell collaborative heart disease studies, Circulation 83 (1991) 836 –844, http://dx.doi.org/10.1161/01.CIR.83.3.836 .10 E.J.R.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"The Framingham study, JAMA 258 (1987) 1183 –1186, http://dx.doi.org/10.1001/jama.1987.03400090067035 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Sheridan, A.S. Wolberg, Contribu- tions of extravascular and intravascular cells to ﬁbrin network formation, struc- ture, and stability, Blood 114 (2009) 4886 –4896, http://dx.doi.org/10.1182/ blood-2009-06-228940 .",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"114 (2012) 275 –285, http://dx.doi.org/10.1213/ANE.0b013e31823a088c .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"38 (2013)507 –511, http://dx.doi.org/10.1139/apnm-2012-0302 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"100 (2) (2007) 235 –239, http://dx.doi.org/10.1007/s00421-007- 0423-x .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"40 (3) (2006) 214 –218, http://dx.doi.org/10.1136/bjsm.2005.020099 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"222 (1999) 283 –292, http://dx.doi.org/10.1016/S0300-483X(03)00151-3 .",OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"79 (1995) 675 –686, http://dx.doi.org/10.5455/oams.010413.rv.005 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"15 (1997) 353 –663, http://dx.doi.org/10.1080/026404197367362 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Sen, L. Packer, O. Hanninen, Exercise and Oxygen Toxicity, Elsevier, Amsterdam, 1994 522 –527, http://dx.doi.org/10.1249/00005768-199512000- 00023 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"959 (2002) 82 –92, http://dx.doi.org/10.1111/j.1749-6632.2002.tb02085.x .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"75 (1993) 566 –572, http://dx.doi.org/10.1007/s00421-011-2175-x .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"26 (1994) 1252 –1261, http://dx.doi.org/10.1249/00005768-199410000- 00012 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"80 (1970) 61 –72,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"95 (2003) 1139 –1144, http://dx.doi.org/10.1152/japplphysiol.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"279 (2000) R440 –R447, http://dx.doi.org/10.1249/MSS.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"84 (1998) 1756 –1762, http://dx.doi.org/10.1249/MSS.0b013e31822a68a5 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"37 (1977) 53 –58, http://dx.doi.org/10.3109/00365517709108803 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Dudley, Blood ﬂow response in individuals with incom- plete spinal cord injuries, Spinal Cord 40 (2002) 640 –646, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"17 (1963) 327 –349, http://dx.doi.org/10.1083/jcb.17.2.327 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"73 (1998) 20 –36, http://dx.doi.org/10.1016/0014- 4886(81)90042-X .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"32 (1960) 33 –83, http://dx.doi.org/10.3389/fphys.2015.00063 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"34 (1964) 171 –181, http://dx.doi.org/10.1038/1961101a0 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"47 (1965) 315 –323, http://dx.doi.org/10.1016/S0065-2423(08)60150-X .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"29 (2010) 1774 –1785, http://dx.doi.org/10.1038/emboj.2010.60 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"300 (2011) C138 –C145, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"102 (2007) 1143 –1151, http://dx.doi.org/10.1152/japplphysiol.00768.2006 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"Langille, F. O'Donnell, Reductions in arterial diameter produced by chronic de- creases in blood ﬂow are endothelium dependent, Science 231 (1986) 405 –407, http://dx.doi.org/10.1126/science.3941904 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"101 (4) (1998) 731 –736, http://dx.doi.org/10.1172/JCI1699 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"28 (2008) 2101 –2107, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"11 (2009) 1651 –1667, http://dx.doi.org/10.1089/ars.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"11 (2009) 1699 –1709, http://dx.doi.org/10.1089/ars.2008.2408 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"21 (2014) 3, http://dx.doi.org/10.1186/1423-0127-21-3 .",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
"18 (2013) 623 –630, http://dx.doi.org/10.1007/ s10741-012-9353-8 .11 E.J.R.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/main.PMC4900297.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/91/main.PMC4900299.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.05.0042214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/61/91/main.PMC4900299.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/91/main.PMC4900299.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–3 DOI: 10.1177/2054270416643891",Non-OADS,/arxiv_data1/oa_pdf/b4/21/10.1177_2054270416643891.PMC4900300.pdf
"To  perform receiver operating characteristic curve analysis  and comparison situation, task, action, result tool was  used	(http://protein.bio.puc.cl/star/home.php).",OADS,/arxiv_data1/oa_pdf/5f/fc/ACA-18-39.PMC4900313.pdf
Available from: From:  https://www.vidanthealth.com/vidant/ newsroomdetail.aspx?id=5202.,Non-OADS,/arxiv_data1/oa_pdf/6a/b4/ACA-18-58.PMC4900322.pdf
Available from: http://www.medscape.com/ viewarticle/803339.,Non-OADS,/arxiv_data1/oa_pdf/6a/b4/ACA-18-58.PMC4900322.pdf
The trial was registered  with the ISRCTN Register: ISRCTN43298975‑http://www.controlled‑trials.com/ISRCTN43298975/.,Non-OADS,/arxiv_data1/oa_pdf/25/b1/ACA-18-45.PMC4900327.pdf
Available from: http://www.cobas.com/ home/product/multiplate‑analyzer.html.,Non-OADS,/arxiv_data1/oa_pdf/25/b1/ACA-18-45.PMC4900327.pdf
Available from: http://www.nature.com/ authors/policies/peer_review.html.,Non-OADS,/arxiv_data1/oa_pdf/91/93/ACA-18-1.PMC4900328.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/52/b1/10.1177_2325967116650432.PMC4900331.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/59/ea/10.1177_2058460116647213.PMC4900332.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/9f/25/10.1177_2325967116649901.PMC4900333.pdf
